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Abstract
Antimicrobial peptides (AMPs) are important components of the innate immune
systems of many different organisms. Their amphipathic and cationic charac-
teristics promote interactions with the cell membrane. Gad peptides are rich in
histidine, and thus have the potential to exhibit pH-dependent activity. The ma-
jor focus of this study was to understand how Gad peptides interact with model
lipid membranes and how these interactions depend on the peptides’ overall charge
and the composition of the model membranes. 2H NMR spectroscopy was used
to study the effect of Gad peptides on lipid acyl chain order of model lipid bilay-
ers at different pH values. 2H NMR results revealed that membrane disruption
by Gad peptides was not pH-dependent. Zeta potential measurements were used
to study the binding of Gad peptides to model lipid membranes. The binding
studies showed that for both Gad-1 and Gad-2 at low pH, less peptide binds to
the membrane and the peptide interacts with a larger number of lipid molecules.
Experiments performed with model membranes containing cardiolipin (CL) in the
presence of Gad-1 showed that the presence of CL allows the membrane to accom-
modate more Gad-1. In the presence of CL the peptide binds more strongly with
the membrane and interacts with a larger number of lipids. Taken together, these
results suggest that Gad peptides might disrupt membrane integrity by cluster-
ing anionic lipids. Clustering of anionic lipids away from zwitterionic lipids by
cationic AMPs might be a contributing mechanism, which does not exclude other
mechanisms, including the carpet mechanism and pore formation. The chemical
shift values of 15N NMR spectroscopy can give an insight about the positioning
of peptides in lipid bilayer surfaces. 15N NMR observations showed that Gad-1
aligned parallel to the membrane surface. The study of AMP-membrane interac-
tions will help to identify criteria to recognize the important features of natural
ii
iii
AMP sequences involved in the antimicrobial action and thus assist in the design of
AMP-based antibiotics to help overcome the problem of antimicrobial resistance.
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Chapter 1
Introduction
Antimicrobial peptides (AMPs) are an integral component of many organisms’
innate immune systems. To help overcome the problem of antimicrobial resistance,
AMPs are currently being considered as potential alternatives for conventional
antibiotics. AMPs interact with cell membranes as a part of their mechanism [1, 2].
AMPs can perturb membrane organization in many different ways depending on
the properties of a peptide as well as on the nature of the membrane [3]. The main
focus of this study was to investigate the interactions of Gad peptides, which are
histidine-rich AMPs, with model membranes at different pH values. This chapter
starts with the introduction of biological and model membranes and goes on with
the description of structure, properties, and modes of action of AMPs.
1
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1.1 Biological and model membranes
Membranes are barriers which give cells their outer boundary (plasma membrane)
and inner compartments (organelles). More than just a covering, biological mem-
branes play a fundamental role in many cellular processes. Membranes are selec-
tively permeabale and able to regulate what enters and exits the cell. Cell mem-
branes mainly consist of three components: lipids, proteins, and carbohydrates.
All membranes have a common general structure consisting of lipid bilayers with
proteins embedded in them [4]. Lipid bilayers are the fundamental components of
these membranes formed by a double layer of lipids, with the polar ends pointing
outwards and the non-polar ends pointing inwards. A schematic representation of
the general membrane structure is shown in Figure 1.1. Membrane lipids are am-
Figure 1.1: A simplified view of membrane structure: lipid bilayer and protein
embedded in it. Membrane curvature is also illustrated here.
phiphilic, i.e, they are composed of hydrophilic (water loving/polar) head groups
and hydrophobic (water avoiding/non-polar) tails. Depending on their molecular
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shapes, lipid molecules form structures of different intrinsic curvature. Quantita-
tively, the nature of intrinsic curvature of a bilayer composed of single lipid species
can be described by the packing parameter (P)
P = V
L× A (1.1)
where V is the volume of a lipid molecule, L is the length of a lipid molecule,
and A is the cross-sectional area of the lipid head group [5]. The value of P and
corresponding intrinsic curvature of lipid bilayers is given in Table 1.1.
Packing parameter Intrinsic curvature Lipid
= 1 zero POPC(1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine)
< 1 positive lyso POPC(1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine)
> 1 negative POPE(1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine)
Table 1.1: The value of packing parameter determines the nature of intrinsic
curvature adopted by a lipid structure. Three possible values of packing parameter
and the corresponding intrinsic curvature of a lipid structures are listed.
When the cross-sectional areas of head group and acyl chain are the same, lipids
can be represented as a cylinder. Cylindrical lipids pack well in bilayer structures
which have zero intrinsic curvature. If a lipid’s head group area is larger than its
acyl chain area, it will fill a conical space. Conical lipids cluster together in the
form micelles with their wider head groups curved around the smaller tails. These
micelles have positive intrinsic curvature. On the other hand, if a lipid’s head
group area is smaller than its acyl chain area, it can be seen as an inverse cone
[6]. The inverted conical lipids have a propensity to form inverted micelles with
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negative intrinsic curvature. In this case, layers are curved with lipid head groups
on the inside of the curve and tail regions on the outside of the curve. Different
shapes of individual lipids and corresponding membrane curvature are shown in
Figure 1.2.
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Figure 1.2: The schematic representation of the different shapes of lipid molecules
and corresponding membrane assemblies with different intrinsic curvature. This
figure is adapted from Haney et al. [6] and reprinted with permission from Elsevier.
Any single membrane can contain hundreds of distinct lipids and the lipid bi-
layer forms a stable structure in which proteins can work. The lipid composi-
tions of eukaryotic (human, animals, plants, and fungi) and prokaryotic (bacterial)
membranes are different from each other. Eukaryotic cell membranes are mainly
composed of zwitterionic lipids (they are neutral in charge but contain positive
and negative charge separation in the headgroup) while prokaryotic cell mem-
branes have a high proportion of anionic (negatively charged) lipids. Eukaryotic
membranes are rich in POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine),
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sphingomyelin, and cholesterol, whereas prokaryotic membranes contain POPE (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), POPG(1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-rac-glycerol), and cardiolipin (1’,3’-bis[1,2-dimyristoyl-sn-glycero-
3-phospho]-sn-glycerol ). The lipid compositions of various bacteria are given in
Table 1.2.
Bacterial species CL(% of totallipids by weight)
PG(% of total
lipids by weight)
PE(% of total
lipids by weight)
Gram-negative bacteria
Escherichia coli 5 15 80
Escherichia
cloacae 3 21 74
Yersinia
kristensenii 20 20 60
Proteus mirabilis 5 10 80
Klebsiella
pneumoniae 6 5 82
Pseudomonas
aeruginosa 11 21 60
Gram-positive bacteria
Staphylococcus
aureus 42 58 0
Streptococcus
pneumonia 50 50 0
Bacillus cereus 17 43 40
Bacillus
polymyxa 8 3 60
Table 1.2: The lipid composition of various Gram-positive and Gram-negative
bacteria. Table is adapted from Wang et. al [7] and reused with permission from
Elsevier.
Biological membranes are very complex in nature but model membranes, which
are composed of synthetic lipids, can be used to mimic the essential components
of cell membranes. Such model membranes can be composed entirely of one type
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of lipid or of a mixture of lipids, and poly-peptides can be added to them to study
lipid-protein interactions and their effects on protein function [8, 9].
1.2 Antimicrobial peptides (AMPs)
1.2.1 AMPs background
AMPs are an integral component of the innate immune system and interact with
the membrane as a part of their mechanism. They are naturally produced by
various organisms, including humans, invertebrate animals, plants, and microbes.
For example, frog skin is a source of more than 300 different AMPs [10–15]. These
AMPs form the first line of defense against invading pathogens and can have a
broad spectrum of activity against bacteria, viruses, fungi, parasites, and some-
times against cancer cells. Based on their target, AMPs can be categorized as
antibacterial, antivirus, antifungal, antiparasite, and anticancer peptides. Gener-
ally, AMPs consist of ∼10-50 amino acid residues and are very diverse in sequence.
This diversity reflects the adaptation of AMPs to act specifically against partic-
ular microbial membrane compositions. In spite of this diversity, most AMPs
have certain features in common: positive charge and hydrophobicity. The over-
all positive charge derives from the presence of arginine, lysine, and histidine. A
significant proportion of AMP amino acid residues, such as alanine, valine, and
leucine, are hydrophobic/non-polar. These features make AMPs well suited to
interact with membranes, via both the hydrophilic head groups and hydrophobic
core [10, 13, 16–18]. A structural feature common to most AMPs is that they
are unstructured in aqueous solution and adopt an amphipathic secondary struc-
ture (separate hydrophobic and hydrophilic patches) upon interaction with the
membrane [13, 15, 16, 18]. Based on their secondary structure, AMPs can be
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divided into different groups. The largest group corresponds to α-helical peptides.
The second group consists of AMPs which make stable β-sheets upon interacting
with membranes and may contain disulphide bonds. The third group represents
extended AMPs which are predominately rich in specific amino acid such as pro-
line, histidine, and arginine. These AMPs may not have any regular secondary
structure elements. The fourth group corresponds to AMPs which adopt a loop
formation with one disulfide bond [18–20]. Examples of different AMPs, along
with their sources of origin, charge, secondary structure, and activity are given in
Table 1.3. In addition to the direct killing of microbes, some AMPs also protect
the host from pathogen attack by modulating the immune system [11, 13, 21]. Im-
munomodulatory AMPs do not target the pathogen directly, but rather selectively
enhance and/or alter the host defense mechanisms. Some AMPs that combine an-
timicrobial properties and innate immune modularity function, are called host
defense peptides [10, 13, 21].
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Table 1.3
AMP Charge
at
neutral
pH
Origin Structure Activity References
Cecropin-A +6 Insect, An-
imal
α- helix anti-bacterial,
anti-fungal
[16, 18, 22,
23]
Magainin +3 Frog α- helix anti-bacterial,
anti-virus,
anti-fungal,
anti-cancer,
wound healing
[16, 18, 20,
22–24]
Dermaseptin-
B2
+4 Frog α- helix anti-bacterial,
anti-fungal,
anti-cancer
[16, 18, 22,
23]
Clavanin-A +1 Invertebrate α- helix anti-bacterial [16, 22]
Styelin-A +5 Sea squirt α- helix anti-bacterial [16, 22]
Pleurocidin +4 Fish α- helix anti-bacterial [16, 22]
Moronecidin +3 Fish α- helix anti-bacterial [16, 22]
LL-37 +6 Human α- helix anti-bacterial,
anti-parasite,
anti-biofilm
[16, 18, 20,
22]
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Table 1.3 continued
AMP Charge
at
neutral
pH
Origin Structure Activity References
Melittin +6 Honey bee α- helix anti-bacterial,
anti-virus,
anti-fungal,
anti-parasite,
anti-HIV, anti-
cancer
[16, 20, 22,
24]
MSI-78 +3 Analogue
of Maga-
inin
α- helix anti-bacterial,
anti-fungal,
anti-parasite,
wound healing,
anti-malarian,
immunomodula-
tory
[16, 20, 22]
Alamethicin -1 Fungi α- helix anti-bacterial,
anti-fungal
[16, 20, 22]
Indolicidin +4 Bovine β turn anti-bacterial,
anti-virus, anti-
fungal, anti-HIV
[16, 18, 22,
23]
Protegrin-1 +7 Pig β- sheet anti-bacterial,
anti-fungal,
anti-HIV
[16, 18, 22]
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Table 1.3 continued
AMP Charge
at
neutral
pH
Origin Structure Activity References
Spepherin-I 0 Plants random
coil
anti-bacterial,
anti-fungal
[16, 22]
Spepherin-
II
0 Plants random
coil
anti-bacterial,
anti-fungal,
anti-virus, anti-
HIV
[16, 22]
Hepcidin +2 Fish, Ani-
mal
β- sheet anti-bacterial [16, 22]
Bactenecin +4 Bovine loop anti-bacterial,
wound healing
[16, 22, 23]
Lactoferricin +10 Human Loop anti-bacterial,
anti-cancer,
anti-biofilm
[16, 22, 24]
α-defensins +2 Human β sheet anti-virus, anti-
fungal
[16, 18, 22]
β-defensins 0 Human β sheet anti-bacterial,
anti-fungal
[16, 18, 22]
Piscidin-1 +3 Fish α- helix anti-bacterial,
anti-virus, anti-
fungal
[16, 22]
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Table 1.3 continued
AMP Charge
at
neutral
pH
Origin Structure Activity References
Omiganan +4 Indolicidin
derivative
β sheet anti-bacterial,
anti-biofilm,
imuunomodula-
tory
[16, 22]
Gad-1 +3 Fish α-helix anti-bacterial [25, 26]
Gad-2 +1 Fish α-helix anti-bacterial [25, 26]
Aurein 1.2 +1 Frog α-helix anti-bacterial,
anti-viral, anti-
fungal, anti-
HIV, anti-cancer
[22]
Citropin
1.1
+2 Frog α-helix anti-bacterial,
anti-fungal,
anti-biofilm,
anti-cancer
[22]
Maculatin +1 Frog α-helix anti-bacterial,
anti-fungal,
anti-HIV, anti-
cancer
[22]
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Table 1.3 continued
AMP Charge
at
neutral
pH
Origin Structure Activity References
Caerin +1 Frog α-helix anti-bacterial,
anti-viral,
anti-parasitic,
anti-HIV, anti-
cancer
[22]
Table 1.3: AMPs from different sources with their known charge, secondary
structure, and activity.
1.2.2 Antibiotic-resistance and AMPs
AMPs have gained attention because they can be effective against pathogens which
are resistant to conventional antibiotics. Their mechanism of action is different
from conventional antibiotics, which makes them less likely to induce resistance.
1.2.2.1 Antibiotic-resistance: a growing concern
Conventional antibiotics are losing their ability to treat bacterial infections. This
has resulted in the emergence of multi-drug resistant bacteria. Accordingly, there
is a continuous search to overcome or control such problems. Due to their unique
mode of action, AMPs are potential alternatives to traditional antibiotics for tack-
ling the issue of bacterial multi-drug resistance.
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Drug resistance is a capacity of bacteria to evade antibiotic attack. Resistance
can be seen as a two-component mechanism: (i) an antibiotic which kills suscep-
tible organisms and leaves resistant ones, and (ii) a resistant component in the
organism. Antibiotic resistance occurs when these two components come together
in a host. Although antibiotic resistance evolves with time, over-prescribing, in-
sufficient doses, and insufficient duration of treatment all are contributing factors.
The concerning factor about this resistance problem is that once it is acquired it
can not be easily abolished [11, 27–29]. A report titled “Antibiotic Threats in the
United States 2013” prepared by the Centers for Disease Control and Prevention
gives an idea of the burden to public health posed by this drug resistance problem.
According to this report, at least 2 million people become infected with bacteria
that are resistant to antibiotics and at least 23,000 people die each year as a di-
rect result of these infections in the United States alone. Many more people die
from other conditions that were complicated by antibiotic-resistant infections be-
cause doctors have run out of drugs to treat these infections [30]. Several studies
have examined the costs of antibiotic resistance. According to the U.S. Center for
Disease Control and Prevention (CDC), the treatment of antibiotic-resistant in-
fections costs $35 billion and 8 million hospital days per year in the United States
[31]. Antibiotic resistant infections increase the duration of hospital stays and the
mortality and morbidity rates as compared to drug-susceptible infections [32, 33].
1.2.2.2 AMPs: a natural alternative to conventional antibiotics
Given their broad spectrum of activity and lower propensity to induce resistance,
AMPs provide an excellent starting point for the development of therapeutics
with a novel mechanism of action. The cationic nature of AMPs makes them
specific to negatively charged bacterial membranes. AMPs act by breaking the
bacterial cell membrane integrity since it is not easy for bacteria to function with
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a highly altered membrane composition and the risk of developing resistance is
very low. On the other hand, conventional antibiotics have specific targets which
allow bacteria to develop mechanisms to avoid antibiotic damage.
Moreover, cationic and amphipathic peptides seem to be perfect molecular struc-
tures to achieve a maximum number of interactions with the membrane [34, 35].
Drugs designed to mimic them can have extensive medical applications. AMPs can
be used individually or in combination with other antibiotics to control multi-drug
resistance problem [10, 36]. In addition to killing isolated bacteria, AMPs have
the potential to work against biofilms. Biofilms are immobile bacterial popula-
tions attached to surfaces such as human tissues and medical implants. Currently,
biofilms are a serious threat in hospitals and medical facilities. The United States
National Institute of Health found that 80% of chronic infections are related to
biofilm formation and more than $3 billion is spent to treat implant-associated
biofilm infections in the United States alone [37]. Biofilms are highly resistant
to conventional antibiotics due to multiple tolerance mechanisms. On the other
hand, it has been found that AMPs can destroy these multilayered communities
of bacteria. The AMP mechanism against biofilms may involve the degradation
of the membrane potential of biofilm embedded cells, interruption of bacterial cell
signaling systems, degradation of the polysaccharide and biofilm matrix, downreg-
ulation of genes responsible for biofilm formation and transportation of binding
proteins [38]. Lactoferrin, LL-37, and human cathelicidin are examples of AMPs
which are effective against biofilms [23, 37, 39].
1.2.3 Challenges in developing AMPs as therapeutics
Using the chemical structure of naturally occurring AMPs as the basis for synthetic
drugs provides a promising strategy to fight against antibiotic-resistant pathogens.
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So far success has been achieved in the development of AMP therapeutics for
topical use only. The use of AMP-based drugs for systemic use is reduced by
the level of toxicity associated with them. In other words, even though AMPs
are more specific towards bacterial membranes, the concentration at which they
are able to kill bacteria is still very toxic to host cells. Another hurdle in the
commercialization of AMPs is their high cost of manufacturing. This has limited
the development and testing of AMPs as therapeutics.
The bottleneck of these disadvantages lies in our incomplete understanding of the
selectivity of natural AMP sequences towards different microbes. To overcome
these difficulties, it is critical to understand how AMPs interact with cells and
disrupt them. Detailed knowledge of AMP mechanisms will help to decipher the
structure-activity relationships and support the identification of essential com-
ponents of AMP sequences with possible sites of substitution. Altogether, this
will help researchers to design short, compositionally simple, and potent AMPs
[36, 40, 41].
1.2.4 Understanding the mechanism of action of AMPs
The conventional understanding of AMP mechanisms centers around their ability
to disrupt the bacterial membrane [19, 37, 42]. This results in the leakage of cell
contents, or possibly transport of the peptide into the cell. After translocating,
the peptide can have contact with intracellular components [43]. The methods by
which AMPs traverse/permeabilize the membrane are not common to all peptides.
They depend on the properties of the peptide (amino acid sequence, charge, and
conformation) and on the target membrane composition. AMPs are thought to
display specificity for bacterial cells over host cells due to the difference in the cell
membrane compositions [26].
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1.2.4.1 Molecular basis of the AMP selectivity
The cationic nature of AMPs contributes to cell selectivity. The main driving
forces in the binding of AMPs to cell membranes are hydrophobic interactions
(between the non-polar amino acids of AMPs and the hydrophobic core of the
membrane) and electrostatic interactions (between cationic AMPs and the anionic
lipids of the membrane). The bacterial membrane is composed of a phospholipid
bilayer with a high proportion of anionic lipids which results in strong electrostatic
interactions between AMPs and bacterial membranes. On the other hand, in
eukaryotic cells, such as human cells, the membrane is abundant in zwitterionic
lipids. There are hydrophobic and electrostatic forces (between cationic AMPs and
head groups of zwitterionic lipids) between AMPs and host membranes but these
are weaker in comparison to the forces between AMPs and bacterial membranes
as shown in Figure 1.3. It is thus the higher anionic lipid content of bacterial
membranes that make them more vulnerable to AMPs. Upon interacting with
bacterial membrane, AMPs can achieve antimicrobial activity in many different
ways as explained below.
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Figure 1.3: Membrane selectivity by AMPs on the basis of lipid composition of the
membrane. This figure is reproduced with the permission of Dr. Michael Morrow.
1.2.4.2 Pore forming mechanisms
The precise details of AMP action are not fully understood yet but their interac-
tions with bacterial membrane appear to be the first steps in their antimicrobial
activity. There are several basic models which might explain the increase in mem-
brane permeability as a result of peptide-induced pores in the lipid bilayer (Figure
1.4). In these models, the interaction starts with adsorption of the peptide to the
membrane surface which results in the peptide assuming a specific conformation.
The initial interaction of the peptide with the membrane surface, more specifically
in the lipid head groups, leads to lateral expansion of the membrane. To reduce
the tension imposed on the lipid bilayer by the peptide, the membrane can respond
in several ways each of which results in transmembrane pores in the lipid bilayer
[44].
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Figure 1.4: The antimicrobial activity of AMPs to kill bacteria lies in their ability
to disrupt the membrane integrity which can be achieved in a number of ways. The
initial membrane-peptide interaction can be followed by many different membrane
disruptive events. A peptide can work via a single mechanism or it can have
multiple mechanisms. This figure is from Nguyen et al. [16] and reprinted with
permission from Elsevier.
(i) Barrel stave model
The barrel stave model was the first model proposed to describe the formation
of transmembrane channels/pores by bundles of amphipathic α helical peptides
[2, 35, 45, 46]. Firstly, the peptide adopts an amphipathic conformation upon
interacting with the membrane and then the peptides interact laterally with one
another to form a large structure. Next, the peptide bundle inserts into the mem-
brane such that the peptide hydrophobic surfaces interact with the lipid core of
the membrane and their hydrophilic surfaces point inward producing an aqueous
pore. This allows for minimal exposure of the hydrophilic residues of AMP to the
hydrophobic tails of the lipids. This model explains the formation of transmem-
brane pores by direct insertion of the peptide into the membrane core through
peptide-peptide interactions. The addition of more peptide molecules may result
Chapter 1. Introduction 20
in the formation of extra pores or it may increase the size of the existing pore.
This pore formation leads to the leakage of cell contents which ultimately results
in cell death. Neutron diffraction and X-ray scattering have shown that Alame-
thicin works via the barrel stave model [16, 17, 19, 37, 43, 44, 47–49]. To date, it
is the only AMP known to work via this mechanism.
(ii) Toroidal pore model
In this model, the peptides are initially attracted to the membrane and undergo
similar secondary structural changes as for the barrel stave model [2, 35, 45, 46]. In
contrast, to the barrel stave, peptide-peptide interactions are not present. Instead,
the peptide changes the membrane curvature by bending the lipid monolayers to
connect the inner and outer surfaces into a continuous channel. Neutron in-plane
scattering and Molecular dynamics (MD) simulations have shown that the AMPs
Magainin 2, Melittin, and Protegrin make pores by toroidal model [16, 17, 19, 37,
43, 44, 49–51].
(iii) Disordered toroidal pore model
The MD simulations have shown that the toroidal pores formed by AMPs involve
a significant disorder [52]. In the disordered toroidal model, a toroidal shaped
pore is formed by one or more α-helical or β-sheet peptide that inserts into the
membrane due to the tension induced by the peptide in the membrane [45]. Above
a threshold number of membrane-bound peptides, one peptide molecule becomes
deeply embedded into the membrane and the membrane-water interface becomes
unstable. This results in the interaction of solvent molecules with the hydrophilic
part of the embedded peptide to make a continuous pore. In contrast to the
classical toroidal pore model, in this model, only one peptide needs to be near the
center of the pore and the remaining peptide molecules lie near the edge of the
pore. The resulting pore is sufficient to allow the passage of peptides from one
side of the membrane to another.
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(iv) Carpet model
In this model, peptide molecules orient themselves parallel to the membrane sur-
face and cover the membrane surface with their hydrophobic faces toward the inte-
rior of the membrane and hydrophilic faces toward the head groups [2, 35, 45, 46].
The accumulation of peptide on the membrane surface induces tension in two
leaflets of the lipid bilayer. Above the threshold concentration, this strain re-
sults in the disintegration of the membrane. MD simulations, vesicle leakage, and
atomic force microscopy (AFM) have shown that the peptides Dermaseptin, Cit-
ropin 1.1, Aurein, and Cecropin disrupt bacterial membrane in a manner consistent
with the carpet model [53–55]. This model suggests that the peptide mechanism
could be concentration dependent. For example, below a threshold concentra-
tion, the peptide might make transmembrane pores, while concentrations above
the threshold might result in the complete fragmentation of the membrane. Also
for the carpet model, specific peptide-peptide interactions are not essential [56].
A particular AMP might function by more than one mechanism, depending on
parameters such as peptide to lipid ratio [16, 17, 19, 37, 43, 44, 49].
1.2.4.3 Non-pore forming mechanisms
In addition to the pore forming mechanisms described above, AMPs might disrupt
the bacterial membrane in other ways which do not result in pore formation. It
has been reported that AMPs can induce membrane thinning/thickening and non-
lamellar lipid phases [6]. Depending on the membrane composition, AMPs can
induce positive and negative curvature which leads to redistribution of lipids. In
some cases, the presence of peptide leads to the formation of domains of charged
lipid clusters surrounding the peptide [57]. The migration of charged lipids to-
wards cationic AMPs might result in the weak attachment of surface proteins to
the re-organized membrane, causing protein delocalization and loss of function
Chapter 1. Introduction 22
[58]. Also, adsorption of the peptide in the outer leaflet of the membrane might
increase the membrane potential and restrict the permeability of the membrane to
many molecules. The peptide might interact with anions across the lipid bilayer
and result in their leakage from the membrane [16]. All these mechanisms are
schematically shown in Figure 1.4.
Besides the ability to make changes to the cell membrane, the peptide might have
intracellular targets as well. Regardless of which model is correct for peptide-
induced disruption in the membrane, they all provide a means for AMPs to cross
the membrane. After crossing the membrane, a peptide might target many cellular
components to achieve antimicrobial activity. Examples of an intracellular activity
include inhibition of protein synthesis, DNA synthesis, inhibition of enzymatic
activity, and inhibition of cell wall synthesis [37, 43, 59]. It is noted that in
both pore/non-pore forming mechanisms the interactions of the peptide with cell
membrane are very important as in each case peptide needs to permeabilize the
membrane. Furthermore, one peptide can act via multiple mechanisms which
makes the peptide less likely to induce resistance against bacteria.
Different methods can be used to study the membrane-peptide interactions with
each method giving a different level of information about the mechanism of AMPs.
The ability of AMPs to permeabilize the lipid membranes can be studied by the
release of internal fluorescent-labelled probes [60]. The orientation of a peptide
in the membrane can be examined using solid-state NMR spectroscopy [60, 61].
Neutron scattering/diffraction and atomic force microscopy are useful techniques
to study the pore formation by AMPs in the membrane [62]. X-ray scattering
can be used to study the membrane thinning/thickening induced by a peptide in
the membrane [63]. Thermodynamics of lipid phase transitions can be studied
using differential scanning calorimetry (DSC). Peptide-induced phase transitions
and peptide aggregation at the membrane surface can be studied by isothermal
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titration calorimetry (ITC) [61]. Molecular dynamics simulations are also a useful
technique to study peptide interactions with lipid membranes [64]. These methods
can be used alone or in combination to study the peptide-membrane interactions.
1.2.4.4 Describing membrane-peptide interactions with a phase dia-
gram
Membrane-peptide interactions are very complex and diverse in nature. Due to
these interactions, membranes may experience many structural changes as de-
scribed by the pore and non-pore mechanisms. Different peptides may utilize dif-
ferent interaction mechanisms or a combination of mechanisms. Furthermore, the
mechanism of interaction might change depending upon peptide concentration and
membrane composition. The complexity of membrane-peptide interactions can be
explained with a phase diagram [65–67] as shown in Figure 1.5(a). The different
models of membrane disruption by AMPs could be different regions in this phase
diagram. The phase boundaries are illustrated as a function of membrane-bound
peptide concentration and lipid composition from POPC to POPE. The vertical
arrow in Figure 1.5 (b) indicates that the phase observed depends on lipid to pep-
tide ratio. At lower lipid to peptide ratio, peptide might disrupt the membrane
by making toroidal pores, while at a higher lipid to peptide ratio, membrane dis-
ruption can occur by the carpet model. The effect of replacing POPC lipid with
POPE lipid to mimic the bacterial membrane composition is indicated by the
horizontal arrow. The horizontal arrow indicates that the size of the lipid head
group can have an effect on the lipid structures induced by the AMP. For a given
lipid to peptide ratio, the more POPE that is in the bilayer the more likely, the
membrane will take on the “wormhole” structure.
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(a)
(b)
Figure 1.5: The phase diagrams of lipid-peptide mixtures as a function of
membrane-bound peptide and membrane composition to depict the ability of a
peptide to disrupt the lipid bilayer integrity. (a) Different models that have been
suggested to explain the pore formation by the peptide in the membrane are shown.
(b) The illustration that the observed phase depends on the lipid to peptide ra-
tio as indicated by the vertical arrow. Furthermore, the horizontal arrow shows
that the size of the lipid head group can have an effect on the lipid structures
induced by the AMP. For a given lipid to peptide ratio, the more POPE that is in
the bilayer the more likely the membrane will take on the “wormhole” structure.
This figure is adapted from Burkhard Bechinger et al. [65] and reprinted with
permission from Elsevier.
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1.2.4.5 Interfacial activity model
The interfacial activity model describes the ability of a peptide to bind to a mem-
brane and induce local rearrangements of lipids. In all the models explained in
Section 1.2.4.2 and 1.2.4.3, AMPs permeabilize the membrane and perturb the
bilayer integrity to achieve antimicrobial activity. According to interfacial activity
model [35], the peptide-induced destabilization of the membrane does not depend
on specific amino acid sequences or specific peptide secondary structure. It does
depend on the amino acid composition and physical-chemical properties of the
peptide. The cationic nature and amphipathicity of AMPs result in their broad
spectrum of activity but perfect amphipathicity is not essential. Instead, imperfect
amphipathicity is necessary for interfacial activity. Also, it is not the net charge
alone that determines the membrane permeabilizing ability of a peptide but also
its charge distribution [68]. The exact spatial arrangement of hydrophobic and
polar residues in the AMP is not important. Instead, the physical-chemical bal-
ance between these two properties helps position the peptide inside the membrane.
When a peptide with an appropriate distribution of polar and non-polar groups
binds to the membrane, the hydrophobic groups partition deep into the interfacial
(hydrophobic) zone while polar residues of peptide interact with lipid polar head
groups and push them deep in the membrane. This might lead to the membrane
translocation of peptide even at low peptide concentration, while high peptide
concentration may result in the formation of pores [35].
1.2.5 Antimicrobial to anticancer peptides: histidine-rich
AMPs
Cancer is caused by the abnormal cell growth in an uncontrolled manner. Chemother-
apy and radiation are the usual methods to treat cancer. These methods have only
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partial success rates, in large part due to their lack of specificity [69]. They target
rapidly dividing cells with relatively small discrimination between the cancer cells
and the normal proliferating cells. Moreover, cancer cells can develop resistance
to anticancer agents and pump drug out from the cell. To control the mortality
and morbidity rate due to cancer, it is necessary to develop more efficient and
selective anti-cancer therapeutics that can be used in place of or in combination
with conventional anti-cancer therapeutics.
Cationic AMPs are under consideration as alternative chemotherapeutic agents
due to their selective toxicity towards cancer cells, ability to avoid resistance and
additive effects in combination therapy [70, 71]. AMPs have been primarily studied
to develop new therapeutics to fight various infections but it has been reported
that certain AMPs like Cecropin A, Cecropin B, BMAP-27, BMAP-28, LL-37,
Magainin, Melittin, Defensins, Lactoferricin, Tachyplesin, Buforin II, and Buforin
IIb, have the ability to kill cancer cells. The cancer cell membranes are different
from normal cells in many ways. Firstly, cancer cell membranes have an anionic
character that is similar to bacterial membranes. For this reason, electrostatic
interactions might be the core of the selectivity mechanism of AMPs towards
cancer cells instead of normal cells. Another major difference between cancer and
normal cells is their acidic environment. The pH level of the extracellular space
surrounding solid tumors is significantly lower than the pH around normal cells.
Therefore, many attempts have been made to develop new pH-dependent anti-
cancer therapies which can be active in the lower pH space of solid tumors [72].
There are few AMPs (Histatin, Clavanin, and Chrysophsin, LAH4) which have
histidine residues in their sequences. These histidine-rich AMPs are potentially
pH sensitive and have an ability to become more active at acidic pH values, as
histidine side chain has a pKa value of 6. Thus at neutral pH its side chain is
uncharged but at acidic pH values, it has charge of +1. So the presence of histidine
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can make the overall charge of a peptide sensitive to pH which, in turn, can affect
the peptide-membrane interaction [73]. Furthermore, cancer cell membranes are
more fluid than healthy cells. This might help AMPs to cause destabilization of
the cell membrane. In addition to this, cancer cells have a larger surface area
than normal cells and this can result in AMP-mediated cytotoxicity due to larger
numbers of AMP molecules interacting with the membrane [74].
Even though AMPs are expected to be selective towards cancer cells without
reduced toxicity to normal body cells, the development of AMP-based anti-cancer
drugs is very challenging because their selectivity is poorly understood and it is not
possible to predict the anti-cancer activity based on AMP structure. A detailed
knowledge of membrane-peptide interactions is needed in order to use AMPs as
anticancer drugs [69].
1.2.5.1 Gad peptides
Gad peptides, Gad-1 and Gad-2, belong to the Piscidin family of AMP from
fish. Piscidins fight against various pathogens in aquatic environments as part of
the innate immune system [25]. Gad peptides are found in Atlantic cod (Gadus
morhua) and are paralogs (coded by related genes). Gad-1 and Gad-2 are 21 and
19 residues long respectively and have tendencies to form α helical structure in
a membrane environment [26]. The primary amino acid sequences of C-terminus
amidated Gad peptides are:
Gad-1:FIHHIIGWISHGVRAIHRAIH-NH2
Gad-2:FLHHIVGLIHHGLSLFGDR-NH2
Gad peptides are natural histidine-rich peptides. Gad-1 has 5 histidines and Gad-
2 has 4. The charge of Gad peptides at pH 7.0 and pH 5.0 is listed in Table 1.4.
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peptide pH 7.0 pH 5.0
Gad-1 +3 +8
Gad-2 +1 +5
Table 1.4: Expected overall peptide charge of Gad-1 and Gad-2 at pH 7.0 and pH
5.0.
There are other histidine-rich peptides such as LAH4 that are artificial, as opposed
to the Gads which are sequences found in nature. Gad peptides provide a means
to understand how nature tunes a peptide’s pH-dependent activity. It has been
shown that there is a relationship between the pH sensitivity of antimicrobial
activity and the number of histidine residues present in the sequence of a peptide
[75–77]. In order to test their pH sensitivity, MIC assay experiments with E.coli
were done in the presence of Gad-1 and Gad-2 at pH 7.0 and pH 5.0 shown in
Figure 1.6. MIC stands for Minimal Inhibitory Concentration and it represents the
minimum concentration of peptide that is sufficient to stop bacterial growth. For
Gad-1, MIC of 5.1 µM (12.5 µg/mL) was found in 4 out of 6 repeated experiments
at pH 5, and in 5 out of 6 experiments at pH 7. For Gad-2, MIC of 11.5 µM (25
µg/mL) was found in 4 out of 6 experiments at pH 5, but the MIC found was
greater than 23.0 µM (50 µg/mL) in 4 out of 6 experiments at neutral pH. This is
interesting considering that Gad-1 has five histidine residues and Gad-2 only four.
At both pHs, Gad-1 was more active than Gad-2 [26].
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Figure 1.6: Minimal Inhibitory Concentration (MIC) results for Gad-1 and Gad-2
at pH 7.0 and pH 5.0. Each bar represents one of six replicate experiments and
the length of the bars indicates the minimum peptide concentration required to
inhibit bacterial growth. No bar indicates an MIC greater than 50 µg/mL (20.2
µM for Gad-1 and 23.0 µM for Gad-2). This figure is taken from McDonald et al.
[26] and reprinted with permission from Elsevier.
1.2.6 Model membrane studies
To fully understand the mechanism of membrane destabilization by AMPs, it is
important to elucidate how membrane properties are affected by the binding of
AMPs. Biological membranes are complex and heterogeneous structures composed
of hundreds of lipids and proteins. The direct analysis of peptide interactions with
real cellular membranes is difficult. For that reason, simple model lipid membranes
are commonly used to understand the role of membrane lipids in the membrane-
peptide interactions.
AMP interactions with model membranes composed of zwitterionic and anionic
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lipids had been investigated for different peptides. AMPs such as Magainin 1, Au-
rein 1.2, Citropin 1.1, Maculatin 1.1, Caerin 1.1, Dermaseptins, Cecropins, Cathe-
licidins, Protegrins, Defensins, Temporins and two hybrid peptides of Cecropin A
and Melittin (CA(1−8)M(1−18) and CA(1−7)M(2−9)), had shown higher affini-
ties for model membranes composed of DMPG lipids than with DMPC membranes
[78–80]. These results suggest that electrostatic interactions might be responsible
for the initial attraction of the peptide on the membrane surface. In addition to
this, it was also found that membrane-peptide interactions do not depend only on
the charge of lipid but also on the head group structure [78]. In model membranes,
peptides were shown to disrupt the bilayer integrity by inducing non-lamellar
lipid phases. MSI-78, Tritrpticin, Indolicidin, LL-37, and bovine Lactoferricin
were shown to induce positive membrane curvature in the membranes composed
of POPE lipids [6]. AMP-induced structures and dynamics of lipid assemblies
were investigated in model membranes using solid-state NMR spectroscopy. 2H
and 31P solid-state NMR spectra revealed that Magainin-2 and Aurein-3.3 pep-
tides induce pores and bilayer thinning in oriented lipid bilayers of POPC and
POPG [81]. Melittin and CEME (Cercropin and Melittin hybrid) peptides inter-
calate into model lipid membranes and induce expansion of the outer leaflet of
the lipid bilayer [82]. PG-1 peptide makes toroidal pores in anionic model lipid
membranes. The mutation of charged residues of PG-1 results in changes in the
peptide-membrane binding underlining the importance of charged residues [41].
To gain further insight into the interactions of AMPs with membranes, the angle
(transmembrane, parallel, or in between) of the peptide in model membranes has
been studied by solid-state NMR spectroscopy. It has been shown that peptides
in transmembrane orientation induce less disorder in the membrane than when
the peptide is oriented parallel to membrane surface [83]. The 15N chemical shift
shows that Alamethicin adopts a transmembrane orientation in POPC/POPG
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lipid bilayers [84], while Magainin 2, aligns parallel to membrane surface [85].
The pH-sensitive antimicrobial activity of the synthetic histidine-rich AMPs LAH4
has been studied in model membranes. At neutral pH, the membrane disruption
is weak, but at acidic pH, the disruption of lipid acyl chains in the presence of
peptide is more drastic [75].
1.3 Current AMP research questions and objec-
tive of present work
Although AMPs provide a promising alternative for conventional antibiotics to
treat various infections, there are only a few success stories. The poor under-
standing of their selectivity is a major obstacle in the development of injectable
AMPs. To improve AMP-drug design, it is essential to know which properties of
natural AMP sequences make them selective to different microbe membrane com-
positions and how membrane properties are affected by the addition of AMPs.
One way to understand the selectivity of AMPs is to modify their overall charge
and study the effect on peptide-membrane interactions. Gad peptides are histidine-
rich peptides and provide a means to tune the peptide charge by changing the
pH. This pH-dependent activity will help us to understand the role of electro-
static interactions in AMP selectivity which will further improve our knowledge
about AMP-membrane interactions. The change in pH from 7.0 to 5.0 is not ex-
pected to alter the membrane charge as the pKa values of lipids used in this work,
POPE, POPC, and POPG are between 2-3 [86]. In addition to understanding
the pH-dependent membrane interaction of Gad peptides, we are also interested
in studying differences between the activities of Gad-1 and Gad-2 in response to
pH alterations. As Gad peptides are encoded by paralogous genes i.e. related
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genes, their activity might be specific to different pathogens. This study will help
us to understand how specificity is tuned to different pathogens in natural AMP
sequences. This knowledge may help to improve AMPs’ therapeutic ratios, a com-
parison of the amount of a therapeutic agent that causes the therapeutic effect to
the amount that causes toxicity.
The main objective of this thesis is to study the interactions of Gad peptides with
model membranes at different pH values. This thesis is organized in the following
way: Chapter 1 provides the background of membranes and AMPs. Chapter 2
describes of the biophysical methods used in this work. It starts with the descrip-
tion of NMR theory with a focus on 2H NMR and goes on with the explanation
of zeta potential and circular dichroism spectroscopy. The first part of Chapter 3
describes the abilities of Gad peptides to perturb the bilayer integrity of vesicle
model membranes at different pH values. In addition to this, the effect of Gad
peptides on fast and slow motions of lipid bilayers are also discussed. The second
part of this chapter is focused on the zeta potential measurements which provide
a link between binding affinities and membrane disruption abilities of Gad pep-
tides at different pH values. In order to better understand the interaction of Gad
peptides with membranes and how differences in peptide-membrane interaction
might be correlated with differences in function, the alignment of Gad peptides
in mechanically oriented lipid bilayers is studied and presented in Chapter 4. An
investigation of the effect of the lipid cardiolipin on Gad membrane disruption is
given in Chapter 5. Finally, a discussion of results from different experiments is
presented in Chapter 6.
Chapter 2
Biophysical methods to study the
interactions of AMPs with model
membranes
A wide range of biophysical techniques have been used to study the interactions
of AMPs with membranes. Some of these techniques, nuclear magnetic resonance
(NMR) spectroscopy, zeta potential, and circular dichroism (CD) spectroscopy are
described in this chapter. NMR spectroscopy can be used to study peptide-induced
disorder in the membrane lipid bilayer, the effect of the peptide on the slow and
fast motion of lipid bilayer, and the alignment of the peptide in the membrane.
Zeta potential measurements provide information about the binding affinities of
peptides. CD spectroscopy can be employed to investigate the secondary structure
of a peptide in the membrane environment.
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2.1 Nuclear magnetic resonance (NMR) spec-
troscopy
NMR spectroscopy is based on the magnetic properties of a nucleus. A nucleus
with non-zero spin angular momentum also possesses a nuclear magnetic dipole
moment. In the absence of the magnetic field, the nuclear magnetic moments do
not have any preferred orientation. On the other hand, when an external static
magnetic field is applied, the interaction of the nuclear magnetic moment with
the magnetic field results in the different orientations (spin states) of magnetic
moments with respect to the magnetic field having different energies. The align-
ment of magnetic moments parallel to the applied magnetic field generates the
net magnetization in the direction of field. If nuclear spins are then subjected to
another oscillating magnetic field at a particular frequency, a spin can flip from
one orientation (spin state) to another, with respect to the static magnetic field.
This happens only when the frequency of the oscillating magnetic field matches
the energy difference between the two spin states. This is termed as the resonance
condition in NMR spectroscopy. Once perturbed from its equilibrium state, the
magnetization vector rotates about the applied field and this motion gives rise to
the NMR signal.
Solid-state NMR is an excellent tool to study molecular orientation and molecular
motion because some nuclear spin interactions are anisotropic, i.e. they depend
on the molecular orientation. Hence, the change in the orientation of a molecu-
lar segment containing a nuclear spin due to the motion of the molecule affects
the resonance frequency of nuclei in a way that changes the shape of the NMR
spectrum.
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2.1.1 Introduction
2.1.1.1 Equilibrium magnetization and Larmor precession
Nuclear spin is represented by an operator Iˆ associated with the spin quantum
number I. The value of I corresponds to a spin angular momentum which is given
by ~Iˆ. Nuclei with a certain value of spin angular momentum can be visualized
as tiny bar magnets with a magnetic dipole moment [87–89]
µˆ = γ~Iˆ (2.1)
where γ is the gyromagnetic ratio of a nucleus. The z component of the magnetic
moment is given by
µˆz = γ~Iˆz. (2.2)
In the absence of an external magnetic field, all magnetic moments in a sample
are randomly oriented. This results in a net zero magnetic moment. When an
external magnetic field is applied, the interaction between the magnetic field and
the dipole moment is governed by the Hamiltonian [87–90]
Hˆ = −µˆ · ~B. (2.3)
When the applied magnetic field is in the z direction, this Hamiltonian is becomes
Hˆz = −γ~IˆZB0. (2.4)
The energy eigenvalues corresponding to the above Hamiltonian can be found by
using the Schrodinger equation [87–89]
H |Ψ〉 = E |Ψ〉 (2.5)
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Hz |Ψ〉 = −γ~B0Iz |Ψ〉
= −γ~B0m |Ψ〉
(2.6)
where m is the magnetic spin quantum number. Therefore, the energy of the
magnetic interaction is given as
Em = −γ~m (2.7)
and it depends on the spin state of the nucleus. For a spin 12 system, m has two
values ±12 . The energy corresponding to each value of m are
Em=1/2 = −12~γB0. (2.8)
Em=−1/2 =
1
2~γB0. (2.9)
The m = 12 state is lower in energy and corresponds to the parallel orientation
of the dipole moment with respect to the external magnetic field. This energy
state is represented by α. The m = −12 state is higher in energy and represents
the anti-parallel orientation of the magnetic moment with the applied magnetic
field. This energy state is represented by β. Hence, in the presence of an external
magnetic field, the degenerate nuclear spin states split into different energy levels
according to their alignment with the direction of field. This is called the Zeeman
splitting [88–91] and is schematically shown in Figure 2.1 for a spin 12 system. At
thermal equilibrium, the relative populations of the states α and β are given by
the Boltzmann distribution. According to this distribution, the α state is more
populated than the β state [89, 92]. Therefore, in the presence of an external
magnetic field, the alignment of magnetic moments in the direction of the field
gives rise to the net magnetic moment. Averaged over an entire sample, this net
magnetic moment is called the equilibrium magnetization. This is schematically
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Figure 2.1: The depiction of the Zeeman splitting for spin 12 system. In the
presence of the external magnetic field, the degenerate energy states split into two
non-degenerate states. The splitting between the two energy states depends on
the strength of the external magnetic field.
shown in Figure 2.2. Once the equilibrium magnetization is established, it does
Figure 2.2: In the absence of the external magnetic field, the magnetic moments of
the individual spins are randomly oriented. On the other hand, if a magnetic field
is applied in the z direction, then there is a slight energy preference for magnetic
moments in the direction of the field. This results in a net magnetization in the
direction of the field.
not change with time unless perturbed by some torque. This external torque
can be provided by an oscillating magnetic field produced by a radio frequency
(RF) pulse. Once the magnetization vector moves away from the z axis, it rotates
about the direction of the magnetic field. This is called Larmor precession and
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the corresponding frequency is called the Larmor frequency [87–90, 92]
ω0 = −γB0 (2.10)
where γ is the gyromagnetic ratio. The values of γ for common NMR-active nuclei
are given in Table 2.1. The gyromagnetic ratio of a nucleus can be positive or neg-
ative and determines the direction of precession. For example, a 1H has a positive
value of γ and hence precesses clockwise in the presence of the external magnetic
field, while 15N has negative a gyromagnetic ratio that results in counterclockwise
precession.
Nuclei Spin γ(MHzT−1) ω0(MHz)
1H 12 42.576 400.0
2H 1 6.536 61.4
15N 12 -4.316 40.5
31P 12 17.235 162.0
13C 12 10.705 94.7
Table 2.1: The gyromagnetic ratio and corresponding Larmor frequency of various
nuclei. The Larmor frequency is calculated in a magnetic field strength of 9.4 T.
2.1.1.2 Free induction decay (FID) signal and NMR spectrum
In an NMR experiment, the magnetization is manipulated via RF pulses. For
this purpose, a coil is mounted around the sample. The axis of the coil is aligned
in the xy plane and the external magnetic field is along the z axis. The RF
pulse generates an oscillating magnetic field in the coil which flips the equilibrium
magnetization vector away from the z axis. This is illustrated in Figure 2.3 (a).
The precessing magnetization vector produces an oscillating current in the coil
that can be amplified and detected as a time-domain signal. This signal is termed
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the Free Induction Decay (FID) signal. The NMR spectrum is acquired by Fourier
transformation of the FID signal which gives the spectrum in the frequency domain
[87, 90, 92]. An FID signal and the corresponding NMR spectrum are shown
schematically in Figure 2.3 (b).
(a)
(b)
Figure 2.3: (a) The schematic representation of the precessional motion of the
magnetization vector about the z axis. A coil positioned along the x axis is used
to apply the RF pulse and to detect the FID signal.(b) The time domain FID
signal and the corresponding Fourier transformed NMR spectrum. This figure is
inspired from “Understanding NMR spectroscopy” by James Keeler [92].
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2.1.1.3 Density operator formulation of spin 12 system for (
pi
2 )x pulse
In order to understand how an oscillating magnetic field produced by a RF pulse
perturbs the equilibrium magnetization away from the z axis, it is helpful to
explain the behavior of a spin system in terms of the density operator [87, 89, 90,
93]. The density operator represents the quantum mechanical state of an entire
spin system without referring to the individual spins. For more details on density
operator and for an effect of an RF pulse on a spin 12 nucleus in the density
operating formulations refer to Appendix A.
2.1.2 NMR spectrometer
Different parts of the NMR spectrometer are described in Appendix B.
2.1.3 2H NMR
The deuteron is a spin 1 nucleus. Due to non-spherically-symmetric charge distri-
bution, it has an electric quadrupole moment. This quadrupole moment interacts
with the Electric Field Gradient (EFG) at the nucleus. These interactions are
termed quadrupole interactions and can be treated as first order perturbations to
the Zeeman interactions where Zeeman interactions are responsible for the split-
ting of degenerate spin states (in the absence of magnetic field) into non degenerate
states (in the presence of magnetic field).
2.1.3.1 Quadrupole Hamiltonian
Consider a nucleus with a charge density ρ(~r). An electrostatic potential due to
the external source is represented by V (~r). Therefore, the Hamiltonian is given
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as [88, 94]
H =
∫
ρ(~r)V (~r)dτ. (2.11)
The potential V (~r) can be expanded about the nuclear center of mass to give
V (~r) = {V0 +
∑
i
xi
(
∂V
∂xi
)
r=0
+ 12
∑
j,k
xjxk
(
∂2V
∂xj∂xk
)
r=0
+ ......}. (2.12)
Equation 2.11 then becomes
H =
∫
dτρ(~r){V0 +
∑
i
xi
(
∂V
∂xi
)
r=0
+ 12
∑
j,k
xjxk
(
∂2V
∂xj∂xk
)
r=0
+ ......}. (2.13)
It is convenient to define (
∂V
∂xi
)
r=0
= Vi (2.14)
(
∂2V
∂xj∂xk
)
r=0
= Vjk. (2.15)
Using Equations 2.14 and 2.15, the quadrupole Hamiltonian becomes
H =
∫
dτρ(~r){V0 +
∑
i
xiVi +
1
2
∑
j,k
xjxkVjk + ......}
= V0
∫
dτρ(~r) +
∑
i
Vi
∫
dτρ(~r)xi +
1
2
∑
j,k
Vjk
∫
dτρ(~r)xjxk + ........
(2.16)
The first term in the above equation represents the electrostatic energy of a nu-
cleus. It does not depend on the shape, size, or orientation of a nucleus and can
be neglected here. The second term involves a dipole moment and vanishes as the
center of mass and the center of charge coincide [94]. Therefore, the quadrupole
Hamiltonian is given as
HQ =
1
2
∑
j,k
Vjk
∫
dτρ(~r)xjxk. (2.17)
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Using the definition of quadrupole moment [88, 94],
Qjk =
∫
(3xjxk − δjkr2)ρ(~r)dτ , (2.18)
we then have ∫
xjxkρ(~r)dτ =
1
3{Qjk +
∫
δjkr
2ρ(~r)dτ} (2.19)
Using Equation 2.19, the Quadrupole Hamiltonian can be written as
HQ =
1
2
∑
j,k
Vjk
∫
dτρ(~r)xjxk
= 16
∑
j,k
{VjkQjk + Vjkδjk
∫
r2ρ ~(r)dτ}.
(2.20)
Vjk satisfies the Laplace equation. Therefore, the second term on the right hand
side of the above equation vanishes. Hence, we have
HQ =
1
6
∑
j,k
{VjkQjk}. (2.21)
Both Qjk and Vjk are symmetric second rank tensors. Furthermore, Vjk can be
written as [94]
Vjk = −∂Ek
∂xj
(2.22)
where Ek is the electric field at the nuclear position. Therefore, quadrupole inter-
actions represent the interaction between the quadrupole moment tensor Qjk and
the EFG, Vjk.
The quadrupole Hamiltonian can be written in terms of angular momentum op-
erators by using the Wigner-Eckart theorem [93–95] to give
HQ =
eQ
6I(2I − 1)
∑
j,k
Vjk[
3
2{IjIk + IkIj} − δjkI
2]. (2.23)
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In the principal axis system (PAS) of EFG tensor, the above Hamiltonian becomes
HQ =
eQ
6I(2I − 1)[Vxx(3I
2
x − I2) + Vyy(3I2y − I2) + Vzz(3I2z − I2)]. (2.24)
Using the Laplace equation, HQ can be written as
HQ =
eQ
4I(2I − 1)[Vzz(3I
2
z − I2) + (Vxx − Vyy)(I2x − I2y )]. (2.25)
It is convenient to define two parameters η and eq [94–96]
η = Vxx − Vyy
Vzz
eq = Vzz.
(2.26)
In terms of these parameters the quadrupole Hamiltonian becomes
HQ =
e2qQ
4I(2I − 1)[(3I
2
z − I2) + η(I2x − I2y )]. (2.27)
The next step is to transfer this Hamiltonian from the EFG principal axis system
to the laboratory frame of reference. The spherical coordinates can be used to
make this transformation using Euler angles (θ, φ). The angles (θ, φ) describe the
orientation of the lab frame z-axis in the PAS. In the lab frame, the quadrupole
Hamiltonian takes the form [96]
HQ =
e2qQ
4I(I − 1)[
1
2(3cos
2θ − 1) + 12ηsin
2θcos2φ][3I2z − I2]. (2.28)
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2.1.3.2 Quadrupole splitting
The total Hamiltonian for a spin 1 system is given as [96, 97]
H = HZ +HQ +HCS +HD (2.29)
where HZ and HQ are the Zeeman and quadrupole Hamiltonians respectively. HCS
is a chemical shift Hamiltonian and HD represents the dipolar coupling Hamilto-
nian. The chemical shift and dipolar splitting for a 2H nucleus are of the order
of 4 kHz and 1 kHz respectively. These interactions are very weak in comparison
to quadrupole interactions which give rise to maximum splittings of 250 kHz [96].
Therefore, the chemical shift and dipolar interactions can be neglected. The total
Hamiltonian becomes
H = HZ +HQ (2.30)
H = γ~IˆZB0 +
e2qQ
4I(I − 1)[
1
2(3cos
2θ − 1) + 12ηsin
2θcos2φ][3Iˆ2z − Iˆ2] (2.31)
For I = 1, the energy eigenvalues corresponding to the total Hamiltonian are given
as
Em = γ~mB0 +
e2qQ
4 [3m
2 − 2)][12(3cos
2θ − 1) + 12ηsin
2θcos2φ] (2.32)
For a carbon-deuterium bond, η = .007 and so the above expression is independent
of φ and
Em = γ~mB0 +
e2qQ
4 [3m
2 − 2][12(3cos
2θ − 1)]. (2.33)
The second term in Equation 2.33 reflects the perturbation of the Zeeman splitting
by the quadrupole interactions. Because of this perturbation, there will be two
transitions allowed by the selection rule ∆m = ±1, as shown in Figure 2.4.
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Figure 2.4: Energy level diagram for a spin 1 system in the presence of a magnetic
field, showing Zeeman and quadrupole splitting.
The resonance energies corresponding to the two transitions are given as
~ν± = γ~B0 ± 34e
2qQ
(3cos2θ − 1)
2 . (2.34)
The resulting quadrupole splitting is defined as
∆ν(θ) = ν+ − ν−
= 32
e2qQ
~
[
3cos2θ − 1
2
]
= 2νQP2(cosθ)
(2.35)
where
νQ =
3
4
e2qQ
~
(2.36)
and P2(cosθ) is the second Legendre polynomial [96].
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2.1.3.3 2H NMR powder pattern spectrum of lipid vesicles
In order to use 2H NMR for lipids, hydrogens on the lipid acyl chains need to
be replaced with deuterons. If this replacement is done only at a single site, the
sample is specifically deuterated. On the other hand if deuterons are placed all
along the lipid acyl chain, then the resulting sample is a chain per-deuterated
sample.
In a lipid bilayer, the bilayer normal is the symmetry axis for molecular reorien-
tation. The EFG of a carbon-deuteron bond is attached to the molecule which
reorients about a local symmetry axis (the bilayer normal) and may, in turn, be
oriented along a direction other than that of the static magnetic field. For this
reason, we need to change the frame of reference of the Hamiltonian from the lab
frame to a frame in which we can express the orientation of the EFG with respect
to the bilayer normal. This can be done by using Wigner rotation matrices. The
resulting expression for orientation dependence of the quadrupole splitting for a
particular deuteron is :
∆ν(θ, β) = 32
e2qQ
~
<
3cos2θ − 1
2 > [
3cos2β − 1
2 ] (2.37)
where θ is the angle between the principle axis of the EFG and the bilayer normal
and β is an angle between the bilayer normal and the static magnetic field. The
angled brackets represent the motional averaging of the quadrupole interaction by
the C-2H bond orientational fluctuations. The schematic representation of these
angles with respect to the static magnetic field is shown in Figure 2.5.
In a vesicle sample, the bilayer normal is randomly oriented with respect to the
external magnetic field. In this case β can have any value between 0◦ to 90◦ with
weighting proportionally equal to the fraction of spherical surface represented
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Figure 2.5: The angular orientation of the bilayer normal with respect to external
magnetic field and carbon-deuteron bond.
by that orientation. So the intensity of the NMR spectrum varies with β, with
higher intensity coming from β = 90◦ [96]. The resulting NMR spectrum has
a characteristic line shape called a Pake doublet, as shown in Figure 2.6 (a).
The averaged motion of the lipid acyl chain with respect to the bilayer normal
determines the splitting of the Pake doublet spectrum. It is given by the average
of the second Legendre polynomial P2(cosθ) in Equation 2.37. For a chain per-
deuterated vesicle sample, the NMR spectrum is a superposition of Pake doublets,
corresponding to all deuterons on the lipid acyl chain, as shown in Figure 2.6 (b).
The splitting of these doublets is given by the averaged motion of the lipid acyl
chains. Close to the lipid head groups, lipid acyl chain motion is more constrained,
resulting in larger splittings while, towards the end of the acyl chain, the large
amplitude of motion gives rise to smaller splittings.
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(a)
(b)
Figure 2.6: (a) Powder pattern spectrum of a vesicle sample deuterated at single
site. Solid and dashed lines represent the two transitions for the deuteron and the
intensity varies with β. (b) Powder pattern spectrum for a bilayer vesicle sample
of chain per-deuterated lipids. This spectrum is the superposition of doublets
corresponding to each deuteron on the lipid acyl chain.
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2.1.3.4 Oriented spectrum and orientational order parameter (SCD)
When the bilayer normal has one particular direction with respect to the static
magnetic field, β has only a single value and the resulting spectrum is an oriented-
sample spectrum, as shown in Figure 2.7 (a). Now consider two frames: one lab
frame (x, y, z) and a second frame attached to the molecule. The bilayer normal
points in the direction of the z axis of the lab frame. The average fluctuations of
the molecular frame around the bilayer normal are measured by the orientational
order parameter Sii [95, 96] which is given by:
Sii =
1
2 < 3cos
2θi − 1 > (i = x, y, z) (2.38)
where cos2θi is the time average of the angular fluctuations of the ith coordinate
axis with respect to bilayer normal. The property of direction cosines gives
n∑
i=1
cos2θi = 1.
3∑
i=1
Sii = 0.
(2.39)
For axially symmetric reorientation, we find S11 = S22.
The quadrupole splitting (the splitting of 90◦ edges of the Pake doublet) is given
as
∆νQ =
3
2
e2qQ
~
[S33 +
1
2η(S11 − S22)]. (2.40)
For η = 0, this gives
∆νQ =
3
2
e2qQ
~
[S33]. (2.41)
Using Equation 2.41, we can calculate the orientational order parameter if we
know the quadrupole splitting, since the factor e
2qQ
~
multiplying S33 is a con-
stant known as the quadrupole coupling constant and has a value of 167 kHz
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for carbon-deuterium bonds. In order to calculate the orientational order pa-
rameter from the powder pattern of chain perdeuterated lipids, we first need to
convert the powder pattern into an oriented spectrum. This can be easily done
by using a technique called “dePaking” [98–100] which transforms a powder pat-
tern spectrum to the corresponding oriented-sample spectrum. From the dePaked
spectrum, quadrupole splittings for all deuterons at different carbon positions can
be calculated, which in turn gives the orientational order parameter. The plot of
orientational order parameter vs. carbon position is called the smoothed order pa-
rameter profile. It assumes a monotonic decrease of the order along the acyl chain.
For acyl chain segments close to the headgroup (the order parameter “plateau”
region), orientational order may not change monotonically with position and the
smoothed order parameter profile does not provide details of the orientational or-
der parameter dependence on chain position for this part of the lipid acyl chain
[101]. An example of order parameter profile is shown in Figure 2.7 (b).
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(a)
(b)
Figure 2.7: (a) The oriented sample spectrum: different peaks correspond to
different deuterons on the lipid acyl chain. (b) The orientational order parame-
ter extracted from an oriented sample spectrum: close to the lipid head groups,
chain motion is more restricted and the smaller averaged motion results in higher
quadrupole splittings and larger order parameter values. Close to the end of the
lipid acyl chain, less constrained motion gives rise to small splittings and order
parameter values decrease from carbon number 2 to 16.
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2.1.3.5 Quadrupole echo
The concept of quadrupole echo was introduced by Davis et al. and co-workers
[102]. In the NMR spectrometer used in this work, we use the same coil to excite
the nuclei and to detect the FID signal. Due to the imperfect isolation of the high
power transmitter from the low power receiver, the preamplifier is overloaded by
the strong RF pulse and it is blinded for a short period (∼ 20 µs) referred to as
the receiver “dead time” or “recovery time” [103]. The NMR spectral width used
for lipid bilayers typically is 250 kHz, so important information is contained in
the very early part of the initial FID. This part of FID can not be detected in a
single pulse experiment because the receiver is affected by the strong RF pulse in
this interval. The practical solution to this recovery time issue is to translate the
FID t=0 point to beyond the receiver’s dead time. This time translation is done
by applying the quadrupole echo pulse sequence shown in Figure 2.8.
Figure 2.8: The representation of the quadrupole echo pulse sequence. A pi2 pulse
along x axis brings the magnetization along y axis. For time τ , spin system evolves
under the quadrupole Hamiltonian. At the end of τ a second pi2 pulse is applied
along y axis. The echo occurs at the end of time period 2τ .
The quadrupole echo experiment consists of two pi2 pulses 90
◦out of phase with
each other and separated by a time much longer than the receiver’s dead time. The
first pulse, (pi2 )x, flips the magnetization from the z axis to the y axis. Then, for a
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period τ , the system evolves under the influence of the quadrupole Hamiltonian.
The quadrupole interactions vary from nucleus to nucleus as a result of differences
in the EFG local orientations. This orientational dependence causes the spins to
get out of phase with each other. At the end of period τ , the second pulse (pi2 )y
is applied. This pulse refocuses the dephasing which occurred due to spread in
ν(θ, β) [96].
2.1.3.5.1 Density operator treatment of spin 1 system
The density operator treatment of spin 1 system is based on the description pre-
sented by Bloom [93]. The density operator formulation can be used to understand
the refocusing of magnetization with the quadrupole pulse sequence. For details
refer to Appendix A.
2.1.3.6 Quadrupole echo decay time T qe2
The quadrupole echo sequence consists of two pi2 pulses that are 90
◦ out of phase
with each other. The echo is formed at 2τ , where τ is the separation between
the two pi2 pulses. By varying the interval between the pulses, it is possible to
measure the characteristic echo decay time. This provides information about the
motions that modulate the orientation-dependent quadrupole interactions during
the interval 2τ . Quadrupole echo decay is characterized by an averaged decay time
T qe2 . The amplitude of the observed echo reflects the extent to which orientation-
dependent quadrupole interactions are left unperturbed by molecular motions [104,
105]. For a given separation, τ , of the pi2 pulses in the quadrupole echo sequence,
the echo amplitude A(2τ) can be written as [93, 106]
A(2τ) =
∑
i
Ai(0)e−Ri2τ (2.42)
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where summation over i represents the contribution from all deuterons at all sites
along the lipid acyl chain and over all orientations of the bilayer normal. Ri is
the echo decay rate for a given deuteron i due to all motions that modulate the
quadrupole interactions for that deuteron. For short τ , the amplitude of the echo
can be written as
A(2τ) =
∑
i
Ai(0)(1−Ri2τ) (2.43)
= A(0)− A(0)2τ∑
i
Ai(0)
A(0) Ri (2.44)
= A(0)e−<R>2τ . (2.45)
In the limit of short τ , the quadrupole echo decays exponentially with a charac-
teristic time T qe2 , which is given as
< R >= (T qe2 )−1. (2.46)
< R > is an average over the entire population of deuterons. If we plot ln
(
A(τ)
A(0)
)
vs. 2τ , the negative inverse of the slope will give T qe2 .
All motions have associated correlation times τci. The distinction between fast and
slow motions is made by comparing τci with (∆M2i)−1/2, where ∆M2i is the second
moment of that portion of the quadrupole interaction modulated by motion i. It
represents the range over which quadrupole splittings vary due to the molecular
motion. In the fast motion regime, the echo decay rate, (T qe2 )−1, is proportional
to the correlation time [93, 107] so that
1
T qe2
= 4M2jτcj. (2.47)
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In the slow motion regime, the echo decay rate, (T qe2 )−1, is inversely proportional
to the correlation time so that
T qe2 = τcj. (2.48)
In particular, quadrupole echo decay can indicate a peptide-induced perturbation
of slow motions, like bilayer undulation, that may be too slow to be directly
detectable by changes in quadrupole splitting.
2.1.4 15N NMR
15N is a spin 12 nucleus. As explained earlier, the application of a static magnetic
field results in precession at the Larmor frequency. The actual resonance frequen-
cies observed in NMR experiments are slightly different from Larmor frequencies
and this difference is termed chemical shift. In a semi-classical view, the mecha-
nism by which this shift occurs can be thought of in two steps: 1) The external
magnetic field induces currents in electron clouds; 2) These currents in turn induce
a magnetic field, Binducedj [90]. Because of this effect, the resultant local magnetic
field experienced by each nucleus is
Blocj = B0 +Binducedj . (2.49)
In this expression, the local induced field can be expressed as
Binducedj = σj · B0 (2.50)
where σj, the second rank chemical shift tensor, characterizes how the shift de-
pends on orientation for a specific chemical spin environment. In the principal
axis system (PAS), the chemical shift tensor has three diagonal elements σ11, σ22
and σ33. These elements near a peptide bond are shown in Figure 2.9 (a). When
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(a)
(b)
Figure 2.9: (a) The components of chemical shift tensor positioned near to the
peptide bond. (b) The representation of chemical shift tensor in the principal axis
system. This figure is inspired from Bechinger et al. [108].
transformed from the PAS to the lab frame using Euler angles Θ,Φ, and Ψ, the z
component in the direction of the applied field corresponds to the measured value
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of chemical shift
σzz = σ11sin2Θcos2Φ + σ22sin2Θsin2Φ + σ33cos2Θ. (2.51)
Graphically, the 15N chemical shift tensor can be represented by an ellipsoid,
as shown in Figure 2.9 (b) [108]. The axes of the ellipsoid are represented by
1√
σii
where σ11, σ22, σ33 are the main tensor elements. The intersection of the
ellipsoid and magnetic field direction gives an observable chemical shift for a given
orientation of the molecule.
For α helical peptides, the N-H vector and σ33 are within 18◦ of each other and
both are oriented to within a few degrees of the helical axis [109, 110]. Therefore,
the observed 15N chemical shift gives the information about the alignment of α
helical peptides within oriented lipid bilayers. For randomly distributed molec-
ular orientations, a powder pattern spectrum is shown in Figure 2.10. It has
Figure 2.10: The schematic representation of 15N powder pattern spectrum for ran-
domly distributed molecular orientations. The tensor elements of the 15N chemical
shift tensor of the amide bond have approximate values of 61, 75, and 223 ppm
(σ11, σ22, and σ33).
been shown that in oriented lipid bilayers, with the bilayer normal parallel to the
static magnetic field, transmembrane alignment of an AMP results in a chemical
shift > 180 ppm while chemical shifts < 100 ppm are observed for in-plane pep-
tide orientation of peptides [109]. The two alignments of peptide with respect to
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membrane surface and corresponding value of 15N chemical shift are schematically
shown in Figure 2.11.
Figure 2.11: The schematic representation of 15N chemical shift values for different
orientations of α helical peptides. This figure is inspired from Bechinger et al. [109]
2.2 Zeta potential
In an electrical double layer, the slipping plane makes an envelope around a
charged particle in which counter-ions make a rigid layer tightly bound to the
charged particle. The electrical potential generated by the charge enclosed by the
slipping plane is called the zeta potential [111].
2.2.1 Electrical double layer
The electrical double layer model explains the distribution of ions in the vicinity
of a charged particle [112–114]. For a negatively charged particle dispersed in
solution, positive counter-ions tend to accumulate around it. The distribution of
ions around a negatively charged particle is assumed to exist in two parts: the
inner (Stern) layer, where ions are strongly bound to the negatively charged surface
and the outer (diffuse) region, where they are less firmly attached to the surface.
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Within the diffuse layer, there is a boundary, when a particle moves, ions within
the boundary move with it, but any ions beyond the boundary do not travel with
the particle. This boundary is called the slipping plane or the surface of shear
[115]. The configuration of the electrical double layer is schematically shown in
Figure 2.12. The concentration of counter-ions is high near the negatively charged
surface and it decreases gradually with distance. When an electric field is applied,
Figure 2.12: The charge distribution around negatively charged particle repre-
sented by the black circle. The inner dotted circle represents the Stern layer and
the outer dotted circle shows the slipping plane. This figure is inspired from Freire
et al. [116]
the ions in the Stern layer that are firmly attached to the negatively charged
surface, move with the particle. The ions beyond the slipping plane stay with the
bulk solution. Therefore, the slipping plane is a boundary where bound charge
and solution move in different directions. The potential at the slipping plane is
Chapter 2. Biophysical methods to study the interactions of AMPs with model
membranes 60
called the zeta potential. Basically, it is the difference between the potential at
the slipping plane and at a point at infinity in the bulk solution [115, 117].
2.2.2 Measurement of zeta potential by electrophoresis
The zeta potential is calculated from the experimentally determined electrophoretic
mobility using Henry’s equation [116]:
UE =
2εζf(κa)
3η (2.52)
where UE is electrophoretic mobility, ζ is the zeta potential, ε is the dielectric
constant, η is the viscosity. The function f(κa) is called the Henry’s function where
κ is the inverse Debye length and a is the particle size. For the low potential regime,
the linearized version of Poisson-Boltzmann equation gives the the variation of
electric potential in an electric double layer [113]
∇2Ψ = −e2
∑
i z
2
i ni
ε0εkT
Ψ (2.53)
= κ2Ψ (2.54)
where
κ =
√√√√e2∑i z2i ni
ε0εkT
(2.55)
is the inverse Debye length, ni represents the bulk concentration of each type of
ion and zi is the charge of the ion. Debye length (1/κ) represents the thickness of
the electrical double layer and has units of length.
The general form of the Henry’s function is given by the numerical solution of
O’Brien and White [118]. Henry’s function distinguishes between Hu¨ckel and
Smoluchowski approximations. These two approximations are two limiting cases
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for very small and very large values of κa. The Hu¨ckel approximation is ap-
plicable when the size of a particle is smaller than the Debye length, while the
Smoluchowski approximation is used when particle size is greater than the Debye
length. This is schematically shown in Figure 2.13.
Figure 2.13: The schematic representation of (a) Hu¨ckel (b) Smoluchowski approx-
imations. For the work reported in this thesis, the Smoluchowski approximation
is used to determine the zeta potential.
The values of Henry’s function for both approximations are given below
f(κa) = 1.5 if a >> 1
κ
= 1.0 if a << 1
κ
.
(2.56)
The electrophoretic mobility of particles is measured experimentally by using the
Phase Analysis Light Scattering (PALS) technique. As the name suggests, in this
technique the phase shift in the light scattered by moving particles is measured.
The laser beam is split into two parts by a beam splitter; one beam is called the
reference beam and the other is called the scattering beam. The scattering beam
passes through the sample cell that has a pair of electrodes. When a voltage is
applied across the electrodes, the charged particles move towards the opposite
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electrodes. The light scattered by moving particles is detected at an angle of 13◦.
The phase shift is measured by comparing the phase of scattered light with the
phase of the reference beam [115, 117, 119, 120]. Knowledge of the phase shift in
the scattered light provides information about electrophoretic mobility from which
the zeta potential can be calculated.
2.3 Circular dichroism (CD) spectroscopy
Circular dichroism (CD) refers to the difference in a chiral molecule’s absorption
of left-handed circularly polarised light (L-CPL) and right-handed circularly po-
larised light (R-CPL)
CD = ∆A(λ) = A(λ)L−CPL − A(λ)R−CPL. (2.57)
The interaction of the electric field component of light with a chiral molecule re-
sults in the linear displacement of charge. This is termed an electric transition
and it is associated with an electric transition moment. On the other hand, when
the magnetic field component of light interacts with a molecule it results in the
circular movement of charge. This is called a magnetic transition and it corre-
sponds to some finite value of magnetic transition moment. Rotational strength
is a property of a given electronic or magnetic transition i→ f and given as
Rif = Im(µif ·mif ) (2.58)
where µif and mif are the electric and magnetic dipole transition moments respec-
tively for the transition i→ f and Im represents the imaginary part of (µif ·mif ).
The rotational strength is non-zero if a transition from i → f state is associated
with both the linear motion of charge in a particular direction and circular motion
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about that direction. This linear and circular motion together corresponds to the
helical motion of charge. The right and left-handed helical motions of charge de-
termine whether R-CPL or L-CPL is absorbed more strongly by a molecule which
in turn leads to CD [121, 122].
2.3.1 CD spectrum of peptides
The most common chromophore in the case of a peptide is the peptide bond
which links different amino acid residues. The alpha carbon in a peptide bond is
asymmetric in nature and gives a chiral character to the peptide backbone. The
CD spectrum of a poly-peptide has a characteristic shape based on its secondary
structure, as shown in Figure 2.14. For α-helical peptides, the CD spectrum
consists of two negative minima near 222 nm and 208 nm and a stronger positive
peak near 190 nm. In the case of β sheet, two negative peaks near 217 nm and
180 nm and one positive peak at 195 nm are observed. For random-coil peptides,
the CD spectrum consists of a stronger negative peak near 200 nm [121, 123].
2.3.2 Measurement of CD and percent helicity of α helical
peptides
The magnitude of CD is measured in terms of ellipticity (θ), an angle expressed in
millidegrees. This angle is schematically shown in Figure 2.15 and is the tangent of
the ratio of the minor to major elliptical axes. It is possible to calculate the percent
helicity from the normalized CD spectrum of α-helical peptides. For this purpose
the experimentally observed CD is converted into the Mean Residue Ellipticity
(MRE)
[θ]MRE = θ
c× L×NR
(2.59)
Chapter 2. Biophysical methods to study the interactions of AMPs with model
membranes 64
Figure 2.14: CD spectrum of poly-peptides results from different absorption of
R-CPL and L-CPL. The curve has a different shape according to the secondary
structure of the poly-peptide.
Figure 2.15: The representation of an ellipticity when L-CPL and R-CPL have
different magnitude. The ER and EL represent the electric field component of
R-CPL and L-CPL respectively.
where θ is recorded ellipticity, c is the peptide concentration in dmol/L, NR is
the number of residues in the peptide, and L is path length in cm. The fractional
helicity of a peptide sequence is the difference between the mean residue ellipticity
and the random coil ellipticity divided by the difference between the helix elliptic-
ity and the coil ellipticity, all measured at 222 nm [124]. It can thus be expressed
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as
fH =
θ222 − θC
θH − θC
(2.60)
where, θC and θH are the ellipticities for the random coil and complete helical
structure. θC and θH both vary linearly as a fuction of temperature
θC = 2200− 53T
θH =
−44000 + 250T
1− 3
Nr
(2.61)
T is the temperature in ◦C.
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The interactions of AMPs with cell membranes are key aspects of their mechanisms
[19, 37, 42, 80]. AMP-membrane interactions can permeabilize the membrane itself
and/or disrupt the membrane as a consequence of the AMP’s transport across the
membrane so it can gain access to intracellular targets [43, 125]. Cell membranes
are very complex in nature. However, model membranes can be used to mimic
the essential components of cell membranes. The interactions of Gad peptides
with model lipid bilayers were studied using solid-state NMR spectroscopy and
zeta potential measurements. 2H NMR was employed to investigate the peptide-
induced disorder in model lipid membranes. Using zeta potential measurements,
the peptide binding to the membrane was quantified in terms of the equilibrium
constant, the partition constant, and lipid to peptide molar ratio (L : P ). Because
Gad peptides take on different charges at pH 7.0 and 5.0, the experiments were
66
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carried out at both pHs to gain insight into the charge dependence of the AMP-
membrane interactions.
3.1 Materials and methods
3.1.1 Lipids
Eukaryotic cell membranes are mainly composed of zwitterionic lipids (POPC,
sphingomyelin, and cholesterol), whereas bacterial membranes also contain POPE
and anionic POPG lipids. In order to understand the interactions of Gad peptides
with model membranes that mimic bacterial membrane lipid composition, a lipid
mixture of POPE/POPG was used. Chain per-deuterated lipid, POPG-d31, along
with non-deuterated POPE were purchased from Avanti Polar Lipids (Alabaster,
AL). All lipids were used without further purification. The molecular weight and
the hydrated bilayer gel to liquid crystal transition temperatures of lipids used in
this study are listed in Table 3.1.
Lipid Molecularweight(g/mole)
Transition temperature
(◦C)
POPC 760 -2
POPE 718 25
POPG-d31 802 -2
Table 3.1: The molecular weights and the hydrated bilayer gel to liquid crystal
transition temperatures of different lipids used in this study. This information was
obtained from Avanti Polar Lipids (Alabaster, AL).
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3.1.2 2H NMR
3.1.2.1 Sample preparation
To prepare multilamellar vesicles, 40 mg of POPE/POPG-d31 (3:1 molar ratio) dry
lipid powder was weighed using a Mettler A260 analytical balance. Lipid powders
were dissolved in 4-5 mL chloroform/methanol (2:1) and placed in a round-bottom
flask. The organic solvent was removed by rotatory evaporation at 40◦C for 20-
30 minutes. To make sure that there were no traces of solvent left, the samples
were further dried in an evacuated desiccator connected to a pump with liquid
nitrogen trap for 6-8 hours. The dry lipid mixture was hydrated with 550 µL of
10 mM potassium acetate buffer at pH 7.0 or 10 mM potassium phosphate buffer
at pH 5.0. The pH of each sample was measured with a pH meter (Beckman 340
pH meter) using a micro-probe (Sigma-Aldrich Co.) and adjusted to the desired
pH to within ± 0.1, by adding 0.1 M HCl or 0.1 M NaOH. Finally, samples
were transferred to pre-cleaned 400 µL NMR tubes and sealed tightly with teflon
tape. To prepare multilamellar vesicles containing Gad peptides, dry powder of
the peptide was mixed with the POPE/POPG-d31 (3:1) lipid mixture, keeping the
L : P ratio at 25:1 (molar ratio). A total of 4.9 mg of Gad-1 and 4.3 mg of Gad-2
dry powder was used in these samples. The dry powder mixture of lipids and
peptide was then dissolved in 4-5 mL chloroform/methanol (2:1) and placed in a
round-bottom flask. After this, the same steps of solvent removal and hydration
were followed as described above for lipid-only samples. All samples were stored
in a freezer at -20◦C after NMR experiments.
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3.1.2.2 Experimental details
All 2H NMR experiments were performed at 61 MHz, corresponding to a magnetic
field strength of 9.4 T, on a locally assembled spectrometer. Sample temperatures
were controlled to ± 0.1◦C using a PID (Proportional−Integral−Differential) tem-
perature controller (model 325, Lake Shore cryotronics, USA). In order to obtain
the powder pattern spectrum, 2H NMR experiments were performed using the
quadrupole echo pulse sequence [126] with a pi2 pulse length of 5.5 µs and pulse
separations of 35 µs. A 15 µs delay was applied before the 5 µs acquisition trigger.
All spectra were obtained by averaging 4000 transients, with repetition times of
0.9 s. Experiments were performed at two temperatures, 25◦C and 37◦C. Oriented
spectra corresponding to the powder pattern spectra were obtained by dePaking.
DePaking is a procedure to transform the multilamellar vesicle sample spectrum
to the spectrum that would be expected for an oriented bilayer sample [98]. The
McCabe and Wassall [99] approach was used to perform dePaking. The free induc-
tion decays used for dePaking were obtained by averaging 60,000 transients. The
orientational order parameter values were calculated from these dePaked spectra.
Additional information about the AMP-membrane interactions can be obtained
from examination of the quadrupole echo decay rate (T qe2 ). The echo decay rate
can indicate how the slow motions of lipid bilayers are perturbed by the presence
of peptide. To obtain the quadrupole echo decay rate at two temperatures, 25◦C
and 37◦C, 2H NMR experiments were performed using the quadrupole echo pulse
sequence with a pi2 pulse length of 5.5 µs and quadrupole echo pulse separations
of 35 µs, 50 µs, 75 µs, 100 µs, 150 µs, 200 µs, 300 µs, and 400 µs. A 15 µs delay
was applied before the 5 µs acquisition trigger. For each pulse separation, 800
transients were averaged to obtain the echo amplitude. The repetition time was
0.9 s.
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3.1.3 Zeta potential (ζ-potential) measurements
3.1.3.1 Sample preparation
Multilamellar vesicles for zeta potential measurements were prepared at a concen-
tration of 6.8 mM using the protocol described in Section 3.1.2.1. Samples were
prepared with total lipid weight of 20 mg using 10 mM sodium acetate buffer at
either pH 5.0 or 7.0. The buffer solution was prepared in ultrapure MilliQ water
(resistivity 18 MΩ). To make large unilamellar vesicles, samples were subjected to
five cycles of freeze-thaw-vortex steps. The samples were frozen in liquid nitrogen
for 3-5 minutes and thawed at room temperature. Samples were vortexed after
each freeze-thaw step. Unilamellar vesicles of uniform size were prepared by 12
cycles of extrusion using a 200 nm filter (Nuclepore Track-Etched Membranes,
Whatman, Toronto ON) under nitrogen gas pressure. Gad peptide stock solutions
were prepared at 50 µM concentration using 10 mM sodium acetate buffer at ei-
ther pH 7.0 or 5.0. The liposome and peptide stock solutions used in this work
were 1-5 days old. For each zeta potential measurement, a sample of 2 mL final
volume was prepared by mixing appropriate volumes of the liposome, the peptide
stock solutions and buffer solution, to obtain the desired final concentrations of
lipids and peptide. The liposome concentration was kept constant at 40 µL and
the peptide concentration was varied. The pH of each sample was tested with a
pH meter using a micro-probe and adjusted to 7.0 ± 0.1 or 5.0 ± 0.1 by adding
0.1 M HCl or 0.1 M NaOH. All mixed peptide/lipid samples were prepared and
used on the same day.
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3.1.3.2 Experimental details
Zeta potential measurements were performed at 25◦C in a Malvern Zetasizer Nano
ZS apparatus (model ZEN 3600, Malvern Instruments Ltd. U.K.). It was fitted
with a 633 nm He−Ne laser. Zetasizer disposable folded capillary cells, DTS 1070
(Malvern Instruments Ltd. U.K.), were used in these experiments. Before each
measurement, the cells were washed thoroughly with ethanol and then with ultra-
pure MilliQ water, and then dried under nitrogen flow. Samples were put in the
measuring cells by injecting slowly using a 1 mL BD (Becton, Dickinson and Com-
pany) syringe to avoid bubbles that could affect the quality of the measurement.
For each sample, 3 measurements (20 runs each), with an initial equilibration time
of 5 minutes were performed at a constant voltage of 40 mV. The error bars on the
binding isotherms represent the standard deviation in the average three measure-
ments. The entered values of viscosity, refractive index, and dielectric constant
were set at 0.8872 cP, 1.330, 78.5 respectively. Malvern DTS software was used to
obtain mean zeta potential values.
3.1.4 Synthesis of Gad peptides
Gad peptides, Gad-1 and Gad-2, were chemically synthesized using O-fluorenylmethyl-
oxycarbonyl (Fmoc) solid-phase synthesis on a CS Bio peptide synthesizer (model
CS336X, CS Bio Company Inc., Menlo Park, CA). The peptide synthesis started
with the attachment of the C-terminal peptide residue to the resin. In order to
prevent polymerization of the amino acid, the alpha amino group and all reactive
side chains were protected with Fmoc groups. Once the amino acid was attached
to the resin, the protecting Fmoc group was removed. Then the next amino acid
was coupled to the C-terminal amino acid. This cycle was repeated until the
peptide sequence was complete. After this, the peptide was removed from the
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resin and purified. The detailed protocol for the synthesis of Gad peptides [26] is
described below:
1. All Fmoc amino acids for 0.2 mmole synthesis were weighed out in 5 × excess
amounts.
2. 0.43 g rink amide resin (CS Bio Company Inc., Menlo Park, CA) was sus-
pended in N, N-Dimethylformamide (DMF) for at least an hour.
3. Amino acids were loaded in a reverse order i.e. C-terminus first.
4. The resin bottle was attached and nitrogen flow and air compressor were
turned on.
5. Reagent bottles 1, 2, 4, and 7 were filled with DMF. Bottle 3 was filled with
20% piperidine in DMF, bottle 5 with 1 M N, N-Diisopropylcarbodiimide
(DIC) in DMF, and bottle 6 was filled with 0.4 M 1-hydroxy-benzotriazole
(HoBt) in DMF.
6. The dissolution of amino acids was carried out with 0.4 M HoBt dissolved in
DMF. The resin washes were performed by DMF and de-blocking of amino
acids was achieved with 20% piperidine dissolved in DMF.
7. Once the peptide synthesis was completed, the peptide-containing resin, was
transferred to a 10 mL syringe (BD Diagnostics Co.), rinsed with methanol
under vacuum and left in the vacuum pump for at least an hour.
8. The cleavage of the peptide from the resin was carried out by using a cleavage
cocktail prepared with 9.4 mL trifluoroacetic acid (TFA), 0.1 mL thioanisole,
0.25 mL 1,2- ethanedithiol (EDT), and 0.25 mL distilled water.
9. After adding the cleavage cocktail, the peptide was stirred for at least two
hours at room temperature.
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10. The resulting solution contained C-terminally amidated peptide. It was
transferred into a 50 mL Falcon tube.
11. 40 mL of -20◦C diethyl ether was added and the tube was left in -20◦C degree
freezer overnight for cold precipitation.
12. The white precipitate was centrifuged at 4690 × g at 4◦C in Thermo Sorvall
RC6+ centrifuge for 10-15 mins. Next, diethyl ether was removed very
gently without disturbing the peptide pellet. This was followed by one more
overnight diethyl ether precipitation.
13. The peptide was purified by High Pressure Liquid Chromatography (HPLC)
as in McDonald et al., 2015 [26]. The molecular weight was confirmed
by mass spectrometry (MALDI-TOF MS-Genomics and Proteomics facility,
Memorial University). HPLC fractions containing the peptide were pooled
and lyophilized.
14. The peptide was desalted by dialysis against 5% acetic acid and then water
using 1kDa molecular weight cutoff of dialysis tubing. The resulting peptide
solution was lyophilized and stored at 4◦C.
3.2 Results
3.2.1 2H NMR results
NMR was used to assess peptide-induced acyl chain disorder in model lipid bilayers
and the effect of peptide on slow motions of lipid bilayers.
As explained in Section 2.1.3.3, the powder pattern of chain per-deuterated lipids is
a superposition of Pake doublets each corresponding to a deuteron on the lipid acyl
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chain. The prominent edge at the maximum splitting for a spectrum corresponds
to the deuterons on carbon atoms close to the lipid head group. The motions of
chain segments containing these carbon atom are more constrained and thus more
orientationally ordered than those of segments farther from the headgroup. The
smallest quadrupole splittings come from the deuterons on the less constrained
carbon atoms at the ends of lipid acyl chains. If the interaction of the peptide
with lipid bilayers perturbs the lipid acyl chain packing and orientational order,
the result will be a change in the range of splittings observed along a deuterated
chain. A quantitative analysis of bilayer disruption by the peptide can be made
by extracting the orientational order parameter, SCD. The effect of the peptide on
slow motions, like bilayer undulation or diffusion over regions of bilayer curvature,
can be studied by measuring quadrupole echo decay time, T qe2 . These motions of a
lipid bilayer can affect refocussing of the quadrupole echo even if their correlation
times are too long to contribute to changes in quadrupole splitting.
3.2.1.1 Peptide-induced disorder in model lipid bilayers
In order to investigate how Gad peptides perturb model lipid bilayers and how
this perturbation changes with pH, a series of 2H NMR experiments were per-
formed with multilamellar vesicles containing Gad peptides at pH 7.0 and pH 5.0.
All samples were prepared following the protocol described in Section 3.1.2.1. 2H
NMR spectra were acquired at two temperatures, 25◦C and 37◦C, using acquisi-
tion parameters listed in Section 3.1.2.2. The resultant 2H spectra are shown in
Figures 3.1 (a) and (b). It is evident from Figure 3.1 that the spectra of the lipids
themselves did not change with pH. The powder pattern free induction decays
obtained from multilamellar vesicles at 37◦C were dePaked to obtain the corre-
sponding oriented sample spectrum. The orientational order parameter (SCD) was
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calculated from these dePaked spectra using
∆νQ =
3
2
e2qQ
~
SCD. (3.1)
The dePaked spectra and corresponding order parameter profiles at pH 7.0 and
pH 5.0 are shown in Figure 3.2 and Figure 3.3 respectively. It is evident from the
order parameter profiles that addition of Gad peptides to POPE/POPG-d31(3:1)
lipid bilayers results in the reduction of order parameter values at both pH val-
ues. It should be noted that the change in orientational order parameter due to
the Gad peptides is small. Comparisons of the order parameter values for each
peptide at two pH values are shown in Figure 3.4 (a) and (b). The comparison of
order parameter values indicates that for both Gad-1 and Gad-2, peptide-induced
disorder in the lipid bilayer was not pH dependent.
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(a)
(b)
Figure 3.1: 2H NMR spectra of multilamellar POPE/POPG-d31(3:1) vesicles with
and without Gad peptides at two pH values (a) at 25◦C (b) 37◦C. All spectra
were obtained by averaging 4000 transients. Comparison of spectra show a small
peptide-induced decrease in splitting. The dashed black lines indicate the maxi-
mum quadrupole splitting for deuterons on the most ordered chain segments in the
absence of peptide at 37◦C. Comparison of maximum splittings for other spectra
with the location of the black line provides an indication of the extent to which the
presence of the peptide alters the observed quadrupole splitting in each sample.
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(a)
(b)
Figure 3.2: The peptide-induced acyl chain disorder in POPE/POPG-d31(3:1)
lipid vesicles was quantitatively analysed by calculating orientational order pa-
rameter SCD. For this, the powder pattern spectra of lipids and lipids + Gad pep-
tides were dePaked to obtain the corresponding oriented sample spectra. (a) The
oriented spectra corresponding to the powder pattern spectra of POPE/POPG-
d31(3:1) lipid vesicles with and without Gad peptides at pH 7.0. (b) Order param-
eter values of POPE/POPG-d31(3:1) lipid vesicles in the absence and presence of
Gad peptides at pH 7.0. The uncertainty in order parameter values was approxi-
mately 5%. The addition of either peptide is seen to decrease the order parameter
values at this pH value.
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(a)
(b)
Figure 3.3: (a) The oriented spectra corresponding to the powder pattern spectra
of POPE/POPG-d31(3:1) lipid vesicles with and without Gad peptides at pH 5.0.
(b) Order parameter values for POPE/POPG-d31(3:1) lipid vesicles in the absence
and presence of Gad peptides at pH 5.0. The uncertainty in order parameter values
was approximately 5%. The addition of either peptide is seen to decrease the order
parameter values at this pH value.
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(a)
(b)
Figure 3.4: (a) The comparison of order parameter profiles for POPE/POPG-
d31(3:1) lipid bilayers interacting with Gad-1 at pH 7.0 and 5.0. (b) The compari-
son of order parameter profile for POPE/POPG-d31(3:1) lipid bilayers interacting
with Gad-2 at pH 7.0 and 5.0. The overlapping of points suggests that peptide-
induced disorder in the lipid acyl chains is not sensitive to change in pH for either
peptide.
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3.2.1.2 Effect of Gad peptides on slow motions of lipid bilayers as
determined by quadrupole echo decay time (T qe2 )
A series of quadrupole echo decay experiments were carried out to see if Gad
peptides can perturb the slow motions of the lipid bilayer and whether any ob-
served perturbations are sensitive to pH. Details of quadrupole echo decay time
are described in Section 2.1.3.6.
Quadrupole echo decay time experiments were performed on multilamellar vesicles
with and without the addition of Gad peptides at pH 7.0 and pH 5.0. Acquisition
parameters listed in the Section 3.1.2.2 were used to perform these experiments.
The echo amplitudes were measured for each value of τ . The averaged echo decay
times, T qe2 , were obtained by plotting ln
(
A(τ)
A(0)
)
vs. 2τ and using the initial slope
of the echo decay curve. The average echo decay time (T qe2 ) results are shown in
Figure 3.5 for two temperatures, 25◦C and 37◦C.
A change in the value of T qe2 with the addition of Gad peptides indicates a per-
turbation of fast or slow lipid motions by Gad peptides in POPE/POPG-d31 (3:1)
lipid bilayers. At 25◦C and pH 7.0, Gad-1 decrease the echo decay time and Gad-2
has little effect on the echo decay time. At 25◦C and pH 5.0, Gad-1 has little ef-
fect on the echo decay time and Gad-2 significantly increases the echo decay time.
At 37◦C and at pH 7.0, Gad-1 decreases the echo decay time slightly and Gad-2
increases the echo decay time. At 37◦C and at pH 5.0, Gad-1 has little effect on
echo decay time and Gad-2 significantly increases the echo decay time.
A decrease in echo decay time (i.e. the effect of Gad-1 at pH 7.0 at either temper-
ature) could reflect an increase in fast motion correlation time (i.e. slowing down
a fast motion) or a decrease in slow motion correlation time (i.e. speeding up a
slow motion). The increase in echo decay time (i.e. the effect of Gad-2 at pH 5.0
at either temperature) could reflect a decrease in fast motion correlation time (i.e.
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a speeding up of fast motion) or an increase in slow motion correlation time (a
slowing down of a slow motion).
For lipid only samples, echo decay time is independent of temperature or only
weakly dependent on temperature. The echo decay times for bilayers with a given
peptide are not sensitive to pH and thus not sensitive to peptide charge. Gad-1 and
Gad-2 seem to have opposite effects on the echo decay times. The interpretation
of these observations is discussed in Section 3.3.
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(a)
(b)
Figure 3.5: (a) The pH dependence of quadrupole echo decay time (T qe2 ) of
POPE/POPG-d31 (3:1) lipid vesicles with and without the addition of Gad pep-
tides at (a) 25◦C (b) 37◦C. The error bars represent the uncertainty in the values
of T qe2 calculated from the uncertainty in the value of initial slope of echo decay
curve.
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3.2.2 Zeta potential (ζ-potential) results
The concentration of AMP required to disrupt a bacterial membrane is an impor-
tant factor. While there needs to be a high enough concentration of AMP for there
to be significant interactions with bacterial membranes, the concentration should
not be so high that host cells are harmed. This fine balance between maximizing
interactions with pathogen membranes and minimizing them with host cell mem-
branes makes it important to understand the binding affinities of peptides to lipid
membranes. Gad peptides have higher overall positive charge at pH 5.0 than at
pH 7.0. Therefore, a stronger electrostatic interaction between peptide and lipid
bilayers was expected at slightly acidic pH than at neutral pH. Also, MIC assay
against E.coli showed that Gad-2 exhibits greater activity at pH 5.0 than at pH
7.0 [26]. However, 2H NMR results showed that there was no difference in the
peptide-induced disorder in POPE/POPG (3:1) lipid bilayers for Gad peptides at
pH 7.0 and pH 5.0. A potential hypothesis to explain this discrepancy could be
that Gad peptides perturb the lipid acyl chain order in the same way at pH 7.0
and at pH 5.0 but there might be a difference in the binding of the peptides at
different pH values. To account for the observed effects of pH on lipid chain order
and MIC, it might then be necessary to further hypothesize that MIC correlates
with the binding of peptide to the membrane rather than to perturbation of lipid
acyl chain order. Two parameters deduced from binding studies, the equilibrium
constant (Keq) and the peptide partition constant (KP ), describe the binding pro-
cess quantitatively [56, 116, 127, 128]. The equilibrium constant and partition
constant can be determined by using different methodologies [116] such as UV-
Vis absorption spectrophotometry, fluorescence spectroscopy, and zeta potential
measurements. In this work, zeta potential measurements were used to quantify
peptide binding to model membranes at two pH values. For this purpose, zeta po-
tentials of model lipid membranes were measured with increasing concentrations
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of peptide. Binding isotherms were obtained by plotting zeta potential vs. peptide
concentration.
3.2.2.1 Binding isotherms
Zeta potentials of POPE/POPG (3:1) lipid vesicles with increasing concentrations
of Gad peptides were measured at pH 7.0 and pH 5.0. Large unilamellar vesicles
were prepared using the protocol described in the Section 3.1.3.1. The sizes of
these vesicles were measured by Dynamic Light Scattering (DLS) using a Malvern
Zetasizer Nano ZS apparatus (model ZEN 3600, Malvern Instruments Ltd. U.K.).
The observed sizes of these vesicles were 140 ± 10 nm. The pH of each sample
was tested with a pH meter using a micro-probe and adjusted to 7.0 ± 0.1 or 5.0
± 0.1. For all zeta potential measurements, temperature was maintained at 25 ±
0.1 ◦C. Firstly, the zeta potential was measured for lipid vesicles in the absence
of peptide at both pHs. As expected, negative zeta potentials were calculated
from electrophoretic mobilities for these liposome samples. This was followed by
the measurement of zeta potentials for lipid vesicles in the presence of increasing
concentrations of Gad peptides. The appropriate amounts of lipid vesicle stock
solution were added to the peptide solution to achieve the desired concentration of
peptide. The lipid concentration was kept constant at 40 µM in all measurements.
For Gad-1, peptide concentration ranged from 0 µM−20 µM in 1 µM steps (0, 1,
2, 3,....20 µM) while for Gad-2 it was increased from 0 µM−50 µM in 5 µM steps
(0, 5, 10.....50 µM). For Gad-2, little change in the zeta potential was observed
when peptide concentration was increased in steps of 1 µM. This is presumably
due to the fact that Gad-2 has less charge than Gad-1 at both pHs. The values of
zeta potential for liposomes with and without the addition of Gad peptides were
calculated from their electrophoretic mobility using Henry’s equation along with
the Smoluchowski approximation [129, 130] using the Malvern DTS software. For a
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given population of liposomes, individual zeta potential values form a distribution.
The mean zeta potential represents the mean of the zeta potential distribution and
is obtained using Malvern instrument software. The error bars were estimated by
averaging the deviation from the mean for three measurements. As explained
in Section 2.2.2, the Smoluchowski approximation can be used when the particle
size is greater than the Debye length (a >> 1/κ). Using Equation 2.55 [131],
Debye lengths were estimated for the solutions in which vesicles were dispersed.
These were found to be less than 3 nm in the absence of peptide. Given that
addition of peptide is expected to reduce the Debye length, this indicates that the
Smoluchowski approximation is valid over the full range of peptide concentrations
studied. Binding isotherms were obtained by plotting mean zeta potential vs.
total peptide concentration. The binding isotherms for Gad-1 at pH 7.0 and pH
5.0 are shown in Figure 3.6 and the binding isotherms of Gad-2 at pH 7.0 and pH
5.0 are shown in Figure 3.7.
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(a)
(b)
Figure 3.6: The binding isotherms of Gad-1 at (a) pH 7.0 (b) pH 5.0. Each point
represents the average of three independent measurements. The first point in
the isotherm represents the zeta potential of liposomes in the absence of peptide.
A negative value of zeta potential was calculated in the absence of peptide. As
the peptide concentration was increased the zeta potential increased toward a
limiting value. When all peptide binding sites are occupied, the limiting value of
zeta potential depends on the overall charge of peptide and the L : P ratio. At
pH 7.0, Gad-1 has charge of +3 and the limiting value is ∼ 5 mV. On the other
hand, at pH 5.0 Gad-1 has charge of +8 and the limiting value in this case is ∼
20 mV. The error bars were estimated by averaging the deviation from the mean
for three measurements.
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(a)
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Figure 3.7: (a) The binding isotherms of Gad-2 at (a) pH 7.0 (b) pH 5.0. Each
point represents the average of three independent measurements. The first point in
the isotherm represents the zeta potential of liposomes in the absence of peptide.
A negative value of zeta potential was calculated in the absence of peptide. As the
peptide concentration was increased the zeta potential increased toward a limiting
value. When all peptide binding sites were occupied, the limiting value of zeta
potential depends on the overall charge of peptide and the L : P ratio. At pH 7.0,
Gad-2 has charge of +1 and the limiting value is ∼ -20 mV. On the other hand,
at pH 5.0 Gad-2 has charge of +5 and the limiting value in this case is ∼ 5 mV.
The error bars were estimated by averaging the deviation from the mean for three
measurements.
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A few different adsorption isotherm models can be used to fit the experimental
zeta potential data for the purpose of quantifying peptide binding to the mem-
brane. A binding model described by Freire et al. [116] allows the calculation of a
partition constant, the molar fraction of peptide bound to the membrane, and the
lipid-peptide ratio. Alternatively, a zeta potential model based on the Langmuir
isotherm model [132, 133] can be applied to determine the fraction of peptide
bound to the membrane, the ratio of available peptide binding sites to total mem-
brane lipids, and an equilibrium constant. Both models allow calculation of the
molar fraction of the total peptide in the sample that is bound to the membrane.
The lipid-peptide ratios determined from the zeta potential model based on the
Langmuir model at high peptide concentration, are the limiting values of the lipid-
peptide ratios calculated using the Freire et al. model. A different binding model,
described elsewhere [127] relates the binding isotherm to electrostatic interaction
and an equilibrium constant.
3.2.2.2 A binding model to calculate the partition constant (KP)
A model that characterizes peptide binding in terms of a partition constant is
described following the treatment of Freire et al. [116]. The main assumption
of this model is that when a cationic peptide interacts with a negatively charged
membrane, one peptide charge neutralizes one lipid charge. The Freire et al.
model treats bound peptide as being dissolved in the lipid environment. This
model uses the linear part of the zeta potential binding isotherm to determine the
molar fraction of peptide bound to the membrane and partition constant. This
model does not use information from the limiting value of the zeta potential at
high peptide concentration.
A summary of the model presented by Freire et al. is given below. The interaction
of a cationic peptide with a model lipid membrane composed of anionic lipids
Chapter 3. Interactions of Gad peptides with model membranes: insights from
NMR and binding studies 89
results in the reduction of negative surface charge on the membrane. The partition
constant, KP , is defined by Freire et al. as the ratio of the peptide concentration
in the lipid to the peptide concentration in the aqueous phase [56, 116, 128] so
that
KP =
[P ]L
[P ]W
(3.2)
where [P ]L and [P ]W are the peptide concentrations in the lipid and the water
environments respectively. Equation 3.2 can be written as
KP =
(
nP,L
VL
)
(
nP,W
VW
) (3.3)
where nP,L and nP,W are the numbers of moles of peptide in lipid and water
environments respectively and VL and VW are the volumes of the lipid and water
environments, respectively. It should be noted that the volume of the lipid phase
is equivalent to the volume of the membrane and it is thus small compared to the
volume of the aqueous phase. The total number of moles of peptide is given as
nP,T = nP,W + nP,L (3.4)
where nP,T is the total numbers of moles of peptide in water and lipid environments
combined.
In terms of the peptide concentration, Equation 3.4 can be written as
[P ]TotalVT = [P ]WVW + [P ]LVL (3.5)
[P ]Total = [P ]W
(
VW
VT
)
+ [P ]L
(
VL
VT
)
(3.6)
so that
[P ]Total ∼= [P ]W + [P ]L
(
VL
VT
)
(3.7)
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where [P ]Total is the total peptide concentration over the total volume. It should
be noted that the simplification of this expression occurs because the volume of
the aqueous phase (VW) is effectively equal to total volume (VT). The volume
occupied by the bilayer membrane can be written as
VL = γL[L]VW (3.8)
where γL is the molar volume of lipid (i.e the volume occupied by one mole of
lipid) and [L] is total lipid concentration.
From Equation 3.3, the partition constant can now be written as
KP =
(
nP,L
nP,W
)(
VW
VL
)
. (3.9)
Using Equation 3.8, Equation 3.9 becomes
KP =
(
nP,L
nP,W
)
1
γL[L]
(3.10)
so that
nP,L = nP,WγL[L]KP . (3.11)
In the Freire et al. model, the parameter of interest is the molar fraction of peptide
that is bound to the membrane,
X = nP,L
nP,L + nP,W
. (3.12)
Using Equation 3.11 and Equation 3.12, X can be written in terms of the partition
constant (KP ) as
X = γL[L]KP1 + γL[L]KP
. (3.13)
The binding of a peptide to the membrane results in the reduction of membrane
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surface charge and this reduction is proportional to the fraction of negatively
charged lipids that are neutralized by the peptide charge so that
|∆ζ
ζ0
| =
nL−neutralized
nL−total
(3.14)
where
∆ζ = ζ − ζ0. (3.15)
In these equations, ζ0 is the zeta potential in the absence of peptide, nL−neutralized is
the number of moles of negatively charged lipid molecules that are neutralized by
peptide, and nL−total is the total number of moles of charged lipid molecules.
Now assuming that one peptide charge neutralizes one lipid charge, nL−neutralized is
given as
nL−neutralized
= nP,LzP (3.16)
where zP is the peptide charge. The values of zP are +3 and +8 for Gad-1 at
pH 7.0 and pH 5.0 respectively and +1 and +5 for Gad-2 at pH 7.0 and pH 5.0
respectively. Using Equation 3.12, Equation 3.16 becomes
nL−neutralized
= XnP,TzP (3.17)
= X[P ]TotalVTzP (3.18)
The total number of charged lipid molecules, nL−total , is given by
nL−total
= [L]VTfL−zL− (3.19)
where fL− is the fraction of lipids that are anionic (0.25 for POPE/POPG (3:1)), zL−
is the charge of anionic lipids (-1 for POPG), and [L] is the total lipid concentration
which is kept constant at 40 µM.
Using Equation 3.18 and Equation 3.19, the relative reduction is zeta potential
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for a given overall peptide concentration becomes
|∆ζ
ζ0
| = XzP
fL− [L]zL−
[P ]Total. (3.20)
Equation 3.20 can be arranged to get the normalized zeta potential
ζ
ζ0
= XzP
fL− [L]zL−
[P ]Total + 1. (3.21)
The slope of ζ
ζ0
vs. [P ]Total yields X which allows the calculation of KP us-
ing Equation 3.13. Equation 3.21 indicates a linear dependence between ζ
ζ0
and
[P ]Total. The zeta potential binding isotherms indicates that
ζ
ζ0
saturates at higher
values of [P ]Total. Hence Equation 3.21 is not true for higher values of [P ]Total. In
other words, the Freire et al. model holds only for the linear part of zeta potential
binding isotherm.
With the knowledge of X, the local concentration of peptide in the membrane can
be determined to be [134]
[P ]L =
X[P ]Total
γL[L]
. (3.22)
The local lipid-to-peptide ratio, (L : P )local, is the number of lipid molecules per
peptide molecule within the membrane and can be determined using [134]
(L : P )local =
nlipids
nP,L
(3.23)
= nlipids
nP,TX
. (3.24)
In terms of peptide and lipid concentration Equation 3.24 becomes
(L : P )local =
[L]VT
X[P ]TotalVT
(3.25)
= [L]
X[P ]Total
. (3.26)
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Using Equation 3.13, Equation 3.26 becomes
(L : P )local =
1 + [L]KPγL
[P ]TotalγLKP
(3.27)
=
 1
[P ]TotalKPγL
+ [L][P ]Total
. (3.28)
In order to determine the partition constant, a portion of the binding isotherm
was selected where the zeta potential appeared to change linearly with increasing
total peptide concentration. From the selected linear portion of the graph, the
normalized zeta potential was calculated by dividing the zeta potential value for
each peptide concentration by the zeta potential value in the absence of peptide.
The binding isotherms and corresponding normalized zeta potentials for Gad-1
at pH 7.0 and pH 5.0 are shown in Figure 3.8 and Figure 3.9 respectively. The
binding isotherms and corresponding normalized zeta potentials for Gad-2 at pH
7.0 and pH 5.0 are shown in Figure 3.10 and Figure 3.11 respectively. The slopes
of normalized zeta potential vs. peptide concentration were used to determine the
molar fraction of peptide that is bound to the membrane using Equation 3.21. The
partition constant was determined using Equation 3.13. The values of fL− , zL, and
γL in Equation 3.21 are 0.25, -1 and 0.763 in liters per mole [56, 135] respectively.
The values of X and KP found in this way for Gad-1 and Gad-2 at pH 7.0 and
pH 5.0 are listed in Tables 3.2 and 3.3 respectively. For both Gad-1 and Gad-2,
the values of X are smaller at pH 5.0 than at pH 7.0. The values of KP are on the
order of 103 for Gad peptides. The larger value of this partition constant reflects
the fact that volume of the membrane is very small compared to volume of the
aqueous phase so that the amount of peptide bound per unit lipid volume is large.
Values of the local peptide concentration ([P ]L) and (L : P )local were calculated
using Equation 3.22 and Equation 3.26 [134] and are listed in Table 3.4 and Table
3.5. The [P ]L increased as the total peptide concentration [P ]Total was increased.
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Values of (L : P )local were higher at pH 5.0 than at pH 7.0. The interpretation of
these results is discussed in Section 3.3 below.
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(a)
(b)
Figure 3.8: (a) Zeta potential measurements for 40 µM POPE/POPG (3:1) in the
presence of Gad-1 at pH 7.0. Addition of peptide to lipid vesicles results in the
reduction of zeta potential values. At higher concentration of the peptide, zeta
potential approaches a positive limit of ∼ 5 mV. The linear portion of this graph,
0 µM - 6 µM peptide concentration, was selected to obtain the normalized zeta
potential plotted in panel (b). (b) Normalized zeta potential dependence on the
concentration of Gad-1 peptide at pH 7.0. The slope of the linear portion of the
binding isotherm was obtained using weighted linear fitting. The size of error bars
was taken into account to estimate the uncertainty in the slope. The slope of this
graph was used to determine the partition constant.
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(a)
(b)
Figure 3.9: (a) Zeta potential measurements for 40 µM POPE/POPG (3:1) in the
presence of Gad-1 at pH 5.0. Addition of peptide to lipid vesicles results in the
reduction of zeta potential values. At higher concentrations of the peptide, zeta
potential value approaches a limit of ∼ 20 mV. The linear portion of this graph,
0 µM - 3 µM peptide concentration, was selected to obtain the normalized zeta
potential plotted in panel (b). (b) Normalized zeta potential dependence on the
concentration of Gad-1 peptide at pH 5.0. The slope of the linear portion of the
binding isotherm was obtained using weighted linear fitting. The size of error bars
was taken into account to estimate the uncertainty in the slope. The slope of this
graph was used to determine the partition constant.
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(a)
(b)
Figure 3.10: (a) Zeta potential measurements for 40 µM POPE/POPG (3:1) in
the presence of Gad-2 at pH 7.0. At higher concentrations of the peptide, the zeta
potential approaches a negative limit of ∼ -20 mV. The first three points in the
graph were selected to obtain the normalized zeta potential plotted in panel (b).
(b) Normalized zeta potential dependence on the concentration of Gad-2 peptide at
pH 7.0. The slope of the linear portion of the binding isotherm was obtained using
weighted linear fitting. The size of error bars was taken into account to estimate
the uncertainty in the slope. The slope of this graph was used to determine the
partition constant.
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(a)
(b)
Figure 3.11: (a) Zeta potential measurements for 40 µM POPE/POPG (3:1) in
the presence of Gad-2 at pH 5.0. Addition of peptide to lipid vesicles results in the
reduction of zeta potential values. At higher concentrations of the peptide zeta
potential value approaches a positive limit of ∼ 5 mV. The linear portion of this
graph, 0 µM - 20 µM peptide concentration, was used to obtain the normalized
zeta potential plotted in panel (b). (b) Normalized zeta potential dependence on
the concentration of Gad-1 peptide at pH 7.0. The slope of the linear portion of
the binding isotherm was obtained using weighted linear fitting. The size of error
bars was taken into account to estimate the uncertainty in the slope. The slope
of this graph was used to determine the partition constant.
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Gad-1
pH Molar fraction of peptide bound tothe membrane (X) Partition constant (KP )
7.0 0.48±0.02 30,000 ± 2000
5.0 0.35±0.01 17,600± 800
Table 3.2: Calculated molar fractions of peptide bound to the membrane (X) and
partition constants (KP ) from zeta potential measurements for Gad-1 at pH 7.0
and pH 5.0. Equation 3.21 and Equation 3.13 were used to calculate X and KP .
Gad-2
pH Molar fraction of peptide bound tothe membrane (X) Partition constant (KP )
7.0 0.4±0.1 24,000 ± 7000
5.0 0.08±0.01 2,800 ± 400
Table 3.3: Calculated molar fractions of peptide bound to the membrane (X) and
partition constants (KP ) from zeta potential measurements for Gad-2 at pH 7.0
and pH 5.0. Equation 3.21 and Equation 3.13 were used to calculate X and KP .
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Gad-1
[P ]Total
(µM)
global
L : P
pH 7.0 pH 5.0
[P ]L
(mM) (L : P )local
[P ]L
(mM) (L : P )local
1 40 16 83 11 114
2 20 31 42 22 57
3 13 47 28 34 38
4 10 63 21 46 28
5 8 79 17 57∗ 23∗
6 6 94 14 68∗ 19∗
Table 3.4: The global L : P is calculated for the total peptide concentration 1 µM
- 6 µM. The range of total peptide concentration is selected from the linear portion
of Figure 3.8 (a). The local peptide concentration in the membrane and (L : P )local
are also calculated using Equation 3.22 and Equation 3.26 for corresponding total
peptide concentration at pH 7.0 and pH 5.0. Note that (L : P )local represents the
lipid to peptide ratio for lipid and peptide complexes.
Note: The values of [P ]L and (L : P )local with ∗ fell outside of the linear region of
zeta potential binding isotherm for Gad-1 at pH 5.0.
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Gad-2
[P ]Total
(µM)
global
L : P
pH 7.0 pH 5.0
[P ]L
(mM) (L : P )local
[P ]L
(mM) (L : P )local
5 8 69 19 13 100
10 4 137 10 26 50
15 3 - - 39 33
20 2 - - 52 25
Table 3.5: The global L : P is calculated for the total peptide concentration 5
µM- 15 µM. The range of total peptide concentration is selected from the linear
portion of Figure 3.11 (a). The local peptide concentration in the membrane
and (L : P )local are also calculated using Equation 3.22 and Equation 3.26 for
corresponding total peptide concentration at pH 7.0 and pH 5.0. It should be
noted that (L : P )local represents the lipid to peptide ratio for lipid and peptide
complexes.
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3.2.2.3 Modeling peptide dependence of the zeta potential using a
Langmuir isotherm approach
The Langmuir isotherm model [132, 133] describes the monolayer surface adsorp-
tion of an adsorbate onto an absorbent. This model assumes 1:1 stoichiometry
between binding sites and adsorbate molecules. The primary parameters extracted
using a zeta potential model based on the Langmuir isotherm model are an equi-
librium constant (Keq) and the number of lipids per peptide binding site. The
equilibrium constant is the ratio of adsorption to desorption rate and reflects the
strength of binding.
Both the zeta potential model based on the Langmuir isotherm model and the
model described by Freire et al. consider the reduction in membrane surface charge
when a cationic peptide interacts with a model membrane composed of anionic
lipids. In the Freire et al. model, only the linear portion of a binding isotherm is
taken into account. Our zeta potential model based on the Langmuir isotherm is
an extension of Freire et al. approach. It takes into account the linear part and the
plateau region of a zeta potential binding isotherm where zeta potential approaches
a limiting value. Both models allow calculation of the fraction of peptide bound
to the membrane and lipid-peptide stoichiometry. The main difference between
the two models is that the Freire et al. approach considers the peptide to be
dissolved in the lipid bilayer volume while the zeta potential model based on
the Langmuir isotherm treats the peptide as being adsorbed on the surface. A
model relating the peptide concentration dependence of zeta potential to Langmuir
isotherm adsorption is outlined below.
For a model in which the total number of moles of lipids is given by nlipids, the
number of available binding sites, nsites available, is assumed to be some fraction, Q,
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of nlipids so that
nsites available = Qnlipids. (3.29)
If nP,ad represents the total number of adsorbed peptide molecules, then the num-
ber of vacant binding sites is
nsites vacant = Qnlipids − nP,ad. (3.30)
Each occupied binding site thus contains 1/Q lipids and one peptide. In accor-
dance with the Langmuir isotherm model, the rate of peptide adsorption is given
as [132]
rad = kad[P ]W
(
Qnlipids − nP,ad
Alipid
)
(3.31)
where kad is the adsorption rate constant, [P ]W is the peptide concentration in
the aqueous environment, Alipid represent the lipid area, and
(
Qnlipids − nP,ad
Alipid
)
is the surface concentration of vacant sites in number per unit area. The rate of
desorption depends on the concentration of filled sites [132] and is thus given by
rd = kd
(
nP,ad
Alipid
)
. (3.32)
where kd is the desorption rate constant. At equilibrium, the rate of adsorption
equals the rate of desorption [136]. The ratio of the adsorption and desorption
rate constants is thus
kad
kd
= 1[P ]W
(
nP,ad
Qnlipids − nP,ad
)
. (3.33)
The ratio of adsorption rate to desorption rate defines the equilibrium constant
(Keq) of the binding process so that
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Keq =
nP,ad
[P ]W
(
Qnlipids − nP,ad
) . (3.34)
Using Equation 3.34, the fractional occupancy of the binding sites is given by
nP,ad
Qnlipids
= Keq[P ]W1 +Keq[P ]W
. (3.35)
If X represents the fraction of peptide that is bound to the membrane then the
number of peptides in water (nP,W) is given as
nP,W = (1−X)nP,T (3.36)
where nP,T is the total number of moles of peptide in both environments combined.
In Equation 3.36, X is the same fraction as that defined in the context of the Freire
et al. approach in Equation 3.13. Dividing by total volume (VT) gives
[P ]W = (1−X)[P ]Total. (3.37)
The fractional occupancy of binding sites can be related to zeta potential by
∆ζ
∆ζmax
= 1−
(
nsites vacant
nsites available
)
(3.38)
= 1−
(
Qnlipids − nP,ad
Qnlipids
)
(3.39)
= nP,ad
Qnlipids
(3.40)
where,
4 ζ = ζ − ζ0 (3.41)
and
4 ζmax = ζmax − ζ0. (3.42)
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The parameters ζ0, ∆ζ, and 4ζmax are schematically shown in Figure 3.12.
Chapter 3. Interactions of Gad peptides with model membranes: insights from
NMR and binding studies 106
Figure 3.12: Schematic representation of zeta potential parameters ζ0, ∆ζ, and
4ζmax. ζ0 is the value of zeta potential in the absence of peptide. ζ represents
the value of zeta potential at a given peptide concentration. ζmax is the maximum
value zeta potential in the plateau region of bindng isotherm. ∆ζ is the difference
between given value of zeta potential and ζ0. 4ζmax is the difference between
ζmax (maximum value of zeta potential in the binding isotherm) and ζ0 (minimum
value of zeta potential in the binding isotherm).
It should be noted that ζ0 is a negative quantity for vesicles containing anionic
lipids. From Equation 3.35 and Equation 3.40
∆ζ
∆ζmax
= Keq[P ]W1 +Keq[P ]W
. (3.43)
The concentration of peptides in the aqueous phase, [P ]W, is unknown but the
total concentration of peptides, [P ]Total, is a known quantity. Equation 3.37 can
be used to write [P ]W in terms of [P ]Total so that the normalized change in zeta
potential becomes
∆ζ
∆ζmax
= Keq(1−X)[P ]Total1 +Keq(1−X)[P ]Total
(3.44)
where X is the molar fraction of peptide bound to the membrane and it is the same
parameter used in Equation 3.13 in the Freire et al. approach. For small [P ]Total,
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∆ζ
∆ζmax
depends linearly on [P ]Total and slope of this linear regime is Keq(1−X).
Both, Keq and X, are unknown parameters and coupled together in the expression
for slope.
Now, the total number of peptide molecules in a sample is [P ]TotalVT so the number
of adsorbed peptide molecules can be written as
nP,ad = X[P ]TotalVT. (3.45)
The total number of lipids can be given as
nlipids = [L]VT. (3.46)
Using Equations 3.45 and 3.46, Equation 3.40 becomes
∆ζ
∆ζmax
= X
Q[L] [P ]Total (3.47)
This gives another expression, X
Q[L] , for the slope of the normalized ∆ζ vs. [P ]Total
curve in the linear regime.
In this expression, Q is the ratio of available peptide binding sites to the total
number of lipids and is an unknown parameter. It can be determined using the
limiting value of zeta potential. The zeta potential approaches its limiting value
when all binding sites are occupied by peptide molecules and it corresponds to the
plateau region in the binding isotherm. The ratio of the limiting zeta potential
value to the peptide-free value of zeta potential is then
ζmax
ζ0
=
QnlipidszP + nlipidsfL−zL−
nlipidsfL−zL−
(3.48)
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so that
Q = ∆ζmax
ζ0
fL−zL−
zP
(3.49)
where fL− is the fraction of lipids that are anionic, zL− is the charge of an anionic
lipid, and zP is the peptide charge. The denominator of Equation 3.48 represents
the total anionic lipid charge in the membrane. That charge is proportional to
the peptide-free value of zeta potential. The numerator is the sum of total anionic
lipid charge and total charge of adsorbed peptides. Using an expression for Q
from Equation 3.49, the initial slope of ∆ζ∆ζmax
versus [P ]Total, from Equation 3.47,
becomes
slope =
(
XzP
fL−zL− [L]
)(
ζ0
∆ζmax
)
. (3.50)
The above expression for slope is similar to the expression for initial slope obtained
for the Freire et al. binding model as shown in Equation 3.21. The only difference
in the expression of slope from two models is a normalization factor, ζ0∆ζmax
.
The limiting value of zeta potential can be used to determine Q using Equation
3.49. The slope of the linear regime of ∆ζ∆ζmax
vs. [P ]Total can thus be used to find
X. The Keq can be determined using the expression, Keq(1 −X), for slope from
Equation 3.44. In the zeta potential model based on the Langmuir isotherm, a
binding isotherm is obtained by plotting ∆ζ∆ζmax
vs. [P ]Total, while in the Friere
et al. model, ζ
ζ0
vs. [P ]Total was plotted. The binding isotherms showing the
variation of ∆ζ∆ζmax
vs. [P ]Total and corresponding selected linear regimes for Gad-
1 at pH 7.0 and pH 5.0 are shown in Figure 3.13 and Figure 3.14 respectively. The
binding isotherms showing the variation of ∆ζ∆ζmax
vs. [P ]Total and corresponding
selected linear regimes for Gad-2 at pH 7.0 and pH 5.0 are shown in Figure 3.15
and Figure 3.16 respectively. For Gad-1 and Gad-2, the calculated parameters
obtained by using the Langmuir isotherm approach are listed in Tables 3.6 and
Table 3.7 respectively. For both Gad-1 and Gad-2, values of X are smaller at pH
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5.0 than at pH 7.0. The values of 1/Q indicate that at pH 7.0, a binding site
consists of a smaller number of lipids than at pH 5.0. For Gad-1, Keq is higher
than Gad-2 at both pHs. These observations are interpreted in the discussion
Section below.
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(a)
(b)
Figure 3.13: (a) ∆ζ∆ζmax
vs. [P ]Total for Gad-1 at pH 7.0. (b) The linear regime (0
µM - 6 µM) was selected and slope of this region was used to find X. The slope of
the linear portion of the binding isotherm was obtained using the weighted linear
fitting. The size of error bars was taken into account to estimate the uncertainty in
the slope. Q was determined from the limiting value of zeta potential using Equa-
tion 3.49. The equilibrium constant (Keq) was determined using the expression,
Keq(1−X), for slope from Equation 3.44.
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(a)
(b)
Figure 3.14: (a) ∆ζ∆ζmax
vs. [P ]Total for Gad-1 at pH 5.0. (b) The linear regime (0
µM - 5 µM) was selected and slope of this region was used to find X. The slope of
the linear portion of the binding isotherm was obtained using the weighted linear
fitting. The size of error bars was taken into account to estimate the uncertainty in
the slope. Q was determined from the limiting value of zeta potential using Equa-
tion 3.49. The equilibrium constant (Keq) was determined using the expression,
Keq(1−X), for slope from Equation 3.44.
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(a)
(b)
Figure 3.15: (a) ∆ζ∆ζmax
vs. [P ]Total for Gad-2 at pH 7.0. (b) The linear regime
(0 µM - 10 µM) was selected and slope of this region was used to find X. The
slope of the linear portion of the binding isotherm was obtained using the weighted
linear fitting. The size of error bars was taken into account to estimate the un-
certainty in the slope. Q was determined from the limiting value of zeta potential
using Equation 3.49. The equilibrium constant (Keq) was determined using the
expression, Keq(1−X), for slope from Equation 3.44.
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(a)
(b)
Figure 3.16: (a) ∆ζ∆ζmax
vs. [P ]Total for Gad-2 at pH 5.0. (b) The linear regime
(0 µM - 20 µM) was selected and slope of this region was used to find X. The
slope of the linear portion of the binding isotherm was obtained using the weighted
linear fitting. The size of error bars was taken into account to estimate the un-
certainty in the slope. Q was determined from the limiting value of zeta potential
using Equation 3.49. The equilibrium constant (Keq) was determined using the
expression, Keq(1−X), for slope from Equation 3.44.
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Gad-1
pH
Molar fraction of
peptide bound to the
membrane (X)
1/Q (number of lipids
per peptide binding
site )
Equilibrium
constant, Keq
(µM−1)
7.0 0.46±0.04 10± 1 0.22±0.03
5.0 0.28±0.03 21 ± 3 0.21± 0.02
Table 3.6: The values of X, 1/Q, Keq for Gad-1 at pH 7.0 and pH 5.0.
Gad-2
pH
Molar fraction of
peptide bound to the
membrane (X)
1/Q(number of lipids
per peptide binding
site )
Equilibrium
constant, Keq
(µM−1)
7.0 0.4±0.2 6± 1 0.11±0.06
5.0 0.08±0.02 20 ± 3 0.04± 0.01
Table 3.7: The values of X, 1/Q, Keq for Gad-2 at pH 7.0 and pH 5.0.
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3.3 Discussion
The addition of Gad peptides to POPE/POPG-d31(3:1) lipid vesicles was found to
cause a small decrease in the quadrupole splitting of the NMR spectra as indicated
in Figure 3.1. This was observed for both Gad-1 and Gad-2 at pH 7.0 and pH 5.0.
The first observation made from order parameter profiles shown in Figures 3.2
and 3.3 was that both peptides reduce the orientational order parameter values,
particularly in the plateau region (i.e. carbon number 2 to carbon number 10),
at both pH values. The orientational order parameter profile comparison suggests
that the two peptides have only small effects on the amplitudes of fast motions
that contribute to motional narrowing. A potential explanation for the observed
change in order parameter is as follows. The peptide likely pushes the lipid head
groups apart which would increase the area per lipid and, in turn, allow the
acyl chains more freedom to move as shown in Figure 3.17(b). The resulting
increase in averaged motion of the lipid acyl chains would increase the extent
to which the quadrupole interaction is averaged and make the splitting smaller.
This is consistent with the idea that many AMPs perturb the bilayer integrity
of bacterial membranes to achieve their antimicrobial activity. Previous model
membrane studies have shown that the addition of AMP causes the reduction in
the order parameter values of model lipid vesicles. The histidine-rich synthetic
peptide LAH4-L1 at acidic pH values [75] and Alamethicin, Ampullosporin [137]
induced a slight reduction in the order parameter values of POPE/POPG-d31
lipid vesicles which is comparable to the effect of Gad peptides on the lipid acyl
chain order of POPE/POPG-d31 lipid vesicles. Other peptides including MSI-78,
MSI-594 [138], IL−8α [139], and LL−37 [140] reduced the order parameter values
of POPC/POPG-d31 lipid vesicles. While comparing the interactions of different
AMPs with lipid bilayers in model membranes, it is important to consider the
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different experimental conditions. For example, all the peptides listed above have
been shown to perturb the lipid bilayer integrity by reducing the order parameter
values, but the POPE/POPG lipid mixture is more relevant to Gram-negative
bacterial membrane than POPC/POPG lipid bilayers. The comparison of order
parameter profiles for each peptide in Figure 3.4 suggests that peptide-induced
bilayer perturbation is not strongly pH-dependent for either peptide between pH
7.0 and pH 5.0. This was unexpected because MIC assay experiments of Gad
peptides against E.coli have shown that Gad-2’s antimicrobial activity is more
pH-dependent [26].
Figure 3.17: Schematic representation of the interaction of the peptide (in orange)
with lipid molecules (in blue). (a) If the peptide locates mainly to the acyl chain
region, it may impede the motion of the chains and only a small change may be
seen in the motion of the lipid chains. (b) If the peptide binds the membrane
in the lipid polar head groups region, it may increase the distance between them
which makes the acyl chains more flexible to move. This Figure is reprinted with
the permission of Dr. Valerie Booth.
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Additional information about the membrane-peptide interactions was obtained
from the quadrupole echo decay time which reflects the perturbation, by Gad
peptides, of slow or fast motions in POPE/POPG-d31 (3:1) lipid bilayers. The
change in the values of T qe2 with the addition of Gad peptides indicates that both
peptides perturb the bilayer motions even though there was not much effect on
the spectrum splittings.
For the lipid-only samples, echo decay time is independent or at most, weakly
dependent on temperature. This is consistent with previous observations for lipid
bilayers in the liquid crystalline phase [141, 142]. Aside from Gad-1 at 25◦C,
echo decay times for bilayers with a given peptide are not sensitive to pH and
thus not sensitive to peptide charge. It was observed that Gad-1 decreases the
echo decay time at pH 7.0 while at pH 5.0 it had little effect on the echo decay
time. The decrease in the echo decay time might indicate slowing down of a fast
motion or speeding up a slow motion. On the other hand, Gad-2 increases the
echo decay time at either pH. The increase in the echo decay time might indicate
speeding up a fast motion or slowing down of a slow motion with the addition
of peptide. Gad-1 and Gad-2 seem to have opposite effects on echo decay times.
Since charge does not seem to be much of a factor, this must reflect differences
in structural effects on motions. Both Gad-1 and Gad-2 have similar effects on
chain order which suggests that they have similar effects on fast (short correlation
time) motions. This suggests that difference in the perturbation of echo decay
time by Gad-1 and Gad-2 reflects effects on slower (longer length scale) motions
like bilayer undulation. If so, the results suggest that Gad-2 tends to increase the
slow motion correlations times (i.e. damp the motions a bit). Gad-1 has a smaller
effect, mostly in the opposite direction.
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To study the binding of Gad peptides in quantitative detail, the molar fractions
of peptide bound to model lipid vesicles (X) were determined from the slopes
of the linear regimes of zeta potential binding isotherms. The partition constant
(KP ) was determined using the Freire et al. approach while the equilibrium con-
stant (Keq) was determined using the zeta potential model based on the Langmuir
Isotherm. The partition constant reflects the peptide partitioning between the
membrane and water while the equilibrium constant reflects the strength of bind-
ing. Higher values of KP indicate strong partitioning of the peptide towards the
lipid membrane, while higher equilibrium constants indicate tighter lipid-peptide
binding. Both the Freire et al. and the Langmuir isotherm models allow the char-
acterization of lipid-peptide stoichiometry in terms of number of lipids per bound
peptide. The local peptide concentration in the membrane (Plocal) and the (L : P )
ratio were estimated using X and KP . The number of lipids per peptide binding
site (1/Q) was determined using the limiting zeta potential value.
In the absence of a peptide, a negative zeta potential of ∼ -55 mV is calculated
from experimentally observed mobilities for POPE/POPG (3:1) lipid vesicles at
pH 7.0 and pH 5.0. The addition of peptide results in neutralization of the nega-
tive zeta potential of the lipid vesicles. Similar zeta potential trends were reported
for peptides pepR and BP100 in model lipid vesicles of POPC/POPG [116]. This
reduction in the magnitude of the zeta potential indicates an interaction of the
negatively charged membrane with the positive peptide. At lower peptide con-
centrations, zeta potential varies linearly with peptide concentration. At higher
concentrations of Gad peptides, the zeta potential approaches a negative, neutral,
or positive limiting value depending on the charge of the peptide and the (L : P )
ratio when all binding sites are occupied. Figure 3.18 illustrates how increased
peptide binding affects the observed zeta potential.
Chapter 3. Interactions of Gad peptides with model membranes: insights from
NMR and binding studies 119
Figure 3.18: The depiction of lipid-peptide interactions corresponding to the differ-
ent points of the binding isotherm. When no peptide is bound, the zeta potential
is negative. The peptide binding to the lipid vesicle results in the reduction in
the magnitude of the negative zeta potential value. The plateau region of binding
isotherm represents the saturation of lipid vesicles with peptide. At this point,
all the binding sites are occupied and zeta potential does not change with further
addition of the peptide.
Gad-1 carries a charge of +3 at pH 7.0 and +8 at pH 5.0, whereas Gad-2 has a
charge of only +1 at neutral pH and +5 at pH 5.0. At higher concentrations of
Gad-1 (10 µM onwards), the zeta potential approaches a positive limit of ∼+5
mV at pH 7.0, while at pH 5.0 it reaches a positive limit of +20 mV. The fact
that the plateau region is positive, rather than neutral indicates that there are
hydrophobic interactions, in addition to electrostatic interactions, at play when
the peptide interacts with the membrane. On the other hand, for Gad-2 at pH
7.0, zeta potential values change more slowly with the addition of peptide. At
pH 5.0, the addition of Gad-2 results in a positive limit of ∼+1 mV in the zeta
potential. The point of electroneutrality (where zeta potential is zero) depends
on the overall charge of peptide. For Gad-1, zeta potential becomes zero at an
overall peptide concentration of 8 µM for pH 7.0. For Gad-1, the higher peptide
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charge at pH 5.0 neutralizes the membrane charge at a peptide concentration of
5 µM. For Gad-2 at pH 7.0, zeta potential does not go to zero and at pH 5.0 the
electroneutrality point occurs at an overall peptide concentration of 45 µM.
The binding of Gad peptides is characterized in terms of molar fraction of peptide
bound to the membrane (X), the partition constant (KP ), the equilibrium con-
stant (Keq), and (L : P ) ratios. The values of X determined using both models,
the Freire et al. approach and the zeta potential model based on the Langmuir
isotherm, are listed in Table 3.8. The two binding models gave consistent results
for X.
Molar fraction of peptide bound to the membrane (X)
model Gad-1 Gad-2
pH 7.0 pH 5.0 pH 7.0 pH 5.0
Freire et al.
approach 0.48±0.02 0.35±0.01 0.4±0.1 0.08±0.01
zeta potential model
based on the
Langmuir isotherm
0.46±0.04 0.28±0.03 0.4±0.2 0.08±0.02
Table 3.8: Comparison of values of X for Gad peptides calculated using Freier
et al. approach and zeta potential model based on the Langmuir isotherm. Both
models give the consistent results for X.
The zeta potential model based on the Langmuir adsorption isotherm provided a
way to extract a binding equilibrium constant. The equilibrium constant (Keq) is
the ratio of the peptide adsorption to desorption rates and it reflects the strength
of binding. The higher the value of the equilibrium constant, the greater the
strength of binding. The partition constant (KP ) was determined using the Freire
et al. approach. In the Freire et al. approach, only the linear part of the binding
isotherm was used to determine binding parameters, while the Langmuir isotherm
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approach used the linear part and the limiting value of zeta potential to charac-
terize the peptide binding. The comparison of the values of Keq and KP is shown
in Table 3.9.
Partition constant (KP ) and equilibrium constant (Keq)
pH Gad-1 Gad-2
KP Keq KP Keq
7.0 30,000 ± 2400 0.22 ± 0.03 24,000 ± 7000 0.11 ± 0.06
5.0 17,600 ± 800 0.21 ± 0.02 2800 ± 400 0.04 ± 0.01
Table 3.9: The partition constant (KP ) and the equilibrium constant (KP ) for
Gad-1 and Gad-2 at pH 7.0 and pH 5.0. The values of KP and Keq convey infor-
mation about how much peptide is bound to the membrane and how tightly bound
is the peptide to the membrane. The greater the value of KP , the stronger the
partitioning of peptide towards the membrane, while higher value of Keq indicate
tighter peptide binding to the membrane. The values of KP and Keq are higher
at pH 7.0 than at pH 5.0 for both Gad-1 and Gad-2.
Both binding models allow the characterization of the stoichiometry of lipid-
peptide interactions for Gad peptides at two pHs. The (L : P )local ratios were
calculated using the Freire et al. approach. The zeta potential model based on
the Langmuir isotherm allows the calculation of number of lipids that correspond
to one binding site and this is expected to be the limiting value of (L : P )local
ratio. The results of lipid-to-peptide ratios obtained using both the models are
listed in Table 3.10.
The insights from the comparisons of the binding parameters for Gad peptides at
the two pH values are discussed below. For both Gad-1 and Gad-2, the fraction of
peptide bound to the membrane is smaller at slightly acidic pH than at neutral pH.
This is schematically represented in Figure 3.19. This suggests that when a peptide
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local lipid-to-peptide ratios
pH Gad-1 Gad-2
L : P 1/Q L : P 1/Q
7.0 14±1 10±1 10±2 6±1
5.0 19±1 21±3 25±3 20±3
Table 3.10: Local lipid-to-peptide ratios determined using Freire et al. approach
and zeta potential model based on the Langmuir isotherm. For Gad-1, L : P corre-
sponds to 6 µM total peptide concentration. For Gad-2, L : P values corresponds
to 10 µM and 20µM total peptide concentrations at pH 7.0 and pH 5.0 respec-
tively. These total peptide concentrations are the highest peptide concentrations
in the linear region of the zeta potential binding isotherms. 1/Q represents the
limiting value of lipid-to-peptide ratios and are calculated using zeta potential
model based on the Langmuir isotherm. Both models gave consistent results for
lipid-to-peptide ratios.
has higher positive charge, a smaller number of peptides can be accommodated
on the membrane surface. This may be due to the fact that when a peptide has
higher positive charge, less peptide is needed to neutralize the membrane surface
charge. In addition, repulsive electrostatic interactions between bound peptides
are expected to be stronger at lower pH and this also might limit the peptide
binding.
Comparing the values of X (Table 3.8) for Gad-1 and Gad-2 at pH 7.0 and at pH
5.0 shows that the extent to which peptide binding to the membrane depends on
overall peptide charge is not the same for Gad-1 and Gad-2. At pH 7.0, Gad-1
has a charge of +3 and Gad-2 has a charge of +1. Regardless of the difference
in peptide charge at pH 7.0, the fraction of Gad-2 bound to the membrane is
approximately the same as the fraction of Gad-1 bound to the membrane.
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(a)
(b)
Figure 3.19: An illustration of lipid-peptide interactions for (a) Gad-1 at pH 7.0
and pH 5.0. (b) Gad-2 at pH 7.0 and pH 5.0. For each peptide, less peptide binds
to the membrane at pH 5.0. At pH 7.0 the amount of peptide that binds to the
membrane is almost the same for both peptides. At pH 5.0, less Gad-2 binds to
the membrane than Gad-1.
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A different case is observed at acidic pH. At pH 5.0, Gad-1 carries a charge of +8
and Gad-2 has a charge of +5. Irrespective of its having a smaller charge than
Gad-1, much less Gad-2 binds to the membrane.
After investigating the fraction of peptide bound to the membrane, the differences
in the strength of binding of Gad-1 and Gad-2 were examined by comparing the
values of Keq. Higher values of the equilibrium constant for Gad peptides indicate
that at pH 7.0, the binding of Gad-1 is 2-fold stronger than that of Gad-2. At
pH 5.0, Gad-2’s binding is 5-fold weaker than that of Gad-1. Gad-1’s equilibrium
constant does not change with pH, while Gad-2’s binding is weaker at pH 5.0
than at pH 7.0. Gad-1 has higher values of the equilibrium constant than Gad-2
at both pH values. This suggests that lipid-peptide interactions are stronger for
Gad-1 compared to Gad-2. Also, for Gad-2 the equilibrium constant values are
more sensitive to changes in pH. The greater sensitivity of Gad-2’s binding to pH
may reflect a higher sensitivity of its structure to changes in pH.
A potential explanation for the differences in the binding of Gad-1 and Gad-2 is
as follows. Structure-function relationship studies of Gad peptides [26] reveal that
Gad-1 and Gad-2 are more helical at pH 7.0 than at pH 5.0. The percent helicity
of both peptides decreases as pH decreases from 7.0 to 5.0. The smaller degree
of Gad peptide helical structure at pH 5.0 compared to pH 7.0 may result in less
peptide being bound to the membrane at lower pH. Gad-1 is more helical than
Gad-2 at both pHs. Also, Gad-1 has higher overall positive charge than Gad-2 at
pH 7.0 and pH 5.0. The combined effect of higher degree of helicity and higher
cationic nature of Gad-1 may result in a stronger binding of Gad-1 than Gad-2 at
both pHs as indicated by higher values of Keq of Gad-1 compared to Gad-2 at both
pH values (Table 3.9). This may indicate that greater helicity of peptide leads
to greater amphipathicity that may drive stronger binding of the peptide to the
membrane. The helicity of Gad-2 is also more sensitive to changes in pH than that
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of Gad-1. Note that Gad-2 has fewer histidines than Gad-1 but that it also has
two histidine-pairs while Gad-1 has only one histidine-pair. Previous molecular
dynamics simulations with Gad peptides have shown that most helical peptide
structures prefer to interact with planar bilayer regions while histidine-histidine
pairs prefer to interact with disordered bilayer regions [143]. This may explain
the weaker binding of Gad-2 than Gad-1 at both pHs. The greater sensitivity of
Gad-2’s helicity to pH and the presence of two histidine pairs may result in an
amphipathic structure with a charge distribution that amplifies the sensitivity of
its binding to changes in pH. Changes in binding with pH might reflect changes in
helicity but might also reflect the smaller number of peptides needed to neutralize
the bilayer and the stronger electrostatic interactions between peptides.
The partition constant (KP ) provides another way to look at the amount of peptide
bound to the membrane. The Gad peptide partition constants extracted from
the zeta potential measurements are of the order of 103. This means that the
peptide concentration in the lipid phase is approximately 10,000 times higher
than its concentration in the aqueous phase [56]. The values of the partition
constant for Gad peptides are comparable with the values found for other AMPs
including Melittin, Omiganan, Indolicidin, Dermaseptin, Cecropin, and Magainin-
2-amide [56, 144–146]. The partition constant for the above-listed peptides is in the
range of 103−105 and was determined using titration calorimetry and fluorescence
spectroscopy.
The comparison of values of X describes how the fraction of peptide bound to
the membrane was affected by the different properties of peptide. When a certain
fraction of peptide is bound to the membrane, the number of lipids interacting
with one molecule of bound peptide may also depend on the properties of the
peptide. This was investigated by comparing the lipid-to-peptide ratios for Gad
peptides at different pH values. The limiting values of (L : P )local, as determined
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by the Freire et al approach, are consistent with the values of 1/Q extracted from
the zeta potential model based on the Langmuir isotherm (Table 3.11). L : P
ratios were higher at pH 5.0 than at pH 7.0 for both Gad-1 and Gad-2. This
suggested that the higher the peptide charge, the larger the number of lipids per
bound peptide. The molecular interactions between cationic Gad peptides and
anionic membrane lipids can result in the promotion of anionic lipid clustering.
Other AMPs including Myxinidin, Aurein 1.2, Arginine rich peptides (PR−9),
(RR−9), (PI−9), and LL−37 [147–151] have been shown to be able to cluster
anionic lipids.
The local peptide concentration ([P ]L) was calculated for a selected range of total
peptide concentration ([P ]Total). The range of ([P ]Total) was selected from the
linear portion of the Gad peptide binding isotherms. For Gad-1, this range is 0
µM - 6 µM and for Gad-2 it is 0 µM - 20 µM. It should be noted that [P ]Total is
the peptide concentration over the total volume and [P ]L is peptide concentration
in the membrane at a given lipid concentration. The local peptide concentrations
were lower at pH 5.0 than at pH 7.0 for both Gad-1 and Gad-2. The comparison of
the [P ]L and the (L : P ) ratios for Gad-1 and Gad-2, indicates that at pH 5.0, Gad-
2 has lower [P ]L and higher (L : P )local values. In other words, less Gad-2 binds to
the membrane and there are more lipid molecules per bound Gad-2 peptide at pH
5.0 than for Gad-1 at same pH. This might suggest that the interaction of peptide
with lipid membrane does not involve only the overall charge of the peptide but
rather the combined effects of parameters like overall positive charge, distribution
of charge, L : P ratios, amphipathicity, and hydrophobicity [152–154].
The results of MIC (Minimal Inhibitory Concentration) assays for the effect of
Gad peptides on bacterial growth of E.coli [26] are shown in Figure 1.6. It is
evident from Figure 1.6 that Gad-1 has lower MIC values than Gad-2. Also,
Gad-2’s anti-E.coli activity is sensitive to pH. Binding studies indicate that the
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binding of a single peptide is stronger for Gad-1 than for Gad-2. This suggests
that for Gad-1 and Gad-2, tighter peptide binding to the membrane corresponds
to higher peptide antimicrobial activity. This rule of “stronger the peptide binding
more active is the peptide” does hold true for Gad-1 at pH 7.0 and pH 5.0. For
Gad-2, on the other hand, there appears to be no simple rule for correlating the
peptide binding to the peptide activity. In particular, it is found that despite
the reduced accommodation of Gad-2 peptide and weaker peptide binding at pH
5.0 than at pH 7.0, Gad-2 MIC values at pH 5.0 are lower than those seen at
pH 7.0. This difference between Gad-1 and Gad-2 might be explained as follows.
Gad-1 is more helical than Gad-2 and Gad-2’s structure is more sensitive to pH.
Also, Gad-2 has two histidines pairs while Gad-1 has only one histidine pair. The
greater sensitivity of Gad-2’s structure to pH and the presence of two histidine
pairs may be related to the pH sensitivity of its antimicrobial activity against
E.coli. It should be noted that MIC assay experiments were performed with real
bacteria. Typical bound P:L ratios needed to inhibit bacterial growth in assays
for AMP antimicrobial activity are 100:1. On the other hand, bound P:L ratios
needed to cause significant perturbation in model embrane studies is typically
1:200 [35]. This very large difference (about 4 orders of magnitude ) may indicate
that peptide may bind to other components of the bacterial membrane such as
the peptidoglycan layer and the lipopolysaccharide layer of the outer membarne.
For instance, the presence of salt can affect the antimicrobial activity of a peptide.
It has been shown in previous studies that antimicrobial activity of peptides such as
Magainin, Thanatin, and s-Thanatin decreased with the increasing concentration
of salt [155, 156].
At pH 5.0, both Gad-1 and Gad-2 have higher overall positive charge and thus
stronger lipid-peptide electrostatic interaction was expected at slightly acidic pH
than at pH 7.0. However, the binding studies of Gad-1 and Gad-2 reveal that less
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peptide binds to the membrane at pH 5.0 than at pH 7.0. Also, Gad peptides
interact with a larger number of lipids at pH 5.0 than at pH 7.0. The MIC
assay results showed that Gad-2’s anti-E.coli activity is sensitive to pH while 2H
NMR results showed that peptide-induced disorder in model lipid bilayers was not
pH-dependent. If perturbation of the amplitudes of lipid acyl chains motions is
not sensitive to small differences in the amount of peptide accommodated on the
membrane surface, then the insensitivity of peptide-induced disorder, as observed
by the 2H NMR spectrum splittings, might be expected. This suggests that Gad
peptides might disrupt membrane stability by inducing anionic lipid clustering
and that the peptide may not perturb the lipid integrity in a way that increases
the amplitude of lipid acyl chain motion.
Chapter 4
Alignment of Gad peptides in
mechanically oriented model lipid
bilayers determined by 15N NMR
spectroscopy
AMP-membrane interactions are a key component in AMP mechanism. Knowl-
edge of the angle of the helical axis of the peptides with respect to the membrane
surface can reveal their structure and function relationships. For 15N-labelled
peptides interacting with mechanically oriented bilayers, chemical shifts observed
using solid-state 15N NMR spectroscopy are sensitive to peptide orientation with
respect to the membrane surface. In this work, solid-state 15N experiments have
been used to characterize the alignment of Gad-1 and Gad-2 in mechanically ori-
ented model membranes at different pH values.
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4.1 Materials and methods
4.1.1 Lipids
The chain perdeuterated lipids POPC-d31 along with non-deuterated lipids POPC
and POPG were purchased from Avanti Polar Lipids (Alabaster, AL). These lipids
were used without further purification.
4.1.2 Solid support (Mica)
To make mechanically oriented lipid bilayers, Muscovite mica (KAl2(Si3Al)O10(OH,F)2)
was used as a solid support because it is an anionic surface that helps lipids to
orient in one direction. The V-1 grade mica sheets of dimensions 50×25 mm were
purchased from SPI supplies (West Chester, PA).
4.1.3 Mechanically Oriented Lipid Bilayers
In order to obtain data on the alignment of the peptide from the 15N experiments,
it was important to prepare bilayers with as high a degree of uniform mechanical
orientation as possible. The following describes the protocol used for the prepa-
ration of mechanically oriented bilayers with and without incorporated peptides.
4.1.3.1 Appropriate lipid mixtures
The first step in the preparation of mechanically oriented lipid bilayers is to select
the appropriate lipids. Ideally, it would be best to use the same lipid composition
as were employed in the liposome experiments in Chapter 3. POPE tends to
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form wedge-like units because the cross-sectional area of the head group is smaller
than that of the acyl chains. On the other hand, POPC tends to form cylindrical
units with cross-sectional area of the head group equal to that of the acyl chains.
Attempts to prepare oriented bilayers with POPE were not successful, persumably
because of POPE’s small head-group to acyl chain area ratio. On the other hand,
oriented lipid bilayers were successfully prepared with POPC and it has commonly
been used in previous studies of this type [157–159].
Another important consideration is that the lipid environment chosen should in-
duce a high level of helicity in the Gad peptides. The percentage helicity of both
Gad-1 and Gad-2 in POPC lipid environments was found to be less than 50%,
as shown in Table 4.1. It is evident from Table 4.1 that Gad peptides have
Lipid pH % helicity of
Gad-1
% helicity of
Gad-2
POPC 5 37% 7%
POPC 6 35% 10%
POPC 7 42% 16%
POPG 5 56% 19%
POPG 6 79% 36 %
POPG 7 100% 100%
Table 4.1: Percent helicity of Gad peptides in POPC and POPG lipid environment
at different pH values. This table is adapted from Mark McDonald et al. [26] and
used with permission from Elsevier.
higher percent helicities in membranes composed of POPG than in POPC mem-
branes. Furthermore, the membrane of E.coli bacteria contains 15% PG and 80%
PE lipids [7]. Based on these considerations, it was decided to use POPC/POPG
(5:1) as the lipid component for experiments involving 15N-labelled Gad peptides
in mechanically oriented bilayers. This lipid mixture has been used in the previous
studies of mechanically oriented samples [160, 161].
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4.1.3.2 Circular Dichroism (CD)
To assess the helicity of Gad peptides in this lipid mixture, far-ultraviolet circu-
lar dichroism (CD) spectra were acquired. Samples were prepared by dissolving
POPC/POPG (5:1) in 20 mM potassium phosphate buffer at pH 7.0, and subject-
ing them to five freeze thaw steps as follows. The samples were frozen in liquid
nitrogen for 3-5 mins and thawed at room temperature for 30 mins. The resulting
liposome solutions were extruded 12 times through a 200 nm filter (Nuclepore
Track-Etched Membranes, Whatman, Toronto ON) under nitrogen gas pressure.
Peptide stock solutions were prepared at a concentration of 1 mg/mL by dry
weight of peptide in 20 mM potassium phosphate buffer at pH 7.0. Appropriate
volumes of the liposome solution and the peptide stock solution were mixed to
give a final lipid concentration of 1.4 mM and peptide concentration of 30 µM.
CD spectra were collected in milli-degrees using Jasco J-810 spectropolarimeter
(Jasco Inc., Easton, MD) in the far ultraviolet range (190-260 nm) with a 0.5
mm quartz cuvette at 25◦C. Firstly, a CD spectrum was obtained with a lipid
sample at 1.4 mM concentration to get the baseline data and then CD spectra
were obtained with liposomes containing Gad peptides. Spectra were normalized
by subtracting a baseline and then converting the units to mean-residue elliptic-
ity (MRE). Percent helicity was estimated from the ellipticity value at 222 nm.
The conversion to MRE units and the method to calculate the percent helicity
are explained in Section 2.3.2. The CD spectra of POPC/POPG (5:1) at 1.4 mM
containing Gad peptides at 30 µM are shown in Figure 4.1. The calculated values
for helicity obtained from these spectra are 92% and 100% for Gad-1 and Gad-2
respectively. Based on these observations, it was concluded that POPC/POPG
(5:1) is an appropriate lipid mixture in which to perform 15N experiments.
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(a)
(b)
Figure 4.1: (a) Far-UV CD spectrum of Gad-1 in lipid mixture of POPC/POPG
(5:1). (b) CD spectrum of Gad-2 in lipid mixture of POPC/POPG (5:1). These
spectra were obtained at 25◦C by averaging 20 scans. The observation of two
minima at 208 and 222 nm in both spectra suggests that Gad peptides adopt
α helical structure in this lipid mixture. See figure 2.14 for comparison of CD
spectrum for α helical peptide structure.
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4.1.3.3 Protocol for making mechanically oriented lipid bilayers
The detection of 15N signal from a mechanically oriented lipid bilayer sample
containing 15N-labelled peptide relies on the degree of orientation of lipid bilayers
and amount of peptide. In making the oriented lipid bilayer samples, it was critical
to incorporate enough 15N-labelled peptide to see a signal, but not so much that
the orientation of the bilayers was disrupted. Mechanically oriented lipid bilayer
samples were initially prepared with POPC as the only lipid using the following
protocol:
1. Before starting sample preparation of an oriented sample the working space
was cleaned to avoid any dust trace deposits on mica plates that can interfere
with the lipid orientation.
2. Six mica plates (clean and flat) of dimensions 12×5 mm were cut from a
mica sheet using a scalpel. In this step, the mica sheets were peeled apart
to produce mica plates as thin as possible. All mica plates were used within
two-three hours of preparation.
3. Stock solutions of lipids were prepared using 6 mg of POPC/POPC-d31 (7:3)
in 60 µL of chloroform/methanol (1:1).
4. This solution was spread (in the middle of each plate) in aliquots of 1 µL
on each plate using a micro-pipette. After a cycle of deposition on all mica
plates, a time of 3-5 mins was allowed for the lipid solution to dry on the
mica plates. Care was taken to avoid spreading lipid to the edge of the
mica plates. After completing the first cycle of deposition, the next cyle of
1 µL aliquots was started and this was repeated until all of the solution was
deposited on the plates.
5. The sample was left in a fume hood to dry for 1-3 hours.
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6. To make sure that no traces of organic solvent were left on the plates, each
sample was put in an evacuated desiccator connected to a pump with a liquid
nitrogen trap for 6-8 hours.
7. To hydrate the dry lipids on mica plates, 3 µL of deuterium depleted water
was deposited on each plate in steps of 1 µL. After depositing 1 µL water
on each plate, intervals of 2-3 minutes were allowed for plates to dry before
starting a new cycle of water deposition. The challenging part of this step
was to deposit water on the dry lipid layer in a way that did not result in
the solution spreading to the edges of the mica plate.
8. In order to make sure that lipids formed fully hydrated bilayer assemblies,
the sample was put in a sealed hydration chamber with a saturated salt
solution of ammonium sulphate dibasic (65 g) in 250 ml of distilled water.
100 mg of sodium azide was added to this salt solution to avoid the growth
of bacteria. The hydration chamber was sealed with vacuum grease (Sigma-
Aldrich, ON) and the sample was left in the chamber at room temperature
for 1-2 days.
9. The hydrated plates were carefully stacked with the addition of one empty
plate on top. This stack of plates was then squeezed gently with finger
pressure between two flat surfaces to uniformly spread lipids on the plates.
Glass microscope slides were used for this purpose. This was the most crucial
step in the protocol. To obtain the best results, it was necessary to apply
uniform pressure to the stack. If mica plates did not stick to each other after
applying pressure, the lipids on the plates were probably not hydrated. In
that case sample had to be left in hydration chamber for more time.
10. The stack of sample plates was finally sealed in thin plastic and inserted
into a rectangular glass insert. The glass inserts used were 20 mm long with
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4.3×6.3 mm ID (inner diameter) and 5.4×7.4 mm OD (outer diameter) and
were purchased from New Era Enterprises, Inc. (Newfield, NJ). To maintain
the hydration level at higher temperatures, 4 µL of deuterium depleted water
was added to the tube and its ends were sealed with wax.
11. The sample was left in a 4◦C refrigerator overnight.
12. The sample was left at room temperature for about two hours before per-
forming the NMR experiment.
4.1.4 NMR experimental details
After preparing a mechanically oriented lipid bilayer sample, 2H NMR spectroscopy
was used to test the orientation of lipids in the sample. Subsequently, 15N NMR
experiment was used to characterize the alignment of Gad peptides in the me-
chanically oriented lipid bilayers. All experiments were performed at 25◦C.
4.1.4.1 2H NMR
All 2H NMR experiments were performed at 61 MHz in a 9.4 T magnetic field
using a locally assembled spectrometer. For mechanically oriented bilayer samples,
the sample was inserted into the probe such the bilayer normal was parallel to the
external magnetic field. The sample was equilibrated at 25◦C for at least 30
minutes before doing the NMR experiment. The 2H NMR spectra were obtained
using quadrupole echo pulse sequence with 3.5 µs pi2 pulses separated by 35 µs.
A 15 µs delay was applied before the 5 µs acquisition trigger. All spectra were
obtained by averaging 8000 transients with the repetition time of 0.9 s.
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4.1.4.2 15N NMR
Proton decoupled solid-state 15N NMR experiments were performed on a Bruker
Advance 14.1 T at 60 MHz in the C-CART facility. All 15N NMR spectra were
obtained using the cross polarization (CP) pulse sequence as shown in Figure 4.2.
In CP, the polarization is transferred from a high γ nucleus (1H) to a low γ nucleus
(15N) and this polarization transfer is mediated by dipolar coupling. Initially, the
pi
2 pulse is applied to
1H nuclei. The polarization transfer occurs during contact
time and requires that the Hartmann-Hahn condition be satisfied. To satisfy this
condition, the Larmor frequencies of the 1H and 15N nuclei in their corresponding
RF fields must be set equal by adjusting the power on two channels [87].
Two types of 15N experiments were conducted: first a spectrum was obtained from
a dry powder of Gad peptides and then a spectrum was obtained from mechan-
ically oriented lipid bilayers with incorporated 15N-labelled Gad peptides. The
acquisition parameters used in these experiments are listed in Table 4.2.
Figure 4.2: The schematic representation of cross polarization (CP) pulse se-
quence. The pi2 pulse is applied to
1H channel and polarization is transferred from
1H nucleus to 15N nucleus during contact time. Afterwards, the 1H nuclei are
decoupled and FID from 15N nuclei is collected.
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Acquisition parameter Value of the acquisition parameter
Dry powder sample Oriented sample
relaxation delay (s) 5 5
contact time (ms) 1.5 1.5
90◦pulse length (µs) 5.5 5.5
90◦pulse power level (dB) 0 -1
cross polarization field (kHz) 50 50
decoupling field (kHz) 45 45
Table 4.2: The list of acquisition parameters used in CP 15N NMR experiments.
4.1.5 Synthesis of 15N-labelled Gad peptides
Gad peptides were synthesized by Fmoc solid phase synthesis [26, 162, 163] and
were further purified by using High Pressure Liquid Chromatography (HPLC), as
explained in Chapter 3. To perform 15N experiments it was necessary to isotopi-
cally label peptides with 15N. This was done by using labelled amino acids during
peptide synthesis. The cost of 15N-labelled amino acids depends on the amino acid
type and it was only practical to label certain types of amino acids, like alanine,
valine, and leucine. For Gad-1, it was decided to label valine at position 13 and
Figure 4.3: Gad peptides selectively labelled with 15N isotopes at two sites indi-
cated by red arrows.
alanine at position 15. For Gad-2, leucine residues at positions 13 and 15 were
labelled. The labelled sites are indicated by arrows in Figure 4.3.
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The 3D structures determined from solution NMR data show the helical portions
of Gad peptides [26]. The 15N-labelled residues for both peptides are expected to
be in the same helical segment.
4.1.6 Protein concentration assay
The Bradford assay is a spectroscopic procedure used to measure the concentration
of protein. The method is based on the proportional binding of the dye Coomassie
Brilliant Blue G-250 to protein. When protein binds to the dye, it results in the
dye changing color from red to blue. The blue protein-dye form is detected at 595
nm in the assay using a Genesys 10S UV-Vis spectrophotometer (Thermo Fisher
Scientific, ON). The Bradford assay [164] involved following steps.
1. The assay reagent was prepared by dissolving 10 mL of Coomassie dye in 40
mL of distilled water.
2. A stock solution of Gad peptides was prepared in 10 mM sodium acetate
buffer.
3. A standard protein solution was prepared by dissolving BSA (Bovine Serum
Albumin) protein (Sigma-Aldrich, Co.) at a concentration of 1 mg/mL in
10 mM sodium acetate buffer.
4. A series of peptide standards was prepared by pipetting 1, 2, .... 10 µL
volumes of 1 mg/mL BSA standard protein solution into clean test tubes and
adding 1 mL of assay reagent to each test tube. Tubes were then vortexed
gently to ensure thorough mixing. One blank test tube containing only 1
mL of assay reagent was also prepared.
5. The spectrophotometer was set to 595 nm and zeroed using the blank sample.
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6. The absorbances of the standard solutions were then measured at 595 nm
and a standard curve was obtained by plotting absorbance vs. volume of
standard solutions.
7. Peptide sample dilutions were then prepared by adding 5 µL and 10 µL of
Gad peptide solution to 1 mL aliquots of assay reagent. Absorbances of
these solutions were measured at 595 nm. If this absorbance did not lie in
the range of the standard curve then other sample dilutions were prepared
until an absorbance falling within the range of standard curve was obtained.
8. Protein concentration was determined from the standard curve and the di-
lution factor.
4.2 Results
4.2.1 Mechanically oriented samples of lipids only
As explained above, the preparation of mechanically oriented lipid bilayers was
first carried out on samples containing lipids only. 2H NMR spectroscopy was
employed to monitor the orientation of the lipid bilayers. A 2H NMR spectrum
of mechanically oriented POPC/POPC-d31 (7:3) lipid bilayers is shown in Figure
4.4 (a). For POPC bilayers, it was found that good orientation could be obtained
by using 1 mg of lipid and 3 µL of water on each plate and allowing a hydration
time of at least 24 hours.
For mechanically oriented lipid bilayers with bilayer normals parallel to the ex-
ternal magnetic field, the deuterium NMR spectrum has peaks corresponding to
deuterons at different positions on the lipid acyl chains. Any fractions of the sam-
ple having randomly oriented bilayer normals are expected to give rise to features
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with half of the quadrupole splitting of corresponding features in the spectrum aris-
ing from the well-oriented fraction of the sample [86, 158, 162]. With successful
sample preparation parameters identified for POPC, the next step was to try this
protocol with POPC/POPG (5:1) lipid mixtures. Mechanical orientation of lipid
mixtures containing POPG was found to be more challenging but it was possible
to make an oriented sample as shown by the 2H NMR spectra in Figure 4.4 (b).
It is evident from the spectrum shown in Figure 4.4 (b) that the POPC/POPG
(5:1) lipid mixture used to obtain that spectrum had some randomly oriented
portions. The red oval on Figure 4.4 (b) indicates spectral features characteristic
of bilayers with randomly oriented bilayer normals. Although the orientation of
this sample was not perfect, it was felt that the fraction of the sample that was
oriented was sufficient to justify proceeding to the stage of incorporating peptide
into the oriented samples.
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(a)
(b)
Figure 4.4: (a) 2H NMR spectrum of mechanically oriented POPC/POPC-d31 (7:3)
lipid bilayers. (b) 2H NMR spectrum of mechanically oriented POPC-d31/POPG
(5:1) lipid bilayers. The addition of POPG resulted in the quadrupole splittings
that are characteristic of randomly oriented bilayer fraction, indicated by red oval.
For both spectra, a total of 6 mg of lipids were deposited on 6 mica plates. The
spectra were obtained at 25◦C by averaging 6000 transients.
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4.2.2 Mechanically oriented bilayer samples of POPC/POPG
(5:1) lipid mixture with incorporated unlabelled Gad
peptides
After making acceptably oriented lipid bilayers with POPC/POPG lipid mixtures,
the next step was to add peptide to this system. This was first attempted using
unlabelled Gad peptides. Keeping the peptide to lipid ratio at 3 mole%, mechan-
ically oriented samples with Gad-1 and Gad-2 were prepared using the protocol
described in Section 4.1.3.3. The resulting spectra are shown in Figure 4.5. As
for POPC/POPG oriented lipid bilayers in the absence of peptides, these spec-
tra also have some spectral features corresponding to a randomly oriented bilayer
fraction. However, the portion of randomly oriented lipid appeared slightly higher
with peptide than without, suggesting that the peptide may affect mechanical bi-
layer orientation. These spectra indicate that approximately 75% of lipid bilayers
were oriented. It was decided that this was adequate to perform 15N experiments.
Another important consideration in planning for 15N NMR experiments was that,
due to the low 15N sensitivity, it was expected that each experiment would need
to run for about a week in order to yield an observable signal [162, 165]. For
this reason, it was necessary to ensure that samples could remain oriented as well
as hydrated for this time period while held at 25◦C. In order to check stability,
samples were held at room temperature and 2H NMR experiments were repeated
over a periods of 12 days for samples containing Gad-1 and 14 days for samples
containing Gad-2. The spectra obtained in these experiments are shown in Figure
4.5. The 2H NMR spectra in Figure 4.5 (a) were obtained from the oriented sam-
ple of POPC-d31/POPG (5:1) containing Gad-1. The resolution of the spectrum
labelled “Day 1” in this series was evidently much poorer that those obtained from
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(a)
(b)
Figure 4.5: 2H NMR spectra obtained at different intervals after sample prepa-
ration (a) mechanically oriented lipid bilayers of POPC-d31/POPG (5:1) with 3
mole% (0.6 mg) of Gad-1 and (b) a mechanically oriented lipid bilayers of POPC-
d31/POPG(5:1) with 3 mole% (0.5 mg) of Gad-2. In both cases, 6 mg of POPC-
d31/POPG (5:1) lipids were deposited on 6 mica plates. All spectra were obtained
at 25◦C and by averaging 6000 number of transients.
other oriented bilayer samples. In order to test whether this was due to incom-
plete hydration of the sample, the sealed NMR tube containing this sample was
carefully opened from one end and 3 µL of deuterium-depleted water was added
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to the tube. The tube was resealed with wax and left at room temperature for a
day after which the better resolved spectrum labelled “Day 2” was obtained. It
was concluded that if a spectrum indicated that a sample was not fully hydrated,
hydration could be improved by adding more water and allowing it to redistribute
through the sample. For oriented POPC-d31/POPG (5:1) lipid bilayers prepared
in the presence of Gad-2, the spectrum stayed the same over the period of 12 days
as indicated by the well resolved individual deuteron peaks in Figure 4.5 (b). Af-
ter having gained some experience with the preparation of mechanically oriented
bilayer samples containing unlabelled Gad peptides, the next step was to prepare
oriented bilayer samples containing 15N-labelled Gad peptides.
4.2.3 Mechanically oriented bilayer samples of POPC/POPG
(5:1) lipid mixture with incorporated 15N-labelled
Gad peptides
A mechanically oriented lipid bilayer sample of POPC-d31/POPG (5:1) containing
3 mole% (i.e. 0.6 mg) of 15N-labelled Gad-1 was prepared using six mica plates
following the protocol explained in Section 4.1.3.3. Before conducting an 15N
NMR experiment, bilayer orientation was tested using 2H NMR spectroscopy.
The resulting spectra are shown in Figure 4.6.
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Figure 4.6: 2H NMR spectra from a mechanically oriented sample prepared using
6 mg POPC-d31/POPG (5:1) with the addition of 3 mole%, i.e. 0.6 mg, 15N-
labelled Gad-1 peptide. The stability of the sample in terms of hydration and
orientation was monitored over a time period of 5 days. The sample was left at
room temperature between day 1, day 2, and day 5. All spectra were obtained at
25◦C and by averaging 6000 transients.
This series of spectra show that about 75% of lipid bilayers were well oriented and
that it remained hydrated for at least five days.
An 15N NMR experiment was then performed on a Bruker Advance 14.1 T at 60
MHz using the acquisition parameters mentioned in Table 4.2. A large number of
transients (66,000) were averaged but no 15N signal was observed. The inability to
obtain an observable 15N signal from a predominantly oriented and well-hydrated
sample suggested that there was not enough peptide in that sample to get an 15N
signal. In order to address this problem it was decided to increase the total amount
of peptide in the sample. Doing this required increasing the total amount of lipids
and hence the number of mica plates. In order to estimate roughly the amount of
labelled peptide needed in a sample to get an 15N signal, a 15N NMR experiment
was run to obtain a powder pattern spectrum using a dry powder of just labelled
peptide. It was thought that if a spectrum could be obtained in a powder sample
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where signal was spread over the range of chemical shifts corresponding to all
orientations then it should be possible to obtain signal from an oriented sample in
which the signal was concentrated at a particular chemical shift. Based on that
reasoning, it was expected that if a powder pattern spectrum could be obtained
with x mg of labelled peptide by averaging a number y of transients then x2 mg
of labelled peptide should be enough to obtain the 15N signal by averaging 4y
transients since signal-to-noise ratio in an NMR experiment is proportional to the
square root of the number of summed transients,
S
N
∝
√
no of averaged transients. (4.1)
An experiment was run with 6 mg of dry 15N-labelled Gad-1 peptide powder.
A powder pattern was obtained by averaging 12,000 number of transients using
the acquisition parameters mentioned in Table 4.2. The resulting powder pattern
spectrum of Gad-1 is shown in Figure 4.7. Based on this result, it was estimated
Figure 4.7: 15N powder pattern spectrum obtained from 6 mg of Gad-1 dry powder
at 25◦C by averaging 12,000 transients.
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that approximately 3 mg of labelled peptide would be sufficient to yield an ob-
servable 15N signal in a reasonable amount of time. In order to maintain the
lipid:peptide ratio while applying the same protocol but using 3 mg of peptide, it
was concluded that approximately 24 mica plates would be required.
4.2.4 Mechanically oriented lipid bilayers prepared using
24 mica plates
In order to test the feasibility of preparing samples with 24 mica plates, samples
with this number of plates were first prepared using lipids only. The basic protocol
was the same as mentioned in Section 4.1.3.3 but the total amount of lipids as
well as the number of mica plates, were increased. A total of 40 mg of POPC-
d31/POPG (5:1) was dissolved in 560 µL of chloroform/methanol (1:1). After
dissolving the lipids in organic solvent, the final volume was reduced to approxi-
mately 200 µL by drying under N2 flow. This solution was deposited on 24 mica
plates in steps of 1 µL on each plate until all of the solution was deposited. After
this step, the protocol followed was the same as is mentioned in Section 4.1.3.3.
The challenging task in this sample preparation was to stack the 24 mica plates.
Two ways of stacking mica plates were tried. The first way was to stack all plates
together as explained in the preceding protocol. The corresponding spectrum is
shown in Figure 4.8. This approach was found to be problematic because after
stacking, all of the plates needed to be squeezed together. Having 24 plates all
together made it very hard to apply uniform pressure on all plates especially the
middle plates. This likely caused a non-uniform distribution of lipids which gave
rise to spectral features corresponding to a randomly oriented sample fraction.
An alternative approach involved making four stacks where each stack contained
6 plates wrapped separately. Spectra corresponding to each of these 6-plate stacks
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Figure 4.8: 2H NMR spectrum of oriented bilayers prepared using 40 mg of POPC-
d31/POPG (5:1) lipids deposited on 24 mica plates. In this case all mica plates
were stacked altogether. The spectrum was obtained at 25◦C and by averaging
6000 number of transients.
are shown in Figure 4.9 (a). The spectrum of stack 1 is narrower than the spectra
of other three stacks. This is likely due to the distribution of water on the mica
plates being better in the case of stack 1. These stacks were then very carefully
inserted into a rectangular NMR tube in a such way that all stacks were aligned
exactly with each other. The resulting spectrum is shown in Figure 4.9 (b).
The degree to which the sample was oriented was almost the same for both plate
stacking methods but it was easier to make a small number of separate stacks
instead of stacking all plates together. Having demonstrated the feasibility of
orienting lipid-only bilayers using 24 mica plates, the next step was to incorporate
peptide into the system.
A mechanically oriented sample containing 3.8 mg of unlabelled Gad-1 peptide and
40 mg of POPC-d31/POPG (5:1) was prepared following the procedure described
above. Lipid orientation in the four stacks was tested for each stack individually
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(a)
(b)
Figure 4.9: 2H NMR spectra of 40 mg POPC-d31/POPG (5:1) lipid mixture pre-
pared using 24 mica plates. The mica plates were divided into four groups, each
having six plates. (a) Spectra obtained from each six-plate stack independently
(b) Spectra obtained after sealing the 4 six-plate stacks together in a rectangular
NMR tube. All spectra were obtained at 25◦C and by averaging 6000 number of
transients.
and after sealing the four stacks together. The resulting 2H NMR spectra are
shown in Figure 4.10. In terms of hydration and orientation, the sample was
stable over the period of nine days and more than half of the lipid bilayer fraction
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was oriented.
(a)
(b)
Figure 4.10: 2H NMR spectra of 40 mg POPC-d31/POPG (5:1) containing 3.8 mg
of Gad-1 peptide. (a) Spectra obtained from each six-plate stack independently (b)
Spectrum obtained after sealing the 4 six-plate stacks together in a rectangular
NMR tube. Spectra were also collected five and nine days after preparation in
order to monitor the stability of orientation and changes in hydration due to
redistribution of water within the stacked bilayers. All spectra were obtained at
25◦C and by averaging 6000 number of transients.
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4.2.5 Adjusting the pH of mechanically oriented lipid bi-
layers
Up to this point, efforts were focused on preparing well oriented and hydrated
mechanically oriented lipid bilayers with enough peptide to get an observable 15N
NMR signal. The main goal of the next part of the project was to study the
alignment of Gad peptides in oriented bilayers at low and high pH values. It was
thus necessary to ensure that it was possible to prepare mechanically oriented
bilayers at a specific pH. The following protocol [86] describes the preparation of
mechanically oriented lipid bilayers in the presence of Gad peptides with inclusion
of an extra step to test and adjust the sample pH.
1. 40 mg of lipids POPC-d31/POPG (5:1) and 3 mole% of Gad peptides were
dissolved in 1500 µL of 10 mM sodium acetate buffer at the desired pH.
2. The sample pH was monitored using a pH meter and adjusted to the desired
pH to within ± 0.1 by adding 0.1 M HCl or 0.1 NaOH.
3. The sample was then freeze-dried overnight.
4. The dried sample was then suspended in chloroform/methanol (1:1) to make
a final volume of 180 µL.
Subsequent steps in preparation of the pH-controlled samples were done as de-
scribed in Section 4.1.3.3. Figure 4.11 shows the 2H NMR spectrum obtained
from a mixture of POPC-d31/POPG (5:1) at pH 7.0 following preparation using
this protocol. The lipid bilayers were oriented up to same extent as the previous
oriented lipid bilayers prepared without the control of pH.
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Figure 4.11: 2H NMR spectrum of oriented POPC-d31/POPG (5:1) bilayers at
pH 7.0 prepared using the protocol described in Section 4.3.5. A total of 40 mg
of lipids POPC-d31/POPG (5:1) were deposited on 24 mica plates. The spectrum
was obtained at 25◦C by averaging 6000 transients.
4.2.6 Alignment of Gad-1 in mechanically oriented lipid
bilayers of POPC-d31/POPG (5:1) at pH 7.0
To study the alignment of Gad-1 in oriented lipid bilayers at pH 7.0, a mechanically
oriented sample at pH 7.0 was prepared using the protocol described in Section
4.2.5. In this sample, 3 mole% (3.8 mg) of 15N-labelled Gad-1 peptide was mixed
with 40 mg of POPC-d31/POPG (5:1).
In order to test bilayer orientation in this sample, a series of 2H NMR experiments
were performed on each 6-plate stack individually and on the sample obtained
by sealing the four 6-plate stacks together in a rectangular NMR tube. The
corresponding spectra are shown in Figure 4.12. These spectra indicate that more
than half of the fraction of POPC-d31/POPG (5:1) lipid bilayers containing Gad-1
was oriented.
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(a)
(b)
Figure 4.12: 2H NMR spectrum of POPC-d31/POPG(5:1) at pH 7.0 containing
15N-labelled Gad-1 peptide. (a) Spectra obtained from each six-plate stack inde-
pendently (b) Spectrum obtained after sealing the 4 six-plate stacks together in a
rectangular NMR tube. A total of 40 mg of POPC-d31/POPG (5:1) mixed with
3.8 mg of Gad-1 were deposited on 24 mica plates. All spectra were obtained at
25◦C by averaging 6000 transients.
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With sample orientation characterized by 2H NMR, the next step was to carry
out a proton-decoupled 15N NMR experiment using a Bruker Advance 14.1 T at
60 MHz. This experiment was conducted using the acquisition parameters listed
in the Table 4.1. The number of transients averaged was 46,000. The resulting
15N spectrum is shown in Figure 4.13 (a). The orientation and hydration of lipid
bilayers was tested after the 15N experiment. The resulting 2H NMR spectrum is
shown in Figure 4.13 (b). The comparison of 2H NMR spectra before and after the
15N experiment indicate that sample was less hydrated after the 15N experiment.
This dehydrating could occur due to radio frequency induced heating of the sample
in the NMR probe.
In order to test how peptide alignment changes in less hydrated lipid bilayers,
the 15N experiment was repeated with the same sample 20 days later than the
first experiment. The spectrum obtained in the second 15N experiment is shown
in Figure 4.14 (a). The 15N chemical shift obtained from the peptide in this
sample changed significantly between the time of the initial spectrum and the one
obtained 20 days later. However, the chemical shift of <100 ppm in both cases
indicates the alignment of peptide was parallel to the membrane surface for both
experiments. The orientation and hydration of lipid bilayers was tested after the
second 15N experiment. The resulting 2H NMR spectrum is shown in Figure 4.14
(b). The two 15N spectra are compared in Figure 4.15.
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(a)
(b)
Figure 4.13: (a) Proton-decoupled 15N solid-state NMR spectrum of Gad-1 re-
constituted into mechanically oriented lipid bilayers of POPC-d31/POPG (5:1) at
pH 7.0. This sample was prepared by mixing 40 mg of POPC-d31/POPG (5:1)
lipids with 3.8 mg 15N-labelled Gad-1. The spectrum was obtained at 25◦C and
by averaging 46,000 number of transients. (b) 2H NMR spectrum obtained with
the same sample after 15N experiment. This spectrum was obtained at 25◦C and
by averaging 6000 transients.
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(a)
(b)
Figure 4.14: Proton-decoupled 15N solid-state NMR spectrum of Gad-1 reconsti-
tuted into mechanically oriented lipid bilayers of POPC-d31/POPG (5:1) at pH
7.0. This experiment was conducted 20 days later than the first 15N experiment.
The spectrum was obtained at 25◦C and by averaging 46,000 number of transients.
(b) 2H NMR spectrum obtained with the same sample after 15N experiment. This
spectrum was obtained at 25◦C and by averaging 6000 transients.
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Figure 4.15: The comparison of two 15N spectra of Gad-1 reconstituted into me-
chanically oriented lipid bilayers of POPC-d31/POPG (5:1) at pH 7.0. The spec-
trum shown in blue was obtained 20 days later than the first spectrum shown in
red.
4.2.7 Alignment of Gad-2 in mechanically oriented lipid
bilayers of POPC-d31/POPG (5:1) at pH 7.0
After obtaining the 15N spectrum for Gad-1 at pH 7.0, the next step was to attempt
the same experiment with Gad-2 in oriented lipid bilayers at pH 7.0.
Before preparing an oriented sample, an 15N experiment was run on 3.2 mg of
Gad-2 dry powder to obtain the powder pattern. The resulting spectrum is shown
in Figure 4.16. This spectrum was obtained using the acquisition parameters listed
in Table 4.1. The number of transients averaged was 100,000. Judging from the
powder pattern spectrum with 3.2 mg of Gad-2 dry powder I expected to need at
least 50,000 transients to get a useable 15N spectrum from an oriented sample, with
the same amount of peptide. After obtaining the powder pattern spectrum with
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Figure 4.16: 15N powder pattern spectrum of Gad-2 acquired with 3.2 mg of
15N-labelled Gad-2 dry powder. The spectrum is obtained at 25◦C by averaging
100,000 transients.
labelled Gad-2 dry powder, a mechanically oriented sample of POPC-d31/POPG
(5:1) with 3 mole% (3.2 mg) 15N-labelled Gad-2 peptide was prepared by following
the protocol described in Section 4.2.5. A series of 2H NMR experiments were then
conducted to test the orientation of the lipid bilayers. The resulting 2H NMR
spectra are shown in Figure 4.17. These spectra indicate that a large enough
fraction of POPC-d31/POPG (5:1) lipid bilayers containing Gad-2 was oriented
and that it was acceptable to proceed with 15N experiments. A proton-decoupled
15N NMR experiment was then performed on a Bruker Advance 14.1 T at 60 MHz
using the acquisition parameters listed in the Table 4.1. The number of transients
averaged were 78,000 and very little 15N signal was observed. The resulting 15N
spectrum is shown in Figure 4.18.
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(a)
(b)
Figure 4.17: 2H NMR spectra of mechanically oriented POPC-d31/POPG (5:1)
lipid bilayers at pH 7.0 containing 15N-labelled Gad-2 peptide. (a) Spectra ob-
tained from six-plate stack independently (b) Spectrum obtained after sealing 4
six-plate stacks together in a rectangular NMR tube. Total 40 mg of POPC-
d31/POPG (5:1) mixed with 3.2 mg of Gad-2 were deposited on 24 mica plates.
All spectra were obtained at 25◦C by averaging 6000 transients.
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Figure 4.18: Proton-decoupled 15N solid-state NMR spectrum of Gad-2 reconsti-
tuted into mechanically oriented lipid bilayers of POPC-d31/POPG (5:1) at pH
7.0. This sample was prepared by mixing 40 mg of POPC-d31/POPG (5:1) lipids
with 3.2 mg of 15N-labelled Gad-2. The spectra were obtained at 25◦C and by
averaging 78,000 transients.
4.3 Discussion
Gad peptides selectively labelled with 15N at two sites were incorporated into
mechanically oriented lipid bilayers of POPC-d31/POPG (5:1). The alignment of
Gad peptides was investigated by proton-decoupled 15N NMR spectroscopy.
For Gad-1 at pH 7.0, two 15N experiments were conducted on the same sample
and the resulting spectra are shown in Figure 4.15. The 15N spectrum obtained
from the first experiment consists of two peaks; one centered at ∼ 55 ppm and
the second at ∼ 80 ppm. 15N spectra of helical peptides and different angles
with respect to the bilayer have been simulated [166]. Smaller 15N chemical shifts
correspond to more in-plane orientations while larger 15N chemical shifts indicate
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more transmembrane orientations. A simplified “rule of thumb” is 15N chemical
shifts >200 ppm corresponds to the transmembrane orientation of peptide with
respect to the membrane surface while 15N chemical shifts <100 ppm correspond
to in-plane alignment of peptide [108–110]. The 15N spectrum of Gad-1 at pH
7.0 indicates chemical shifts of <100 ppm corresponding to in-plane alignment
of Gad-1 in oriented bilayers. A second 15N experiment was conducted on this
sample 20 days after the first one. The resulting 15N spectrum is shown in 4.14
(a). It is evident from second experiment that, after 20 days, the 15N spectrum
has evolved into a single, narrower chemical shift peak centered at ∼ 95 ppm.
This might mean the peptide orientation has become more uniform with time.
However, the change in shift from ∼ 80 to ∼ 95 ppm suggests that the peptide
has become more tilted within the membrane [166]. Mechanically oriented lipid
bilayers are known to be less hydrated than liposomes sample [86] and old oriented
lipid bilayer samples tend to dehydrate more as indicated by the 2H NMR spectra
of before and after the second 15N NMR experiment. This drying of lipid bilayers
may cause the observed change in the alignment of peptide. The observation that
the overall chemical shift was still <100 ppm indicates that the peptide alignment
remained relatively parallel to the membrane surface. It is interesting that the
peptide appears to have become slightly more tilted as the membrane became
dehydrated.
For Gad-2 at pH 7.0, the observed 15N spectrum is shown in Figure 4.18. There is
a small bulge at ∼ 100 ppm but the signal-to-noise ratio is very poor. There are
two factors that might have contributed to the poor signal-to-noise ratio in this
sample:
(i) orientation and hydration of the lipid bilayers
(ii) amount of peptide in the sample
It is evident from Figure 4.17 that the oriented lipid bilayers prepared in the
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presence of Gad-2 were at least partially oriented. Comparison of the spectra in
Figures 4.17 and 4.12 suggest that the bilayers in the 15N-labelled Gad-2 sample
were not substantially less oriented than those in the 15N-labelled Gad-1 sample.
Therefore, it was expected that an 15N signal from Gad-2 should be observable
in approximately the same amount of Gad-1. The signal-to-noise ratio of 15N
spectrum obtained from oriented lipid bilayer sample containing 3 mole% Gad-2
is very poor compared to 15N signal observed from oriented lipid bilayer sample
prepared with 3 mole% of Gad-1. Based on these considerations, attention then
focused on the second potential explanation i.e that the amount of peptide actually
present in the prepared sample might have resulted in the poor signal-to-noise ratio
in case of Gad-2.
The dry weight of a chemically synthesized peptide is known to contain a substan-
tial amount of non-peptide contaminants, mainly salt from the HPLC purification.
It is not possible to get rid of all the contaminants even by using desalting methods
such as dialysis or gel filtration. It is possible there is a larger fraction of salt in
Gad-2 than for other peptides and thus less peptide in my sample than indicated
by the dry weight.
The Bradford assay was used to estimate the actual peptide concentration present
in the dry powder and oriented bilayer samples for which 15N NMR spectra were
obtained. Apparent peptide concentrations were obtained and are listed in Table
4.3. These concentrations were then used to estimate the actual masses of Gad
peptides present in each of the dry powder and oriented bilayer samples. In Table
4.4, the masses determined from the Bradford assay are compared with the masses
of dry peptide used in the preparation of each sample. It is noted that the Bradford
assay gives only an estimate of the actual peptide mass present in the dry powder.
This estimate is poorer for small peptides than for large proteins. Since Gad-1
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and Gad-2 are similar in size it is thus illustrative to compare the Bradford assays
for the two peptides.
Peptide Total dry powder
peptide concentra-
tion
Apparent peptide con-
centration based on
Bradford assay result
Gad-1 1 mg/ml 0.35 mg/ml
Gad-2 1 mg/ml 0.2 mg/ml
Table 4.3: The apparent concentrations of Gad peptides determined using Brad-
ford assay.
Peptide Dry powder sample Oriented lipid bilayer sample
Peptide dry
powder mass
Apparent
peptide mass
Peptide dry
powder mass
Apparent
peptide mass
Gad-1 6 mg 2.1 mg 3.8 mg 1.3 mg
Gad-2 3.2 mg 0.6 mg 3.2 mg 0.6 mg
Table 4.4: The mass of Gad peptides in powder and oriented lipid bilayer samples
calculated using Bradford assay result.
It can be seen that for Gad-1, it is likely that the 3.8 mg of dry, nominally peptide
powder used to prepare the oriented bilayer sample actually contained 1.3 mg
of peptide. For Gad-2, however, the amount of peptide found in the sample by
Bradford assay was only a fifth of the nominal mass added in the preparation.
This presumably reflects the presence of additional non-peptide material in the
dry Gad-2 powder. The overall effect is that the amount of Gad-2 peptide in the
oriented bilayer sample appears to have been slightly less than half of the amount of
Gad-1 in the corresponding sample. This may account for the significant difference
in signal obtained from the two samples.
In order to enhance the signal-to-noise ratio, one option would be to increase
the amount of labelled Gad-2 peptide in the sample. The Bradford assay result
indicates that in order to have 1.3 mg of Gad-2 peptide in an oriented bilayer
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sample it would be necessary to use 6.5 mg of peptide dry powder to prepare the
sample. Increasing the amount of peptide in an oriented bilayer sample by the
factor of two would require to double the amount of lipids as well as number of
mica plates. It is extremely difficult to prepare an oriented lipid bilayer sample
using 48 mica plates.
Another option would be to run NMR experiment for longer time. In order to
enhance the signal-to-noise ratio by the factor of two, it would be necessary to
collect four times as many transients. In NMR the signal-to-noise ratio varies as
S
N
∝
√
no of averaged transients. (4.2)
The 15N spectrum of Gad-2 peptide shown in Figure 4.16 is obtained by averaging
78,000 number of transients. In order to enhance the signal-to-noise ratio by the
factor of two it would be necessary to average 200,000 number of transients. It is
impractical to run the experiment for this long a time. Therefore, it was decided
that 15N experiments on Gad-2 would not be pursued further. In summary, the
best oriented sample preparation strategy is to make uniform and thin mica plates
and then doing good practice to deposit lipid solution on small mica plates before
making final samples. The crucial step in the sample preparation was to stack the
mica plates together. It should be made sure to apply uniform pressure to stack
the mica plates together. Any mistake in this step can result in the randomly
oriented part of lipids. The main finding from this chapter was that Gad-1 is
nearly in-plane with the membrane in well hydrated lipid bilayers, but becomes
slightly more tilted as the bilayer dehydrates. Combined with the observations
from Chapter 3, this suggests that Gad-1 aligns parallel to the membrane surface
and promotes the clustering of anionic lipids.
Chapter 5
Investigating the role of
cardiolipin in the
AMP-membrane interactions
5.1 Introduction
AMPs show specificity for bacterial membranes over host membranes. This speci-
ficity is thought to come from, at least in part, differences in the anionic lipid
content of bacterial membrane and host cell membrane [16, 26, 35, 41, 167]. Bac-
terial membranes have a high proportion of anionic lipids such as POPG and
cardiolipin, while host membranes are mainly composed of zwitterionic lipids such
as POPC and sphingomyelin. Because of the electrostatic interactions between
the cationic peptide and anionic lipids in the bacterial membrane, the binding
of AMPs with the bacterial membrane can be stronger than AMP binding to
host membranes [35]. Model membranes composed of anionic lipids which mimic
the bacterial membrane can be used to understand important features of AMP-
membrane interactions. In Chapter 3, interactions of Gad peptides with model
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lipid membranes composed of POPE and POPG lipids were studied. In addi-
tion to POPG, bacterial membranes also have cardiolipin (CL) as an anionic lipid
component. For the purpose of understanding the role of CL in AMP-membrane
interactions, model membranes composed of POPE, POPG and CL were used.
The work reported in this chapter examined how the presence of cardiolipin af-
fects the AMP-membrane interactions and how these interactions were affected
by the change in peptide charge. The AMP-membrane interactions of Gad-1 with
model membranes containing CL were characterized using 2H NMR spectroscopy
and zeta potential measurements. Gad-1 is a histidine-rich peptide and takes on
a different charge at pH 7.0 and at pH 5.0. To examine how AMP-membrane in-
teractions are affected by peptide overall charge, all experiments were performed
at pH 7.0 and pH 5.0.
5.2 Cardiolipin in bacterial membranes
Cardiolipin is an anionic glycerophospholipid. Unlike many other phospholipids,
cardiolipin has a single headgroup glycerol molecule shared by two phosphatidyl
moieties. This chemical structure results in a relatively small head group and
large hydrophobic region formed by four acyl chains (Figure 5.1). It can carry
two negative charges [168–171]. The small size of the polar head group brings
the hydrocarbon chains closer, which in turn elevates the transition tempera-
ture of CL relative to other phospholipids [172]. The transition temperature of
tetramyristoylcardiolipin is 47◦C. A recent study with synthetic CL provided ev-
idence that the CL headgroup behaves as a strong dibasic acid with first pKa1
at 2.15 and second pKa2 one unit larger [171]. The smaller size of its polar head
group enhances the tendency of CL to form inverted non-lamellar phases [173].
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Figure 5.1: Chemical structure of cardiolipin (CL). This Figure is taken from
Alder et al. [171] and reused with permission from Elsevier.
Furthermore, because the CL headgroup is shared by two phosphatidate moi-
eties, the cardiolipin headgroup is less flexible compared to other phospholipid
headgroups [174]. The restricted mobility and conformational inflexibility of the
headgroup also makes it less likely to have interactions with other headgroup moi-
eties. Hence CL−containing membranes are more exposed to interactions with
water, ions, peptides, and proteins [172]. The cardiolipin structure contributes to
membrane structural stability. Cardiolipin is found in the membranes of many
Gram-positive and Gram-negative bacteria (Table 5.1).
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Bacterial species CL(% of totallipids by weight)
PG(% of total
lipids by weight)
PE(% of total
lipids by weight)
Gram-negative bacteria
Escherichia coli 5 15 80
Escherichia
cloacae 3 21 74
Yersinia
kristensenii 20 20 60
Proteus mirabilis 5 10 80
Klebsiella
pneumoniae 6 5 82
Pseudomonas
aeruginosa 11 21 60
Gram-positive bacteria
Staphylococcus
aureus 42 58 0
Streptococcus
pneumonia 50 50 0
Bacillus cereus 17 43 40
Bacillus
polymyxa 8 3 60
Table 5.1: The lipid composition of various Gram-positive and Gram-negative
bacteria. Table is adapted from Wang et. al [7] and reused with permission from
Elsevier.
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5.3 Materials and Methods
Due to the very small yield of Gad-2 in chemical synthesis, it was decided to use
only Gad-1 peptide in studies of interactions with model membranes containing
cardiolipin.
5.3.1 Lipids
Chain per-deuterated lipid, POPG-d31 along with the non-deuterated lipids POPE
and cardiolipin were purchased from Avanti Polar Lipids (Alabaster, AL). All lipids
were used without further purification.
5.3.2 Gad-1 peptide
A part of the Gad-1 used in these experiments was purchased from Genscript
(GenScript Inc. NJ, USA) and the rest of the peptide was chemically synthesized
in our laboratory using O-fluorenylmethyl-oxycarbonyl (Fmoc) solid-phase synthe-
sis as described in Section 3.1.4. The peptide from both the sources, was desalted
using dialysis against 5% acetic acid and then water using dialysis tubing with a
1kDa molecular weight cutoff. The resulting peptide solution was lyophilized and
stored at 4◦C.
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5.3.3 2H NMR
5.3.3.1 Sample preparation
Multilamellar vesicles were prepared with POPE/ POPG-d31/CL molar ratios of
79/16/5, 75/15/10, and 83/6/11 using the protocol described in Section 3.1.2.1.
A sample with 79/16/5 molar ratio was prepared at 5% CL concentration of total
lipids and effective zwitterionic to negative lipid ratio was kept 3:1. After that
CL concentration was increased to 10% of total lipid concentration and a sample
was prepared at molar ratio of 75/15/10. In this sample the effective zwitterionic
to negative lipid ratio was not 3:1 but POPE/POPG ratio was kept the same as
the previous sample prepared at molar ratio 79/16/5. After that, a sample was
prepared at molar ratio of 83/6/11. In this sample the CL concentration was 10%
of total lipid concentration and effective zwitterionic to negative lipid ratio was
3:1.
5.3.3.2 Experimental detail
All 2H NMR experiments were performed as detailed in Chapter 3 at temperatures
of 25◦C, 37◦C, and 50◦C. For each sample, the temperature was raised sequentially
to 25◦C, 37◦C, and 50◦C, then lowered to 37◦C and finally to 25◦C.
5.3.4 Zeta potential measurements
5.3.4.1 Sample preparation and Experimental detail
For zeta potential measurements, multilamellar vesicles were prepared using POPE/POPG-
d31/CL (79/16/5 molar ratio) at concentration of 6.8 mM. The protocol described
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in Section 3.1.3.1 was used to prepare samples for zeta potential measurements.
All zeta potential measurements were performed following the procedure explained
in Section 3.1.3.2.
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5.4 Results
The work reported in this chapter examines how the presence of cardiolipin (CL)
affects the interaction of Gad-1 with POPE/POPG membranes. To this end, 2H
NMR and zeta potential experiments were performed using model membranes
composed of a POPE/POPG/CL lipid mixture. Firstly, the effects of CL on the
membrane dynamics of POPE/POPG lipid bilayers were investigated by using
2H NMR. After this, 2H NMR was used to study the effects of Gad-1 on lipid
acyl chain order and bilayer motions in POPE/POPG/CL lipid bilayers. In ad-
dition, peptide binding to POPE/POPG/CL lipid bilayers was characterized by
measuring binding parameters, the partition constant, the equilibrium constant,
and molar fraction of peptide bound to the membrane, using zeta potential mea-
surements. In order to examine how AMP-membrane interactions were affected
by the presence of CL, 2H NMR and zeta potential results of POPE/POPG lipid
bilayers were compared with the results of POPE/POPG/CL lipid bilayers in the
presence of Gad-1. For this purpose, the effective zwitterionic to negative lipid
ratio was kept the same (3:1 molar ratio) in both lipid-only samples. The effective
zwitterionic to anionic lipid ratio was calculated by dividing the total number of
zwitterionic lipids by total number of anionic lipids. For CL−containing samples,
CL is taken as equivalent to two anionic phospholipids.
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5.4.1 2H NMR
5.4.1.1 2H NMR spectra of POPE/POPG-d31/CL lipid bilayers at pH
7.0 and pH 5.0
In order to investigate the mixing of cardiolipin with POPE and POPG in lipid
bilayers, model membranes were prepared using POPE/POPG-d31/CL (79/16/5
molar ratio) following the protocol described in Section 3.1.2.1. A series of 2H
NMR spectra were acquired at selected temperatures using the acquisition pa-
rameters listed in Section 3.1.2.2. Experiments were carried out at different tem-
peratures beginning at 25◦C. After this, temperature was raised from 37◦C to 50◦C
(above the transition temperature of CL, 47◦C). Then the sample was cooled back
to 25◦C. The sample was allowed to equilibrate for at least 30 minutes at each
temperature after which a spectrum was acquired at that temperature. The re-
sulting spectra are shown in Figure 5.2. Vertical dotted black lines are included to
facilitate comparison of quadrupole splittings. It can be seen that the splittings of
the prominent spectral edges decrease as the sample is initially warmed from 25◦C
to 50◦C. This reflects the fact that, at higher temperature, the model lipid bilayer
is more fluid and the amplitudes of lipid acyl chain motion are larger compared
to the amplitudes of acyl chain motion at 25◦C.
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Figure 5.2: A series of 2H NMR spectra of model membranes composed of
POPE/POPG-d31/CL (79/16/5 molar ratio) at pH 7.0. The spectra are shown
from bottom to top, in the order of acquisition. For each spectrum, 10000 tran-
sients were averaged and a minimum time of 30 minutes was given to equilibrate
the sample at each temperature. The dotted black lines mark the prominent
spectral edges observed at 37◦C. The prominent edges correspond to the most
ordered chain segments of lipid acyl chains. For the shown spectra, the rotatory
evaporation step during the sample preparation was done at 40◦C.
An important point to note from the set of spectra shown in Figure 5.2 is that
the line width of the quadrupole doublet features did not change reversibly with
temperature. In particular, the spectra obtained while first warming through 37◦C
and at 50◦C had sharper peaks than the 37◦C spectrum subsequently observed on
cooling. This might indicate that warming above the CL bilayer transition tem-
perature was necessary to obtain complete mixing of lipid components that were
not fully mixed after the initial sample hydration. It should be noted that during
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this sample preparation, the organic solvent was removed by rotatory evaporation
at 40◦C, which was below the transition temperature of CL. To test the possibil-
ity that the spectra of Figure 5.2 were affected by changes in lipid mixing, a new
sample was prepared at the same composition but using rotatory evaporation at
50◦C. The resulting spectra at selected temperatures are shown in Figure 5.3.
Figure 5.3: A series of 2H NMR spectra of model membrane composed of lipids
POPE/POPG-d31/CL (79/16/5 molar ratio) at pH 7.0. The spectra are shown
from bottom to top, in the order of acquisition. For each spectrum, 8000 tran-
sients were averaged and a minimum time of 30 minutes was given to equilibrate
the sample at each temperature. The dotted black lines indicate the prominent
spectral edge observed at 37◦C. For the shown spectra, the rotatory evaporation
step during the sample preparation was done at 50◦C.
It can be seen from Figure 5.3 that the spectra obtained at 37◦C were less sensitive
to whether or not the sample had already been cycled to a higher temperature.
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This suggests that mixing of lipids at a temperature above the transition temper-
ature of all lipid components facilitated a more homogenous initial sample mixing.
The rotatory evaporation was done at 50◦C for the rest of the experiments.
In order to learn how the addition of CL affected the lipid acyl chain order of
POPE/POPG-d31, the 2H NMR spectrum of POPE/POPG-d31/CL (79/16/5 mo-
lar ratio) was compared with the spectrum of POPE/POPG-d31 (3:1 molar ratio).
It should be noted that in both spectra, the effective zwitterionic to negative lipid
ratio was 3:1. The compared spectra are shown in Figure 5.4.
Figure 5.4: The 2H NMR spectra of POPE/POPG-d31 (3:1 molar ratio) and
POPE/POPG-d31/CL (79/16/5 molar ratio) at pH 7.0. The dotted black lines
facilitate comparison of the spectral splittings observed at 25◦C. The zwitterionic
to negative charge ratio in the samples was 3:1. It should be noted that CL carries
a charge of -2 while, POPG has a charge of -1.
Comparison of the spectra in Figure 5.4 indicates that addition of CL to POPE/POPG
at this molar fraction did not change 2H NMR spectrum doublet splittings. In
other words, the presence of CL did not affect the amplitudes of lipid acyl chain
motions in POPE/POPG/CL (79/16/5 molar ratio) lipid bilayers. In this sample,
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CL was only 5% of the total lipid composition and it is possible that this amount
of CL in the sample was too small to make any substantial changes in the 2H
NMR spectrum splittings. In the next step, a sample was prepared with double
the amount of CL while keeping the POPE/POPG lipid ratio the same so that the
POPE/POPG/CL proportions were 75:15:10 (by mole). An effective zwitterionic
to anionic lipid ratio was calculated by dividing total number of zwitterionic lipids
(75) by total number of anionic lipids( 15+20). CL is taken as equivalent to two
anionic lipids. This results in an effective zwitterionic to anionic lipid ratio of
about 2:1 rather than 3:1. The resulting spectra are shown in Figure 5.5.
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Figure 5.5: A series of 2H NMR spectra of model membranes composed of lipids
POPE/POPG-d31/CL (75/15/10) at pH 7.0. The spectra are shown, from bot-
tom to top in the order of acquisition. For each spectrum, 6000 transients were
averaged and a minimum time of 30 minutes was given to equilibrate the sample
at each temperature. The dotted black lines indicate the prominent spectral edges
observed at 37◦C. In this sample the POPE : POPG ratio (5:1) was kept the same
as the sample shown in Figure 5.3, but the CL fraction was doubled from 5% to
10% of total lipid composition.
Comparison of the spectra shown in Figure 5.3 and Figure 5.5 suggests that in-
creasing the amount of CL from 5% to 10% of total lipid composition did not
change the 2H NMR spectrum splittings.
Next, a sample was prepared with a 10% CL fraction of total lipid composition
and with an effective zwitterionic to negative lipid ratio of 3:1. In the calculation
of this ratio, CL is again treated as being equivalent to two anionic lipids. The
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resulting spectra of POPE/POPG-d31/CL (83/6/11 molar ratio) are shown in
Figure 5.6. Comparison of the spectra shown in Figures 5.3, 5.5, and 5.6, indicates
that changing the CL concentration from 5% to 10% of total lipid composition
and changing the POPE:POPG ratio still did not change the 2H NMR spectrum
doublet splittings.
Figure 5.6: A series of 2H NMR spectra of model membranes composed of lipids
POPE/POPG-d31/CL (83/6/11 molar ratio) at pH 7.0. The spectra are shown,
from bottom to top, in the order of acquisition. For each spectrum 6000 tran-
sients were averaged and a minimum time of 30 minutes was given to equilibrate
the sample at each temperature. The dotted black lines show the prominent edges
observed at 37◦C. In this sample the POPE:POPG ratio is 15:1 and the zwitteri-
onic to negative charge ratio was 3:1.
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The spectra shown in Figures 5.1 to 5.6 suggest that CL did not change the 2H
NMR doublet splittings of POPE/POPG. In other words, the addition of CL to
POPE/POPG up to the molar CL fraction studies, did not affect the amplitudes
of lipid acyl chain motions that contribute to motional narrowing.
The next step was to examine the changes in the spectrum of POPE/POPG-
d31/CL resulting from a change in pH from 7.0 to 5.0. For this purpose, 2H
NMR spectra of POPE/POPG-d31/CL (79/16/5 molar ratio) at pH 5.0 were first
obtained at selected temperatures. The resulting spectra are shown in Figure 5.7.
To see if the spectra of POPE/POPG-d31/CL change with pH, 2H NMR spectra
of POPE/POPG-d31/CL were compared at pH 7.0 and pH 5.0 ( Figure 5.8). It
can be seen that changing pH from 7.0 to 5.0 did not change the 2H NMR spectra
of POPE/POPG-d31/CL (79/16/5 molar ratio).
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Figure 5.7: A series of 2H NMR spectra of model membranes composed of lipids
POPE/POPG-d31/CL (79/16/5 molar ratio) at pH 5.0. The spectra are shown,
from bottom to top, in the order of acquisition. For each spectrum 6000 transients
were averaged and a minimum time of 30 minutes was given to equilibrate the
sample at each temperature. The dotted black lines indicate the prominent edges
observed at 37◦C.
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Figure 5.8: Comparison of 2H NMR spectra of POPE/POPG-d31/CL (79/16/5
molar ratio) at pH 7.0 and pH 5.0. Both spectra were obtained at 25◦C.
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5.4.1.2 Effect of CL on the slow motions of POPE/POPG-d31 lipid
bilayers at pH 7.0 and pH 5.0
Slow motions whose correlation times are greater than the characteristic NMR
time (10−5s) do not contribute to motional narrowing. Along with faster motions,
such slow motions can perturb the refocusing of the quadrupole echo and change
the quadrupole echo decay time [175]. How fast or slow motions of POPE/POPG
lipid bilayers were perturbed by the addition of CL was examined by measuring the
quadrupole echo decay time. The quadrupole echo decay experiments were per-
formed using the acquisition parameters listed in Section 3.1.2.2. The quadrupole
echo experiments with POPE/POPG-d31/CL at pH 5.0 and pH 7.0 show that
CL reduces the echo decay times at both pHs (Figure 5.9 and Figure 5.10). The
reduction in echo decay time resulting from the addition of CL to POPE/POPG
bilayers indicates either the slowing down of a fast lipid motion or the speeding up
of a slow bilayer motion. Since CL does not have any effect on the amplitudes of
fast lipid acyl chain motions, it seems likely that CL perturbs the slower diffusive
or collective motions of POPE/POPG lipid bilayers. The interpretation of these
results is discussed in the Section 5.5.
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(a)
(b)
Figure 5.9: The quadrupole echo decay time of POPE/POPG-d31/CL lipid mix-
ture at pH 7.0 (a) at 25◦C (b) 37◦C. The addition of CL to POPE/POPG-d31
lipid mixture decreased the echo decay time.
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(a)
(b)
Figure 5.10: The quadrupole echo decay time of POPE/POPG-d31 and
POPE/POPG-d31/CL lipid mixture at pH 5.0 (a) at 25◦C (b) 37◦C. The addition
of CL to POPE/POPG-d31 lipid mixture decreased the echo decay time.
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5.4.1.3 2H NMR spectra of POPE/POPG-d31/CL lipid bilayers in the
presence of Gad-1 at pH 7.0 and pH 5.0
After having obtained spectra from POPE/POPG/CL model membranes, the next
question asked was how the presence of CL in a model bacterial membrane might
affect the response of the lipid bilayer to a peptide like Gad-1. To address this, 2H
NMR spectra of POPE/POPG-d31/CL (79/16/5 molar ratio) with added Gad-1
were obtained at various temperatures for pH 7.0. The lipid-to-peptide ratio was
kept at 25:1(molar ratio). The resulting spectra are shown in Figure 5.11. It is
apparent that the presence of Gad-1 reduced the resolution of quadrupole doublets
in the spectra of POPE/POPG/CL+Gad-1. This may reflect a peptide-induced
decrease in quadrupole echo decay time.
Figure 5.12 compares spectra of the lipids with and without CL and Gad-1. It can
be seen from the spectra compared in Figure 5.12 that the addition of Gad-1 to
both POPE/POPG-d31 and POPE/POPG-d31/CL lipid bilayers slightly reduces
all of the quadrupole doublet splittings which indicates a reduction in chain orien-
tational order. In addition to a change in splittings, there was a qualitative change
in the spectrum with the addition of Gad-1 and CL together. In particular, the
addition of Gad-1 to POPE/POPG-d31/CL lipid bilayers resulted in a significant
broadening of the individual doublets of the spectrum. The interpretation of this
observation is discussed in Section 5.5.
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Figure 5.11: A series of 2H NMR spectra of POPE/POPG-d31/CL (79/16/5 molar
ratio) + Gad-1 at pH 7.0. The zwitterionic to negative lipid ratio was 3:1(molar
ratio) and the lipid-to-peptide ratio was 25:1(molar ratio). The spectra are shown,
from bottom to top, in the order of acquisition. For each spectrum 6000 transients
were averaged and a minimum of 30 minutes was given for the sample to equilibrate
at each temperature. The dotted black lines represent the prominent spectral edges
observed at 25◦C .
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Figure 5.12: 2H NMR spectra of POPE/POPG-d31 acquired at 25◦C with addition
of CL and/or Gad-1 at pH 7.0. The number of transients averaged for each
spectrum are indicated on the spectrum. The black dotted lines are intended to
facilitate comparison of the prominent edges in different spectra. The zwitterionic
to negative lipid ratio was 3:1(molar ratio) and lipid:peptide ratio was 25:1 (molar
ratio) in these spectra.
In order to examine whether changing the peptide overall charge has any effect on
the AMP-membrane interactions in POPE/POPG-d31/CL lipid bilayers, spectra
were also obtained from samples in which peptide charge was altered by changing
pH from 7.0 to 5.0 (Figure 5.13).
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Figure 5.13: A series of 2H NMR spectra of model membrane composed of lipids
POPE/POPG-d31/CL(79/16/5) + Gad-1 at pH 5.0. For each spectrum 6000
transients were averaged and a minimum of 30 minutes was given for the sample
to equilibrate at each temperature. The dotted black lines are intended to facilitate
comparison of the prominent edges in different spectra. The lipid:peptide ratio
was 25:1(molar ratio).
To show how peptide charge affects the perturbation of a POPE/POPG bilayer by
Gad-1 in the presence of CL, Figure 5.14 compares a spectrum of POPE/POPG-
d31/CL (79/16/5) obtained at 25◦C and pH 5.0 with a 25◦C spectrum of POPE/POPG-
d31/CL (79/16/5) from Figure 5.7 and 25◦C spectra of POPE/POPG-d31 (3:1)
with and without Gad-1, from Figure 3.1. These comparisons indicate that
similarly to the results at pH 7.0, the addition of Gad-1 to POPE/POPG-d31
and POPE/POPG-d31/CL lipid bilayers at pH 5.0 slightly reduces lipid chain
quadrupole splittings, which indicates a reduction in chain orientational order.
Chapter 5. Investigating the role of cardiolipin in the AMP-membrane
interactions 191
Also, addition of the peptide also broadened spectral doublets for lipid bilayers
containing CL.
Figure 5.14: 2H NMR spectra of POPE/POPG-d31 acquired at 25◦C with addi-
tion of CL and/or Gad-1 at pH 5.0. The number of transients averaged for each
spectrum are indicated on the spectrum. The black dashed lines facilitate com-
parison of prominent spectral edges. The zwitterionic to negative lipid ratio was
3:1(molar ratio) and the lipid:peptide ratio was 25:1 (molar ratio).
To show how pH affects the perturbation of POPE/POPG/CL bilayers by Gad-1,
spectra for POPE/POPG-d31/CL(79/16/5) with and without Gad-1 at pH 5.0 and
pH 7.0 are compared in Figure 5.15. These comparisons indicate that perturbation
of POPE/POPG-d31/CL lipid bilayers by Gad-1 is not pH-sensitive.
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Figure 5.15: Comparison of the 2H NMR spectra of POPE/POPG-d31/CL with
and without the addition of Gad-1 at pH 7.0 and pH 5.0. The dotted black lines
are intended to facilitate comparison of prominent spectral edges.
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5.4.1.4 Effects of Gad-1 on the slow motions of POPE/POPG-d31/CL
lipid bilayers at pH 7.0 and pH 5.0
How fast or slow motions of POPE/POPG/CL lipid bilayers were perturbed by
the addition of Gad-1 was examined by measuring the quadrupole echo decay
time. In order to examine how the presence of CL affects the perturbation of fast
or slow motions of POPE/POPG bilayers by Gad-1, the quadrupole echo decay
times of POPE/POPG/CL bilayers with and without Gad-1, were compared with
the echo decay times of POPE/POPG bilayers with and without the addition of
Gad-1. These comparisons at two temperatures, 25◦C and 37◦C, are shown in
Figure 5.16 and Figure 5.17 for pH 7.0 and pH 5.0 respectively. Interestingly, the
addition of Gad-1 to POPE/POPG/CL had opposite effects at pH 7.0 and pH
5.0. At pH 7.0, Gad-1 decreased the echo decay time of POPE/POPG-d31/CL
while at pH 5.0 the echo decay time of POPE/POPG-d31/CL bilayers increased
with the addition of Gad-1. Interpretation of these observations will be discussed
in Section 5.5.
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(a)
(b)
Figure 5.16: The quadrupole echo decay time of POPE/POPG-d31 and
POPE/POPG-d31/CL lipid mixture with and without the addition of Gad-1 at pH
7.0 (a) at 25◦C (b) 37◦C. The addition of CL to POPE/POPG-d31 lipid mixture
decreased the echo decay time and addition of Gad-1 to POPE/POPG-d31/CL
further decreased the echo decay time.
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(a)
(b)
Figure 5.17: The quadrupole echo decay time of POPE/POPG-d31 and
POPE/POPG-d31/CL lipid mixture with and without the addition of Gad-1 at pH
5.0 (a) at 25◦C (b) 37◦C. The addition of CL to POPE/POPG-d31 lipid mixture
decreased the echo decay time and addition of Gad-1 to POPE/POPG-d31/CL
increased the echo decay time.
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5.4.2 Zeta potential
To examine the binding of Gad-1 to model membranes, zeta potentials of POPE/POPG/CL
(79/16/5 molar ratio) vesicles were measured with and without the addition of
Gad-1. To study the peptide binding quantitatively, several binding parameters
were obtained. A binding model described by Freire et al. allows the calculation of
the partition constant (KP), molar fraction of the peptide bound to the membrane
(X), local concentration of peptide in the membrane ([P ]L), and stoichiometry of
lipid- peptide complexes. A slightly different zeta potential model based on the
Langmuir isotherm was used to determine the equilibrium constant (Keq), the mo-
lar fraction of the peptide bound to the membrane (X), and number of lipids per
bound peptide. These models are described in detail in Sections 3.2.2.2 and 3.2.2.3
in Chapter 3. The zeta potential binding isotherms were obtained by plotting zeta
potential vs. total peptide concentration. To compare the binding of Gad-1 to
POPE/POPG/CL lipid bilayers with the binding of the peptide to POPE/POPG
lipid bilayers, the zwitterionic to negative charge ratio was kept same at 3:1(molar
ratio). Because Gad-1 takes different charge at pH 7.0 and pH 5.0. All experi-
ments were performed at pH 7.0 and pH 5.0 to study how peptide overall charge
could affect the peptide binding.
5.4.2.1 Binding isotherm
Zeta potentials of POPE/POPG/CL (79/16/5 molar ratio) lipid vesicles with in-
creasing concentrations of Gad-1 were measured at pH 7.0 and pH 5.0 as described
in the Section 3.1.3.1 and Section 3.1.3.2. The sizes of these vesicles were mea-
sured by Dynamic Light Scattering (DLS) using a Malvern Zetasizer Nano ZS
apparatus (model ZEN 3600, Malvern Instruments Ltd. U.K.). The observed
sizes of these vesicles were 145± 10 nm. The zeta potential binding isotherms for
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POPE/POPG/CL + Gad-1 at pH 7.0 and pH 5.0 are shown in the Figure 5.18
(a) and (b) respectively.
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(a)
(b)
Figure 5.18: (a) The binding isotherms of Gad-1 at (a) pH 7.0 (b) pH 5.0. Each
point represents the average of three independent measurements. The first point in
the isotherm represents the zeta potential of liposomes in the absence of peptide.
A negative value of zeta potential was observed in the absence of peptide. As the
peptide concentration was increased the zeta potential increased toward a limiting
value. When all peptide binding sites were occupied, the limiting value of zeta
potential depends on the overall charge of peptide and the L : P ratio. At pH 7.0,
Gad-1 has charge of +3 and the limiting value is ∼ -35 mV. On the other hand,
at pH 5.0 Gad-1 has charge of +8 and the limiting value in this case is ∼ -10 mV.
The error bars were estimated by averaging the deviation from the mean for three
measurements.
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5.4.2.2 Characterizing the binding of Gad-1 to POPE/POPG/CL lipid
bilayers using Freire et al. binding model
The binding isotherms and corresponding normalized zeta potentials for Gad-1
at pH 7.0 and pH 5.0 are shown in Figure 5.19 and Figure 5.20 respectively. As
in Section 3.2.2.2, the slope of linear regime of the normalized zeta potential vs.
peptide concentration plot was used to determine the molar fraction (X) of Gad-1
that is bound to the membrane using
ζ
ζ0
= XzP
fL− [L]zL−
[P ]Total + 1. (5.1)
The partition constant (KP) was determined using
X = γL[L]KP1 + γL[L]KP
(5.2)
where zP is the peptide charge, [L] is the total lipid concentration, fL− is the fraction
of lipid accounted for by anionic species, zL is the charge of the anionic lipids, and
γL is the lipid molar volume. The value of molar volume of lipids is 0.763 in liters
per mole [56]. The values of X and KP for Gad-1 at pH 7.0 and pH 5.0 are listed
in Table 5.2. The values of X were smaller at pH 5.0 than at pH 7.0. The value
of KP at pH 7.0 is ten times higher than the value at pH 5.0. This suggests that a
smaller amount of peptide is accommodated on the membrane at pH 5.0 compared
to at pH 7.0.
The values of the local peptide concentration ([P ]L) and (L : P )local were calculated
using
[P ]L =
X[P ]Total
γL[L]
. (5.3)
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(L : P )local =
1 + [L]KPγL
[P ]TotalγLKP
(5.4)
=
 1
[P ]TotalKPγL
+ [L][P ]Total
. (5.5)
The values of [P ]L and (L : P )local for Gad-1 at pH 7.0 and pH 5.0 are listed in
Table 5.3. The [P ]L increases as the total peptide concentration [P ]Total increases.
The (L : P )local values were higher at pH 5.0 than at pH 7.0. This indicates that
one peptide molecule interacts with a larger number of lipids at pH 5.0 than at
pH 7.0. The interpretation of these results is discussed in Section 5.5.
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(a)
(b)
Figure 5.19: (a) Zeta potential measurements for 40 µM POPE/POPG/CL
(79/16/5) in the presence of Gad-1 at pH 7.0. Addition of peptide to lipid vesicles
results in the reduction of zeta potential values. The linear portion of this graph,
0 µM - 2 µM peptide concentration, was selected to obtain the normalized zeta
potential plotted in panel (b). (b) Normalized zeta potential dependence on the
concentration of Gad-1 peptide at pH 7.0. The slope of the linear portion of the
binding isotherm was obtained using the weighted linear fitting. The size of error
bars was taken into account to estimate the uncertainty in the slope. The slope
of this graph was used to determine the molar fraction of peptide bound to the
membrane (X) and partition constant (KP).
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(a)
(b)
Figure 5.20: (a) Zeta potential measurements for 40 µM POPE/POPG/CL
(79/16/5 molar ratio) in the presence of Gad-1 at pH 5.0. Addition of peptide to
lipid vesicles results in the reduction of zeta potential values. The linear portion of
this graph, 0 µM - 6 µM peptide concentration, was selected to obtain the normal-
ized zeta potential plotted in panel (b). (b) Normalized zeta potential dependence
on the concentration of Gad-1 peptide at pH 7.0. The slope of the linear portion
of the binding isotherm was obtained using the weighted linear fitting. The size
of error bars was taken into account to estimate the uncertainty in the slope. The
slope of this graph was used to determine the molar fraction of peptide bound to
the membrane (X) and partition constant (KP).
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Gad-1
pH Molar fraction of peptide bound tothe membrane (X) Partition constant (KP )
7.0 0.8±0.2 100,000 ± 90000
5.0 0.32±0.01 15,400± 700
Table 5.2: Calculated molar fractions of peptide bound to the membrane (X) and
partition constants (KP) from zeta potential measurements for Gad-1 at pH 7.0
and pH 5.0.
Gad-1
[P ]Total
(µM)
global
L : P
pH 7.0 pH 5.0
[P ]local
(mM) (L : P )local
[P ]local
(mM) (L : P )local
1 40 26 50 10 125
2 20 52 25 21 63
3 13 78 17 31 42
Table 5.3: The global L:P is calculated for the total peptide concentration 1 µM -
3 µM. The range of total peptide concentration is selected from the linear portion
of the zeta potential binding isotherms of Gad-1. The local peptide concentration
([P ]local ) in the membrane and local L : P are also calculated for corresponding
total peptide concentration at pH 7.0 and pH 5.0. Note that (L : P )local represents
the lipid to peptide ratio for lipid and peptide complexes.
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5.4.2.3 Modeling peptide dependence of the zeta potential using the
Langmuir isotherm approach
The zeta potential model based on the Langmuir isotherm also considers the re-
duction in membrane surface charge when a cationic peptide interacts with a
model membrane composed of anionic lipids. It takes into account both the linear
part and plateau region of a zeta potential binding isotherm where zeta poten-
tial approaches a limiting value. The main difference between the two models is
that the Freire et al. approach considers the peptide to be dissolved in the lipid
bilayer volume while the zeta potential model based on the Langmuir isotherm
treats the peptide as being adsorbed on the surface. The summary of the zeta
potential model based on the Langmuir isotherm was given in Chapter 3. This
model was used to determine the equilibrium constant (Keq), molar fraction of
peptide bound to the membrane (X), and number of lipids constituting the pep-
tide binding sites (1/Q). To determine these parameters, the binding isotherms
showing the variation of ∆ζ
ζmax
vs [P ]Total were obtained.
The slope of the linear regime of ∆ζ
ζmax
vs [P ]Total was used to determine X using
slope =
(
XzP
fL−zL− [L]
)(
ζ0
∆ζmax
)
. (5.6)
where fL− is the fraction of lipids that are anionic, zL− is the charge of an anionic
lipid, zP is the peptide charge, and [L] is the total lipid concentration.
The equilibrium constant Keq was determined using
∆ζ
∆ζmax
= Keq(1−X)[P ]Total1 +Keq(1−X)[P ]Total
. (5.7)
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In the linear region of the binding isotherm, the expression for the slope, Keq(1−
X), allows the calculation of Keq. The limiting value of the zeta potential was
used to determine Q, the ratio of available peptide binding sites to total lipids,
using
Q = ∆ζmax
ζ0
fL−zL−
zP
. (5.8)
The binding isotherms showing the variation of ∆ζmax
ζ0
vs [P ]Total and correspond-
ing linear regime for Gad-1 at pH 7.0 and pH 5.0 are shown in Figure 5.21 and
Figure 5.22 respectively. The error bars in the binding isotherm at pH 7.0 are
larger than the error bars in the binding isotherm at pH 5.0. This is due to the
difference in the value of maximum zeta potential value obtained at pH 7.0 and pH
5.0. At pH 5.0 the value of maximum zeta potential is positive while at pH 7.0 it
is a negative quantity. This resulted in the difference in the relative uncertainties
∆ζmax
ζ0
.
The calculated values of X, Keq, and 1/Q for Gad-1 at pH 7.0 and pH 5.0 are
shown in Table 5.4. The values of X and Keq are smaller at pH 5.0 than at pH
7.0. This suggests that when a peptide has more positive charge, less peptide is
accommodated on the membrane surface and less peptide is needed to neutralize
the membrane charge. Also, electrostatic repulsions between individual peptide
molecules might limit the peptide binding to the membrane. The peptide binding
to the membrane is stronger at pH 7.0 compared to pH 5.0 as indicated by the
higher values of Keq at pH 7.0. The number of lipids per bound peptide are higher
at pH 5.0 than at pH 7.0. The interpretation of these results is given in Section
5.5.
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(a)
(b)
Figure 5.21: (a) ∆ζ∆ζmax
vs. [P ]Total for Gad-1 at pH 7.0. (b) The linear regime (0
µM - 2 µM) was selected and slope of this region was used to find X using Equation
5.6. The slope of the linear portion of the binding isotherm was obtained using the
weighted linear fitting. The size of error bars was taken into account to estimate
the uncertainty in the slope. Q was determined from the limiting value of zeta
potential using Equation 5.8. The equilibrium constant (Keq) was determined
using the expression, Keq(1−X), for slope from Equation 5.7.
Chapter 5. Investigating the role of cardiolipin in the AMP-membrane
interactions 207
(a)
(b)
Figure 5.22: (a) ∆ζ∆ζmax
vs. [P ]Total for Gad-1at pH 7.0. (b) The linear regime (0
µM - 3 µM) was selected and slope of this region was used to find X using Equation
5.6. The slope of the linear portion of the binding isotherm was obtained using the
weighted linear fitting. The size of error bars was taken into account to estimate
the uncertainty in the slope. Q was determined from the limiting value of zeta
potential using Equation 5.8. The equilibrium constant (Keq) was determined
using the expression, Keq(1−X), for slope from Equation 5.7.
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Gad-1
pH
Molar fraction of
peptide bound to the
membrane (X)
1/Q (number of lipids
per peptide binding
site)
Equilibrium
constant,Keq
(µM−1)
7.0 0.8±0.1 24± 3 2±1
5.0 0.31±0.01 33 ± 2 0.38± 0.04
Table 5.4: The values of X, 1/Q, Keq for Gad-1 at pH 7.0 and pH 5.0.
5.5 Discussion
In order to understand the role of cardiolipin (CL) in AMP-membrane interac-
tions, a series of 2H NMR and zeta potential experiments were performed with
model membranes composed of POPE/POPG/CL in the presence of Gad-1. To
investigate how these membrane-peptide interactions were affected by the change
in overall peptide charge, all experiments were performed at two pH values, 7.0
and 5.0.
The first step was to characterize how incorporation of CL modified the proper-
ties of POPE/POPG lipid bilayers. To examine how the addition of CL affects
the fast motions of POPE/POPG-d31 lipid bilayers that contribute to the mo-
tional narrowing, the 2H NMR spectrum of POPE/POPG-d31/CL was obtained
and compared to the 2H NMR spectrum of POPE/POPG-d31 (Figure 5.4). This
comparison suggests that addition of CL to POPE/POPG-d31 lipid bilayers did
not change quadrupole splittings of the spectral doublets. In other words, CL did
not affect the amplitude of lipid acyl chain motions that can result in motional
narrowing.
In order to investigate the effect of pH on the lipid−only spectrum of POPE/POPG-
d31/CL, the 2H NMR spectrum of POPE/POPG-d31/CL at pH 7.0 was compared
Chapter 5. Investigating the role of cardiolipin in the AMP-membrane
interactions 209
with the spectrum of bilayers with the same composition obtained at pH 5.0 (Fig-
ure 5.8). This comparison indicates that changing the pH from 7.0 to 5.0 did not
have any effect on the spectral shape and spectrum maximum splitting of 2H NMR
spectrum of POPE/POPG-d31/CL.
The comparison described immediately above indicates that the presence of CL
did not perturb the fast motions of POPE/POPG-d31 lipid bilayers that con-
tribute to motional narrowing. In order to investigate if CL perturbs motions of
POPE/POPG-d31 lipid bilayers with correlation times longer than the character-
istic 2H NMR timescale (10−5s), the quadrupole echo decay time was determined
in the presence of CL. Figure 5.9 and Figure 5.10 show the quadrupole echo decay
times of POPE/POPG-d31 lipid bilayers with and without the addition of CL at
pH 7.0 and at pH 5.0. The addition of CL reduced the quadrupole echo decay time
of POPE/POPG-d31 lipid bilayers at pH 7.0 and at pH 5.0. As the addition of CL
to POPE/POPG-d31 did not seem to affect the fast motion of lipid bilayers that
contribute to the motional narrowing, the changes in the quadrupole echo decay
time with the addition of CL to POPE/POPG-d31 lipid bilayers suggests that CL
perturbs the slower motions of POPE/POPG-d31 lipid bilayers, such as bilayer
undulations. The contribution to echo decay rate for slow motions is inversely
proportional to correlation time. The decrease in echo decay times (increase in
echo decay rate) with the addition of CL indicates the reduction in correlation
times for the slower motions.
To investigate whether higher CL concentrations might affect the fast motions
of POPE/POPG-d31 lipid bilayers that contribute to the motional narrowing, 2H
NMR spectra of POPE/POPG-d31/CL were also obtained when the amount of CL
was doubled from 5% to 10% of the total lipid concentration. Comparison of 2H
NMR spectra for POPE/POPG-d31/CL at two concentrations of CL (Figure 5.3
and Figure 5.5) indicates that increasing CL concentration did not affect the fast
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lipid chain motions that can change the quadrupole splitting. Figure 5.9, shows
the values of echo decay times for two concentrations of CL at both pH values
and both temperatures studied. The echo decay times of the observed spectra did
not change with an increase in CL concentration. Taken together, these results
showed adding a small amount of CL (5% of total lipid composition) changed the
echo decay times but doubling the amount (10% of total lipid composition) added
did not increase the effect. This implies that the presence of CL does perturb
the motions that determine echo decay time but that the effect saturates at a
relatively small CL concentration so that adding more CL did not enhance the
effect.
After investigating the effects of CL on the bilayer motions of POPE/POPG, the
interactions of Gad-1 with POPE/POPG-d31/CL lipid bilayers were examined. To
investigate how the presence of CL affects the response of POPE/POPG bilayers
to Gad-1, the 2H NMR spectra of POPE/POPG-d31/CL and POPE/POPG-d31
at pH 7.0 were compared in the presence and absence of Gad-1 (Figure 5.12). The
addition of Gad-1 to both POPE/POPG-d31 and POPE/POPG-d31/CL lipid
bilayers reduced all of the POPG-d31 acyl chain quadrupole doublet splittings.
This means the peptide slightly increased the amplitude of lipid acyl chain mo-
tion. The extent of this perturbation is same in both POPE/POPG-d31 and
POPE/POPG-d31/CL bilayers. In addition to this, however, Gad-1 also broadened
the quadrupole peaks in the case of POPE/POPG-d31/CL. This might indicate
that Gad-1 perturbs slow motions of lipid bilayers that affect the refocusing of the
quadrupole echo signal. This can be investigated by determining the quadrupole
echo decay time as discussed later in this Section.
The next step was to investigate if peptide-induced disorder in POPE/POPG-
d31/CL bilayers by Gad-1 was sensitive to pH. For this, the 2H NMR spectrum
of POPE/POPG-d31/CL was obtained with the addition of Gad-1 at pH 5.0 and
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compared to the spectrum obtained at pH 7.0 (Figure 5.15). This comparison
indicates that the perturbation of POPE/POPG-d31/CL lipid bilayers by Gad-1
was not pH- sensitive and thus not sensitive to the charge of Gad-1.
Additional information about the peptide-induced perturbation of POPE/POPG-
d31/CL lipid bilayers was obtained from the quadrupole echo decay time. The
changes in the echo decay time of POPE/POPG-d31/CL with the addition of
Gad-1 indicates the perturbation of slower bilayer motions with correlation times
greater than the characteristic 2H NMR time scale (10−5s). A reduction in spec-
trum splittings at the same time as the individual doublets are broadened suggests
that both fast and slow motions were affected by the presence of CL.
Figure 5.16 and Figure 5.17 shows the quadrupole echo decay times for POPE/POPG-
d31 and POPE/POPG-d31/CL lipid bilayers, with and without the addition of
Gad-1, at pH 7.0 and pH 5.0, at two temperatures, 25◦C and 37◦C. For lipid
only samples (POPE/POPG-d31 and POPE/POPG-d31/CL) the quadrupole echo
decay time was only weakly dependent on temperature. The addition of CL to
POPE/POPG-d31 lipid bilayers the reduced quadrupole echo decay time. This
reduction in the echo decay time was not pH-sensitive. In the presence of Gad-1,
the quadrupole echo decay time of POPE/POPG-d31/CL lipid bilayers was inde-
pendent of temperature. Notably, Gad-1 seemed to have opposite effects on the
echo decay time of POPE/POPG-d31/CL lipid bilayers at pH 7.0 and pH 5.0.
The addition of Gad-1 to POPE/POPG-d31/CL lipid bilayers decreased the echo
decay time at pH 7.0 while it increased the echo decay time at pH 5.0. Gad-1
had similar effects on chain orientational order which suggests that the effects of
Gad-1 on fast (short correlation time) motion is similar for both pH values. Any
pH-dependence in the perturbation of quadrupole echo decay by Gad-1 reflects
effects on slower (longer length scale) motions like bilayer undulation. Another in-
teresting observation is that adding Gad-1 and CL together to POPE/POPG-d31
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lipid bilayers reduced the quadrupole echo decay time. This might indicate that
CL perturbs the slow motions of lipid bilayer in a similar way as Gad-1 perturbs
the slow bilayer motions.
After observing the effects of Gad-1 on the fast and slow motions of POPE/POPG-
d31/CL lipid bilayers, the binding of Gad-1 to POPE/POPG/CL lipid bilayers
was studied quantitatively using zeta potential measurements. In the absence of
peptide, a negative zeta potential of ∼-55 mV is observed for POPE/POPG/CL
(79/16/5 molar ratio) lipid vesicles at pH 7.0 and pH 5.0. The addition of pep-
tide results in progressive neutralization of the negative zeta potential of the lipid
vesicles. This reduction in the magnitude of the zeta potential indicates an inter-
action of the negatively charged membrane with the positive peptide. At higher
concentrations of Gad-1 peptide, the zeta potentials of POPE/POPG/CL vesicles
approach negative limiting values depending on the charge of the peptide and the
(L : P ) ratio when all binding sites are occupied. The sign of the limiting zeta
potential, at high peptide concentration, is an interesting difference between the
vesicles with and without CL incorporated.
Comparison of the zeta potential binding isotherms of POPE/POPG/CL (79/16/5
molar ratio) and POPE/POPG (3:1 molar ratio) provides a way to compare the
binding of Gad-1 to two lipid vesicles qualitatively. At pH 7.0, the zeta potential
reached a positive limit of ∼+5 mV for POPE/POPG lipid vesicles while it ap-
proached a negative limit of ∼-25 mV for POPE/POPG/CL vesicles. At pH 5.0,
the zeta potential reached the positive limit of ∼+20 mV for POPE/POPG lipid
vesicles while it approached a negative limit of ∼-5 mV for POPE/POPG/CL
vesicles. It should be noted that for both lipid vesicles the effective zwitterionic to
negative lipid ratio was 3:1. Comparisons of the zeta potential binding isotherms
indicate that in the presence of CL, Gad-1 did not fully neutralize the membrane
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charge. This suggests that it is the presence of CL, not just the membrane charge,
that affects the binding of Gad-1 to POPE/POPG lipid bilayers.
The comparison of values of X for POPE/POPG and POPE/POPG/CL lipid bi-
layers gives an idea how the presence of CL could affect the total amount of peptide
that can be accommodated on the membrane surface. For Gad-1, the fraction of
peptide bound to the membrane at pH 7.0 is greater than the fraction of peptide
bound to the membrane at pH 5.0 for both lipid mixtures. This suggests that the
higher the peptide charge, the smaller the amount of peptide accommodated on
the membrane. This may be due to the fact that when a peptide has more positive
charge, less peptide is needed to neutralize the membrane charge and electrostatic
repulsive interactions between peptide molecules limit the peptide binding to the
membrane. The values of X for POPE/POPG and POPE/POPG/CL lipid bi-
layers are compared in Table 5.5. This comparison indicates that the fraction
of Gad-1 bound to POPE/POPG/CL lipid bilayers is approximately two times
greater than the fraction of Gad-1 bound to POPE/POPG lipid bilayers at pH
7.0. At pH 5.0, the fraction of Gad-1 bound to both types of lipid bilayers is
approximately same. It is interesting to observe that even though the zwitterionic
to negative lipid ratio is same in both type of lipid bilayers, the presence of CL
allows more peptide to be accommodated on the lipid bilayer at pH 7.0. It has
been reported in the previous peptide binding studies that CL increases binding
of the peptide to lipid bilayers [176, 177]. AMPs have also been shown to induce
the clustering of anionic lipids [147, 148, 150, 151, 178]. The clustering of anioinic
lipids creates a region that is rich in negative charge and a cationic peptide might
be attracted to this negative-charge-rich lipid domain due to strong electrostatic
interactions. Clustering of CL would form a CL-rich domain that has more nega-
tive charge compared to PG-rich domain. In addition to this, CL has a relatively
smaller head group compared to its acyl chain region. Hence CL provides more
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room for peptide to accommodate in the head group area. This might explain that
the increased accommodation of peptide on the membrane surface in the presence
of CL.
Molar fraction of peptide bound to the membrane (X)
lipid
bilayers
Gad-1
pH 7.0 pH 5.0
POPE/POPG-d31 0.48±0.02 0.35±0.01
POPE/POPG-d31 /CL 0.8±0.1 0.31±0.02
Table 5.5: Comparison of values of X for Gad-1 peptide for POPE/POPG-d31
and POPE/POPG-d31/CL bilayers at pH 7.0 and pH 5.0.
After investigating the fraction of peptide bound to the membrane, the next step
was to examine how tightly the peptide is bound to the membrane and how the
presence of CL affects this binding strength? The binding strength of Gad-1 to
POPE/POPG/CL lipid bilayers was characterized in terms of the equilibrium
constant (Keq). The Gad-1 the equilibrium constants for POPE/POPG-d31 and
POPE/POPG-d31/CL bilayers at pH 7.0 and pH 5.0 are listed in Table 5.6. The
higher value of Keq at pH 7.0 than at pH 5.0 suggests that the binding of Gad-1
to POPE/POPG/CL is tighter at pH 7.0 than at pH 5.0. In addition to this,
the binding strength of Gad-1 to POPE/POPG/CL lipid bilayers is pH-sensitive.
When compared to the binding strength of Gad-1 to POPE/POPG lipid bilayers,
it was observed that the presence of CL makes the binding of Gad-1 stronger.
This may be due to clustering of CL in the presence of Gad-1. As explained
above, the domain formation may result in the accommodation of more peptide
on the membrane and stronger binding of the peptide. However, the binding of
Gad-1 to POPE/POPG/CL lipid bilayers was weaker at pH 5.0 than at pH 7.0.
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This may be due to the fact that Gad-1 is less helical at pH 5.0 compared to pH
7.0. It has been observed in molecular dynamics simulations with Gad peptides
that more helical peptide structures tend to interact more strongly with planar
regions while peptide structure with smaller helical contents tend to interact with
disordered bilayer regions [143]. This may result in the weaker binding of Gad-1
to the membrane at pH 5.0 than at pH 7.0.
(Keq)
lipid
bilayers
Gad-1
pH 7.0 pH 5.0
POPE/POPG-d31 0.22±0.03 0.21±0.02
POPE/POPG-d31 /CL 2±1 0.38±0.04
Table 5.6: Comparison of values of Keq for Gad-1 peptide for POPE/POPG-d31
and POPE/POPG-d31/CL bilayers at pH 7.0 and pH 5.0.
The comparison of X shows how the fraction of peptide bound to the membrane
was affected by the different properties of peptide and the membrane. When
a certain fraction of peptide is bound to the membrane, the number of lipids
interacting with one molecule of bound peptide may also depend on properties of
the peptide and the membrane. This was investigated by comparing the lipid-to-
peptide ratios for Gad-1 peptide bound to two lipid bilayers, POPE/POPG and
POPE/POPG/CL, at different pH values (Table 5.7). L : P ratios were higher
at pH 5.0 than at pH 7.0 for both type of lipid bilayers. This suggests that the
higher the peptide charge, the larger the number of lipids per bound peptide.
AMPs are cationic and can interact more strongly with anionic lipids than with
zwitterionic lipids. A consequence of added Gad peptides recruiting anionic lipids
could result in domains or patches that are rich in anionic lipids surrounding the
peptide. Other AMPs including Myxinidin, Aurein 1.2, Arginine rich peptides
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(PR−9), (RR−9), (PI−9), and LL−37 [147, 148, 150, 151, 178] have been shown
to be able to cluster anionic lipids. For POPE/POPG/CL the L : P ratios were
higher than the L : P ratios for Gad-1 bound to POPE/POPG at both pH 7.0 and
pH 5.0. This suggests that, in the presence of CL, Gad-1 interacts with a larger
numbers of lipids. It has been reported in previous studies that CL can translocate
from the inner bilayer leaflet to the outer leaflet (CL flip-flop) in the presence of
polycationic substances [176, 179]. Considering these observations, Gad-1 might
be able to induce CL flip-flop and hence a higher number of interactions between
the peptide and lipid molecules.
1/Q
lipid
bilayers
Gad-1
pH 7.0 pH 5.0
POPE/POPG-d31 10±1 21±3
POPE/POPG-d31/CL 24±3 33±2
Table 5.7: Comparison of values of 1/Q for Gad-1 peptide for POPE/POPG-d31
and POPE/POPG-d31/CL bilayers at pH 7.0 and pH 5.0.
CL is, relatively, a small component of the bacterial membrane lipid composi-
tion, but it appears to play an important role in AMP-membrane interactions.
The presence of CL allows the membrane to accommodate more Gad-1. In ad-
dition to this, the peptide binds more strongly with the lipid bilayers containing
CL and it interacts with larger numbers of lipids in CL-containing model mem-
branes. Considering these observations, binding of Gad-1 to the membrane might
cause the clustering of anionic lipids (POPG and CL). This redistribution of lipids
would concentrate the negative charge in anionic lipid-rich domains to which more
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cationic peptide would be attracted. In addition to promoting the peptide con-
centration on the anionic membrane surface, domain formation could create phase
boundaries that could lead to the membrane destabilization [180].
Chapter 6
Discussion
The cell membrane is the primary target of AMPs [1, 2]. To fully understand the
mechanism of membrane destabilization by AMPs, it is important to elucidate how
membrane properties are affected by the binding of AMPs [3, 26, 35, 181–185].
Gad peptides are histidine-rich peptides, which makes the peptide overall charge
pH-dependent. This pH-dependence provides a way to understand the role of pep-
tide charge in AMP-membrane interactions. Also, Gad-1 and Gad-2 are paralogous
genes (coded by related genes), and hence have a potential to demonstrate how
specificity is tuned in natural peptide sequences [26]. In addition to antibacterial
activities, some AMPs have anticancer properties. The pH level of the extracel-
lular space surrounding solid tumors is significantly lower than the pH of normal
cells. Therefore, many attempts have been made to develop new pH-dependent
anti-cancer therapies which can be active in the lower pH space of solid tumors
[1, 186, 187]. The pH-dependent activity of histidine-rich Gad peptides provides
a way to understand their potential to treat tumors.
The major focus of this study was to understand how Gad peptides interact with
model lipid membranes, with particular attention to the question of how these
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interactions depend on the peptide overall charge and composition of model mem-
branes. In addition to variation of AMP-membrane interaction with pH, we are
also interested in studying the differences in AMP-membrane interactions for Gad-
1 and Gad-2. Physical methods, including NMR spectroscopy, zeta potential
measurements, and circular dichroism spectroscopy were used to study the AMP-
membrane interactions with Gad peptides. 2H NMR experiments were performed
to investigate how Gad peptides perturb the lipid bilayer integrity. Circular dichro-
ism spectroscopy was used to examine the secondary structure of Gad peptides
in model lipid membranes. To gain insights into the binding of Gad peptides to
model lipid membranes, zeta potential measurements were performed. To exam-
ine the positioning of Gad peptides in the lipid bilayers 15N NMR experiments
were carried out. All experiments were performed with model lipid membranes
that mimic the bacterial membrane lipid composition. Firstly, 2H NMR and zeta
potential experiments were performed with a lipid mixture of POPE/POPG. Sec-
ondly, experiments were performed with a lipid mixture of POPE/POPG/CL to
gain insights into the role of CL in AMP-membrane interactions. 15N NMR ex-
periments were performed with mechanically oriented lipid bilayers using a lipid
mixture of POPC/POPG.
When a peptide interacts with the model lipid membrane, the peptide may perturb
the packing of hydrophobic acyl chains. Perturbation of model bilayers by Gad
peptides was studied using 2H NMR. It was found that adsorption of Gad peptides
to POPE/POPG-d31 bilayers slightly reduced the lipid acyl chain order. Many
helical cationic peptides such as MSI-78 [188], LL-37, Magainin [189], alamethicin
[190], ampullosporin [137], have been shown to induce disorder in bilayer lipid
acyl chains. Gad peptides perturb the membrane to a similar degree to the other
mentioned peptides. The decrease in lipid acyl chain order has been related to
the membrane thinning induced by the presence of peptide [189, 191, 192]. This
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membrane destabilization by AMPs can result in impairment of many membrane-
associated functions [45, 57]. Next, pH-dependence of peptide-induced disorder
was examined and it was found that the reduction in order parameter by Gad
peptides was not pH-dependent. The histidine-rich synthetic peptide LAH4-L1
also induced a slight reduction in the order parameter values of POPE/POPG-d31
lipid vesicles. However, in the case of L4H4-1, the reduction in order parameter was
weakly dependent on pH [75]. This may suggest that different AMPs disrupt the
membrane by different means. It is still unclear whether there is one fundamental
mechanism or there are different multiple mechanisms for AMP action[193].
Knowledge of AMP peptide orientation in the membrane can contribute to under-
standing of the mechanism of membrane destabilization by AMPs. The alignment
of Gad-1 in oriented model lipid bilayers was examined using 15N NMR, (Chapter
4). The 15N NMR observation showed that Gad-1 aligned parallel to the membrane
surface. Other alpha-helical peptides such as Magainin [85], Piscidin-1, Piscidin-3
[194], Cecropin A [195] have also been shown to adopt in-plane alignment with
respect to the membrane. While 15N NMR was found to be useful for samples con-
taining Gad-1, it was found that obtaining 15N NMR spectra with Gad-2 peptide
was not feasible. The dry weight of a chemically synthesized peptide is known to
contain a substantial amount of non-peptide contaminants, mainly salt form the
HPLC purification. However, Gad-2 peptide dry powder contained larger fraction
of salt than for Gad-1(discussed in Section 4.3). The amount of salt present in the
dry peptide powder reduced the amount of peptide actually present in the sample
and the obtained 15N NMR spectrum had poor signal-to-noise ratio.
Binding studies of Gad peptides with model lipid membranes showed that there
is a difference in the binding of Gad-1 and Gad-2 to the membrane even though
peptide-induced disorder was similar for the two peptides in the same model lipid
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membrane composed of POPE and POPG lipids. Also, unlike the case for peptide-
induced acyl chain disorder, the binding of Gad peptides to the membrane was
also found to have a pH-dependence. The results showed that for both Gad-1
and Gad-2, smaller amounts of peptide bind to the membrane at slightly acidic
pH compared to neutral pH. Also, the peptide interacts with a larger number of
lipid molecules at acidic pH than at neutral pH. Added cationic Gad peptides
can interact more strongly with anionic lipids than with zwitterionic lipids due to
electrostatic forces. The molecular interactions between cationic Gad peptides and
anionic lipids can result in the reorganization of membrane lipids and promotion
of anionic lipid clustering. Taken together, 2H NMR and zeta potential results
suggest that Gad peptides might disrupt membrane integrity by clustering the
anionic lipids rather than by inducing a disorder in the hydrophobic core of the
lipid membrane. The lipid clustering model has been proposed for other AMPs as
well [45, 57, 149, 180]. The differences in the binding of Gad-1 and Gad-2 to the
model lipid membrane may be attributed to the differences in the distribution of
charge, to differences in helical contents of their secondary structure upon binding
to the membrane, and to differences in the presence of histidine pairs in their
sequences.
To understand the role of CL in AMP-membrane interactions, 2H NMR and zeta
potential experiments were performed with model membranes containing CL in
the presence of Gad-1 (Chapter 5). The main finding was that the presence of
CL allows the membrane to accommodate more Gad-1. It was also found that
the presence of CL allows the peptide to bind more strongly with the membrane
and to interact with a larger number of lipids. The stronger interactions between
cationic peptides and anionic lipids (POPG and CL) can result in a reorganization
of membrane lipids, increasing the concentration of anionic lipids and cationic
peptide within a membrane domain. In other words, the interactions of Gad
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peptides with model membranes containing CL may result in the promotion of
anionic lipid clustering. More experiments could be performed by using increasing
amounts of CL. Table 5.1 indicates that different bacterial species have different
amounts of CL in the membrane. The results of experiments at different CL
concentrations could contribute to understanding of how different amounts of CL
affects the AMP-membrane interactions.
The AMP-membrane interaction studies of Gad peptides described here suggest
that Gad peptides might be able to cause the clustering of anionic lipids in the
membrane. It has been reported in the literature that several peptides can target
the membrane lipids and can alter the bulk physical properties of the membrane
[196]. Peptide-induced clustering of anionic lipids is also likely to perturb existing
domains in the membrane and might destabilize the membrane by introducing
boundary defects [197–201].
The AMP-membrane interaction is a key factor in the antimicrobial action, both
when the membrane is the primary target or when the membrane is permeabilized
in the course of peptides gaining access to the intracellular components. The
work in this thesis contributes to our understanding of how a specific type of
AMP, the Gad peptides, interact with membranes at different pH values. The
study of AMP-membrane interactions will help to identify criteria to recognize
the important features of natural AMP sequences involved in the antimicrobial
action and thus assist in the design of AMP-based antibiotics to combat drug
resistance problem.
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6.0.1 Directions for future work
The work reported in this thesis investigates the interactions of histidine-rich
Gad peptides at different pH values. The AMP-membrane interactions for other
histidine-rich peptides have been studied but those studies have focused on in-
corporating histidine residue in designed peptide sequences. On the other hand,
Gad peptides are natural histidine-rich peptides, and hence provide a way to alter
the AMP charge and understand its role in AMP-membrane interactions. An-
other important point about this work is that AMP-membrane interactions are
investigated quantitatively in terms of different binding parameters using zeta po-
tential measurements. Much of the vast literature on interactions of AMPs with
model membranes is devoted to using lipids POPE, POPC, POPG for the model
membranes. This thesis reports the interactions of Gad peptides with model
membranes containing cardiolipin (CL), which is an important lipid-component
of bacterial membranes.
The main observation of this study was that Gad peptides might be able to cause
the clustering of anionic lipids in the membrane. In order to further investigate this
point, differential scanning calorimetry (DSC) experiments could be performed to
study phase/domain formation by Gad peptides in the model lipid membrane. It
is possible that histidine pairs in Gad peptide sequences might play a role in AMP-
membrane interactions. To understand the role of histidine pairs, future 2H NMR
and zeta potential experiments could be performed by using a scrambled peptide
sequence in which histidine is not present in pairs. The model membranes used in
this study mimic the membrane of E. coli which is a gram negative bacteria. It
would be interesting to investigate how Gad peptides interact with model mem-
branes mimicing the composition of gram positive bacteria. In terms of looking
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at the bigger picture of AMP study, future binding study experiments could be
planned with real bacterial membranes.
Appendices
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Appendix A
Density operator formulation of
spin 12 and spin 1 system
A.1 Density operator
The total magnetization is the sum of innumerable small contributions from indi-
vidual spins. One way to acquire this summation is to treat all spins individually
and then add the results to get net magnetization. Another alternative is to use
the concept of density operator, which describes the quantum state of an entire
sample, without referring to individual spins. The density operater formulation
treats the sample as an ensemble average where ensemble is a collection of inde-
pendent identical systems.
For spin 12 system, a single spin state can be represented as the superposition of
states α and β [87]
|Ψ〉 = Cα |α〉+ Cβ |β〉 (A.1)
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where Cα and Cβ represent the probability of α and β states respectively. In the
matrix form spin state can be written as
|Ψ〉 =
Cα
Cβ
 〈Ψ| = [Cα Cβ] . (A.2)
The expectation value of any operator Qˆ can be expressed in terms of Ψ [87]
〈Qˆ〉 = 〈Ψ| Qˆ |Ψ〉
= Tr[〈Ψ| |Ψ〉]Qˆ
(A.3)
where
〈Ψ| |Ψ〉 =
CαC
∗
α CαC
∗
β
CβC
∗
α CβC
∗
β
 . (A.4)
Consider a system of two independent spins with spin states Ψ1 and Ψ2, respec-
tively. In this case, the observed value of Q is given as
QObservable = 〈Ψ1| Qˆ |Ψ1〉+ 〈Ψ2| Qˆ |Ψ2〉 (A.5)
= Tr[〈Ψ1| |Ψ1〉+ 〈Ψ2| |Ψ2〉]Qˆ. (A.6)
The above formulation can be extended to a system containing N number of spins
QObservable = 〈Ψ1| Qˆ |Ψ1〉+ 〈Ψ2| Qˆ |Ψ2〉+ ......+ 〈ΨN | Qˆ |ΨN〉 (A.7)
= Tr[〈Ψ1| |Ψ1〉+ 〈Ψ2| |Ψ2〉+ ........+ 〈ΨN | |ΨN〉]Qˆ (A.8)
= NTr[ρˆQˆ]. (A.9)
The expectation value of operator Q is
< Qˆ >= Tr[ρˆQˆ] (A.10)
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where
ρˆ = 1
N
[〈Ψ1| |Ψ1〉+ 〈Ψ2| |Ψ2〉+ ........+ 〈ΨN | |ΨN〉] (A.11)
is called the density operator.
It is important to note that the < Qˆ > is not an expectation value for a single
spin, but rather, it is the average over the entire ensemble. Therefore, the result of
any macroscopic observable can be calculated by using two operators. One is the
density matrix operator representing the spin state of the entire system without
referring to individual spins, and second is the observable itself [87, 90].
Furthermore, the density operator for a spin 12 system is a 2 ∗ 2 matrix
ρˆ =
CαC
∗
α CαC
∗
β
CβC
∗
α CβC
∗
β
 . (A.12)
The diagonal elements of the density matrix are called the populations, and the
off diagonal elements are called the coherences. The difference between the popu-
lations give the net magnetization in z axis, while coherences represent the mag-
netization in the xy plane [90, 91]. This density matrix concept can be used to
understand the effect of RF pulses on equilibrium magnetization.
A.2 Density operator formulation of spin 12 sys-
tem for (pi2 )x pulse
In order to understand how an oscillating magnetic field produced by a RF pulse
perturbs the equilibrium magnetization away from the z axis, it is helpful to
explain the behavior of a spin system in terms of the density operator[87, 89, 90,
93]. The density operator represents the quantum mechanical state of an entire
spin system without referring to the individual spins (Section A.1). The density
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operator treats the spin system as an ensemble and can be written in the matrix
form. For a spin 12 system, the density operator is a 2 × 2 matrix. The diagonal
elements represent the populations of α and β states and the difference between
the diagonal elements gives the net magnetization in the direction of field i.e. the
longitudinal component of magnetization. This represents the thermal equilibrium
state of a spin system. The off-diagonal elements of a density matrix are called
coherences. They oscillate harmonically in time. The vanishing of the off-diagonal
elements represent the equilibrium state of spin system. On the other hand, if off-
diagonal elements do not vanish it results in time varying observable signal in the
direction perpendicular to the static magnetic field [88]. The equation of motion
for the density operator ρ is given as [87, 89, 93]
dρ
dt
= −i[H, ρ] (A.13)
where H is the Hamiltonian of the spin system and ρ is the density operator. The
density operator can be written in terms of the unit operator, 1op, and a set of
three other independent operators P¯ [87, 93]
ρ(t) =
∑
P
CP (t)P¯ (A.14)
where
Tr[P¯ , P¯
′
] = δ
PP
′ . (A.15)
In Equation A.14, the CP represent the coefficients of different spin states. Using
Equation A.14, the Equation of motion of the density operator becomes
d(∑P CP (t)P¯ )
dt
= −i[H,∑
P
CP (t)P¯ ]. (A.16)
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For spin 12 system, there are three independent terms in the density operator.
So the Cartesian components of angular momentum can be used as independent
operators
Ix = 1/2
0 1
1 0
 , Iy = 1/2
0 −i
i 0
 , Iz = 1/2
1 0
0 −1
 .
(i) Zeeman Hamiltonian:
Before and after the RF pulse, the spin system evolves under the Zeeman Hamil-
tonian, Hz [87, 93]
Hz = −ω0Iz. (A.17)
Using this Hamiltonian, the Equation A.13 becomes
d[CxIx + CyIy + CzIz]
dt
= −i[−ω0Iz, CxIx + CyIy + CzIz] (A.18)
Ix
dCx
dt
+ Iy
dCy
dt
+ Iz
dCz
dt
= iω0{[Iz, CxIx], [Iz, CyIy], [Iz, CzIz]} (A.19)
= iω0{iCxIy − iCyIx}. (A.20)
The commutation relation [Ii, Ij] = iεijkIk is used in the above equation. By
comparing the coefficients on both sides we have
dCx
dt
= −iω0Cy (A.21)
dCy
dt
= iω0Cx (A.22)
dCz
dt
= 0. (A.23)
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The solution to the above equations can be written as
Cx(t) = Cx(0)cosω0t− Cy(0)sinω0t
Cy(t) = Cy(0)cosω0t+ Cx(0)sinω0t
Cz(t) = constant.
(A.24)
Initially, there is no magnetization in the xy plane. Therefore, Cx(0) = Cy(0) = 0
and Equation A.24 becomes
Cx(t) = 0
Cy(t) = 0
Cz(t) = constant.
(A.25)
If the initial conditions are set right i.e. Cx(0) = Cy(0) = 0, then the evolution of
spin system under the Zeeman Hamiltonian corresponds to the net magnetization
in the z axis.
(ii) pi2 pulse along x axis:
When a pi2 pulse is applied along the x axis, the system evolves under the following
Zeeman Hamiltonian [87, 93]
Hx = −ω1Ix. (A.26)
The equation of motion for the density operator becomes
d[CxIx + CyIy + CzIz]
dt
= −i[ω1Ix, CxIx + CyIy + CzIz]
= −i{[Ix, CxIx] + [Ix, CyIy] + [Ix, CzIz]}
= −iω1{iCyIz − iCzIy}.
(A.27)
Again, by comparing the coefficients on both sides we have
dCz
dt
= ω1Cy. (A.28)
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dCy
dt
= −ω1Cz. (A.29)
The solutions of the above equations are given as
Cz(t) = Cz(0)cosω1t+ Cy(0)sinω1t (A.30)
Cy(t) = Cy(0)cosω1t− Cz(0)sinω1t. (A.31)
For the special case
Cz(0) = M0, Cy(0) = 0, and ω1t =
pi
2 , the above solutions becomes:
Cz(t) = 0 (A.32)
Cy(t) = −M0 (A.33)
Hence, it can be seen that a pi2 pulse applied along the x axis flips the magnetization
from the z to the−y axis. This is depicted in Figure A.1. After the pi2 pulse, Equa-
tions A.24 describe precession of the magnetization about the z axis. The density
operator formulation can be used to understand the evolution of magnetization
for any pulse sequence.
Figure A.1: When the external magnetic field is applied along the z axis, the
equilibrium magnetization is formed in the direction of field. At this point, if
(pi2 )x pulse is applied, it flips the magnetization from the z to the -y axis.
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A.3 Density operator treatment of spin 1 system
The following treatment is based on the description presented by Bloom [93].
The density operator formulation can be used to understand the refocusing of
magnetization with quadrupole pulse sequence. Using Equation A.13 we have
d(∑q Cq(t)q¯)
dt
= −i[H,∑
q
Cq(t)q¯] (A.34)
Following 8 operators are used to express the density matrix of spin 1 system [93].
1¯ = 1√
2
Ix , 2¯ =
1√
2
Iy , 3¯ =
1√
2
Iz
4¯ = 1√
6
(3I2z − 2)
5¯ = 1√
2
(IxIz + IzIx), 6¯ =
1√
2
(IyIz + IzIy)
7¯ = 1√
2
(I2x − I2y ), 8¯ = 1√2(IxIy + IyIx)
Taking the trace with P¯ on both sides of Equation A.34, we have
dCP
dt
= −iT r{P¯ [H,∑
q
Cq(t)q¯]}
= iT r{P¯ [∑
q
Cq(t)q¯, H}
= i
∑
q
Cq{TrP¯ [q¯, H]}
(A.35)
When magnetic filed is applied in the z direction it results in the equilibrium
magnetization in the direction of field. Therefore,
C3 = M0
C1 = C2 = 0
(A.36)
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A.3.1 pi2 pulse along x axis
In this case, the spin system evolves under the Hamiltonian H1 = −
√
2ω11¯ [93].
The rate change of magnetization along z axis is given as
dC3
dt
= −√2ω1i
∑
q
CqTr{3¯[q¯, 1¯]}. (A.37)
The following commutator relation can be obtained by using the definition of
operators
[2¯, 1¯] = −i√
2
3¯. (A.38)
Therefore, Equation A.37 becomes
dC3
dt
= −ω1C2 (A.39)
Following the same treatment, the rate change of C2 can be determined
dC2
dt
=
√
2ω1i
∑
q
CqTr{2¯[q¯, 1¯]} (A.40)
dC2
dt
= −ω1C3 (A.41)
The solution of differential Equations A.39 and A.41 are given as
C3(t) = C3(0)cos(ω1t)− C2(0)sin(ω1t) (A.42)
C2(t) = C3(0)sin(ω1t)− C2(0)cos(ω1t) (A.43)
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For special case:
C3(0) = M0 , C2(0) = 0, and ω1t =
pi
2
C2(
pi
2ω1
) = M0 (A.44)
C3(
pi
2ω1
) = 0 (A.45)
Hence, the pi2 pulse applied along x axis results in the magnetization along y axis.
A.3.2 For time τ the spin system evolves under the Quadrupole
Hamiltonian
After the first pi2 pulse, the magnetization precesses in the xy plane under the
influence of the Quadrupole Hamiltonian
HQ =
√
2
3ωQ4¯. (A.46)
The rate change of the magnetization along y axis is given as
dC2
dt
= i
√
2
3ωQ
∑
q
CqTr{2¯[q¯, 4¯]}. (A.47)
Using the commutator relation
[5¯, 4¯] = −i
√
3
22¯ (A.48)
Equation A.47 becomes
dC2
dt
= ωQC5. (A.49)
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Now, the rate change of C5 is given as
dC5
dt
= i
√
2
3ωQ
∑
q
CqTr{5¯[q¯, 4¯]}. (A.50)
dC5
dt
= −ωQC2 (A.51)
The solutions of Equations A.49 and A.51 are
C2 = C2(0)cos(ωQt) + C5(0)sin(ωQt) (A.52)
C5 = C2(0)sin(ωQt)− C5(0)cos(ωQt) (A.53)
.
For special case:
C2(0) = M0, t = τ , and C5(0) = 0 above solutions becomes
C2(τ) = M0cos(ωQτ) (A.54)
C5(τ) = M0sin(ωQτ). (A.55)
A.3.3 pi2 pulse along y axis
During the second pi2 pulse is applied, the spin system precesses under the effect
of Hamiltonian
H2 = −
√
2ω12¯ (A.56)
In this case C2 = M0cos(ωQτ) is invariant and rate change of C5 is
dC5
dt
= −i√2ω1
∑
q
CqTr{5¯[q, 2¯]}. (A.57)
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Using the commutator relations [4¯, 2¯] = −i
√
3
25¯ and [7¯, 2¯] =
i√
2
5¯, Equation A.57
becomes
dC5
dt
= −√3ω1C4 + ω1C7
= −ω1{
√
3C4 − C7}.
(A.58)
Moreover, the rate change of C4 and C7 can be obtained as
dC4
dt
= −i√2ω1
∑
q
CqTr{4¯[q¯, 2¯]}
=
√
3ω1C5
(A.59)
dC7
dt
= −i√2ω1
∑
q
CqTr{7¯[q¯.2¯]}
dC7
dt
= ω1C5.
(A.60)
The Equations A.58 and A.60 can be combined as
√
3dC4
dt
+ dC7
dt
= 4ω1C5 . (A.61)
In this case the equations of motion are
dC5
dt
= −ω1(
√
3C4 + C7) (A.62)
d(
√
3C4 + C7)
dt
= 4ω1C5. (A.63)
The solutions to above equations are
C5 = C5(0)cos(2ω1t)− {
√
3C4(0) + C7(0)}cos(2ω1t) (A.64)
√
3C4 + C7 = C5(0)sin(2ω1t) + {
√
3C4(0) + C7(0)}cos(2ω1t). (A.65)
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For special case:
√
3C4(0) + C7(0) = 0 ans C5(0) = M0sin(ωQτ)
C5 = −M0sin(ωQτ) (A.66)
√
3C4 + C7 = 0 (A.67)
Now, if the system is further allowed to evolve under HQ for τ , Equation A.52 and
A.53 can be used to write expression for C2 and C5
C2 = M0cos2(ωQτ) +M0sin2(ωQτ) = M0 (A.68)
C5 = M0cos(ωQτ)sin(ωQτ)− sin(ωQτ)cos(ωQτ) = 0 (A.69)
Therefore, an echo is formed at the end of 2τ and refocuses the magnetization
along y axis.
Appendix B
NMR spectrometer and the
temperature controller
B.1 NMR spectrometer
The basic operational principle of a NMR spectrometer involves the irradiation of
a sample with a RF pulse generated by the transmitter section. This RF pulse
goes to the probe section and induces an oscillating magnetic field in the coil. If
the duration of the pulse is carefully chosen, this leaves the magnetization in the xy
plane where it precesses at the Larmor frequency. The FID signal produced by the
precessing magnetization in the coil is directed towards the receiver section where
it is amplified and processed to get a NMR spectrum. The main components of a
NMR spectrometer are explained below.
B.1.1 The magnet
The magnet is a heart of the NMR spectrometer. It produces a homogeneous and
static magnetic field that is used to generate the bulk magnetization in a sample.
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The magnet consists of a superconducting wire solenoid immersed in liquid helium
contained in a vessel that is surrounded by liquid nitrogen to minimize the helium
loss. The whole assembly is enclosed in a vacuum chamber to further reduce heat
flow. The probe containing the NMR sample is placed in the vertical tube passing
through the middle of the magnet.
B.1.2 The transmitter and the probe section
The main function of the transmitter section is to generate a RF pulse of desired
frequency, amplitude, and pulse length. The RF pulse from the transmitter is
delivered to the probe where sample is irradiated with the RF pulse to manipulate
the net magnetization of the sample.
The probe section consists of a coil and two capacitors known as matching and
tuning capacitors. The coil locates the sample in the homogeneous magnetic field.
When RF pulse is applied, it generates an oscillating current in the coil, which in
turn produces an oscillating magnetic field. This magnetic field exerts an external
torque on the net magnetization vector and moves it away form the z axis. The
precessing magnetization left after the pi2 pulse produces an oscillating current in
the coil that is amplified and stored as time domain FID signal.
B.1.2.1 Matching and tuning
In order to have maximum energy transfer from RF pulse to a sample, it is im-
portant to match the impedance of the transmitter section with the impedance
of probe circuit. Once impedance is matched, the RF pulse can be transferred to
the probe without any reflection. For impedance matching a variable capacitor
known as matching capacitor is used. Although, impedance matching ensures the
maximum transfer of RF pulse energy to sample but it is also necessary to tune
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the probe to enhance the amplitude of both the oscillating magnetic field produce
by RF pulse in the coil and the oscillating current produced by the precessing
magnetization in the same coil. This is achieved by using another variable ca-
pacitor known as the tuning capacitor. Basically, the tuning capacitor and the
coil (inductor) makes a tank circuit whose resonance frequency depends upon the
values of capacitance (C) and inductance (L) through
ω0 =
1√
(LC)
. (B.1)
The RF pulse generates oscillations in the coil. If the frequency of the RF pulse
matches with the resonance frequency of the tank circuit, the amplitude of these
oscillations is enhanced. This results in the large oscillating magnetic field produce
by the RF pulse in the coil. The amplitude of the oscillating current produced by
the precessing magnetization in the coil is also amplified if the LC circuit is tuned
[103].
B.1.2.2 Quarter wavelength transmission line
It is important to note that in a NMR experiment, same coil is used to excite
the sample and to detect the FID signal. Therefore, it is necessary to separate
the transmitter and the receiver sections. In other words, the RF pulse must
be directed towards the probe and blocked from travelling towards the receiver
section where it can damage the pre-amplifier. On the other hand, the FID signal
should go to the receiver section and must not travel back to the transmitter. To
achieve this, two set of crossed diodes and λ4 transmission line is used as shown
in Figure B.1. An individual set of the crossed diodes act like a switch that are
open for small voltage signal (FID signal) and closed for high voltage signals (RF
pulse). An individual set of the crossed diodes act like a switch that are open for
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small voltage signal (FID signal) and closed for high voltage signals (RF pulse).To
protect the pre-amplifier from the RF pulse during transmission, a set of crossed
diodes is placed just before the preamplifier and connected to ground. Both diode
switches are closed for high voltage RF signal. As soon as voltage developed at
point B is more than the forward bias voltage of the diodes, it will be shorted
to ground. Furthermore, if the distance between points A and B is exactly the
quarter of the wavelength then for a reflected wave, an anti-node and node is
formed at point A and B respectively. Thus, with this transmission set-up RF
pulse is directed towards the probe. On the other hand, the voltage of FID signal
is much too small to turn on the diodes. Therefore, the FID signal proceeds to
the pre-amplifier [103].
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(a)
(b)
Figure B.1: (a) The schematic representation of the probe section of the NMR
spectrometer with two crossed diode switches and λ4 transmission line. (b) A
picture of the NMR probe used in this work. The white rectangular piece at the
top of probe is the coil used to hold the sample.
B.1.3 Receiver section
The receiver section of a NMR spectrometer consists of a pre-amplifier and dig-
itizer. The FID signal is amplified by the pre-amplifier. The next step is the
digitization of FID signal followed by the Fourier transformation to obtain the
NMR spectrum in the frequency domain.
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B.2 Temperature controller
To do NMR experiments at desired temperatures, a temperature controller is
connected to the probe. The temperature controller used in this work is a PID
controller, model 325 (Lake Shore cryotronics, USA) where PID stands for Pro-
portional (P), Derivative (D) and Integral (I). It is a control loop feedback system
and the output of controller is sensed. The desired temperature is called a set
point. Based on the difference between set point and measured value, an error is
calculated. This error determines the correction provided by three controllers P,
I, and D [202].
(i) Proportional term: The proportional term must have value greater than
zero in order for the control loop to work. The proportional response is given by
an error multiplied with a constant known as proportional gain
P = Kpe(t). (B.2)
The higher value of a Kp results in the large change in the output for a given change
in error while a smaller value of it generates a slight change in the temperature
fluctuations from the desired set point.
(ii) Integral term: The integral term takes into account both the magnitude
and duration of an error. It is the accumulation of the instantaneous errors over
time given as
I = KI
∫ t
0
e(t)dt (B.3)
where KI is called the integral gain. Combined with the proportional term, the
integral term moves the measured value towards the set point quickly. It is noted
that the integral term responds to the past errors therefore, it can result in the
overshooting of the present value of measured variable.
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(iii) The derivative term: The derivative term consists of the rate change of
error multiplied by a constant called derivative gain
D = KD
de(t)
dt
. (B.4)
It slows down the rate change of output and damps the overshooting.
The response of P, I, and D for a given set point is shown in Figure B.2.
Figure B.2: The output of a PID temperature controller is shown in the above
figure. A horizontal line represent the set point. The orange line shows the
response of P,I,and D terms together.
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